<SEC-DOCUMENT>0001140361-26-002005.txt : 20260122
<SEC-HEADER>0001140361-26-002005.hdr.sgml : 20260122
<ACCEPTANCE-DATETIME>20260122132554
ACCESSION NUMBER:		0001140361-26-002005
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20260122
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260122
DATE AS OF CHANGE:		20260122

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Strive, Inc.
		CENTRAL INDEX KEY:			0001920406
		STANDARD INDUSTRIAL CLASSIFICATION:	FINANCE SERVICES [6199]
		ORGANIZATION NAME:           	09 Crypto Assets
		EIN:				881293236
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41612
		FILM NUMBER:		26550872

	BUSINESS ADDRESS:	
		STREET 1:		200 CRESCENT CT
		STREET 2:		SUITE 1400
		CITY:			DALLAS
		STATE:			TX
		BUSINESS PHONE:		855-427-7360

	MAIL ADDRESS:	
		STREET 1:		200 CRESCENT CT
		STREET 2:		SUITE 1400
		CITY:			DALLAS
		STATE:			TX

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Asset Entities Inc.
		DATE OF NAME CHANGE:	20220330
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ny20063534x3_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2025" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:asst="http://strive.com/20260122" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2026 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_22c7004511a34a66ab3d6b9048af361a" contextRef="c20260122to20260122" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_358e7cdac84e415d86e5d5d4b7934f1a" contextRef="c20260122to20260122">0001920406</ix:nonNumeric><ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_80deb7176f0f47178894d59ecea12264" contextRef="c20260122to20260122">TX</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_24b6ab989cd84664b903375412b82790" contextRef="c20260122to20260122_StatementClassOfStockAxis_ClassACommonStock0001ParValuePerShareMember">NASDAQ</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_14bd3851600745a9943ce5bd50bf8f37" contextRef="c20260122to20260122_StatementClassOfStockAxis_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember">NASDAQ</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="asst-20260122.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20260122to20260122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001920406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-22</xbrli:startDate><xbrli:endDate>2026-01-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20260122to20260122_StatementClassOfStockAxis_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001920406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">asst:VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-22</xbrli:startDate><xbrli:endDate>2026-01-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20260122to20260122_StatementClassOfStockAxis_ClassACommonStock0001ParValuePerShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001920406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">asst:ClassACommonStock0001ParValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-22</xbrli:startDate><xbrli:endDate>2026-01-22</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
<div><span style="font-size: 14pt;">UNITED





        STATES</span></div>
</div>

    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

    <div style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_c315a1d0e4bc41b0b926f684ab6026c3" contextRef="c20260122to20260122">8-K</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

    <div><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</div>

    <div><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_df120e472c91452f9dbd4aae818a98a4" contextRef="c20260122to20260122" format="ixt:date-monthname-day-year-en">January 22, 2026</ix:nonNumeric></div>

    <div style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 24pt;">
            <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_b8287a6aba0b467dbced28b6b9278476" contextRef="c20260122to20260122">STRIVE, INC.</ix:nonNumeric><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 100%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Exact name of Company as specified in its charter)</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 31.82%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_49b487f7ab844947af08c7a6a5f2579b" contextRef="c20260122to20260122" format="ixt-sec:stateprovnameen">Nevada</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 1.82%; vertical-align: top;">&#160;</td>

    <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_ec4955b7dbc949da98deee6a74566c5c" contextRef="c20260122to20260122">001-41612</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 1.82%; vertical-align: top;">&#160;</td>

    <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_85533a8a2e6f430595002a733ee65754" contextRef="c20260122to20260122">88-1293236</ix:nonNumeric><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 31.82%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(State or other jurisdiction</div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">of incorporation)</div>
          </td>

    <td style="width: 1.82%; vertical-align: top;">&#160;</td>

    <td style="width: 32%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Commission File Number)</div>
          </td>

    <td style="width: 1.82%; vertical-align: top;">&#160;</td>

    <td style="width: 32%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(IRS Employer</div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Identification No.)</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 66%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_63f10eccc74446bf8e6c17776034c873" contextRef="c20260122to20260122">200 Crescent Ct</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_cc577476b6b24626a2043648da48ed08" contextRef="c20260122to20260122">Suite 1400</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_6c60f85d359b44c1aea70e544af6535e" contextRef="c20260122to20260122">Dallas</ix:nonNumeric>, <span style="-sec-ix-hidden:Fact_80deb7176f0f47178894d59ecea12264">TX</span></div>
          </td>

    <td style="width: 1.82%; vertical-align: top;">&#160;</td>

    <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_ed3508ea180741b99e64425e27541513" contextRef="c20260122to20260122">75201</ix:nonNumeric><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 66%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Address of principal executive offices)</div>
          </td>

    <td style="width: 1.82%; vertical-align: top;">&#160;</td>

    <td style="width: 32%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Zip Code)</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_140592797eff4b99ab312b5683ff66db" contextRef="c20260122to20260122">855</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_d313a6e2805642a891cdf982d39e7dfd" contextRef="c20260122to20260122">427-7360</ix:nonNumeric></div>
          </td>

  </tr>

  <tr>

    <td style="width: 100%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Company&#8217;s telephone number, including area code)</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 100%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 100%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Former name or former address, if changed since last report)</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any of the
      following provisions:</div>

    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 4%; vertical-align: top; text-align: center;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_c2ae78445c6148f69c8a1d237ee62956" contextRef="c20260122to20260122" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
          </td>

    <td style="width: 96%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 4%; vertical-align: top; text-align: center;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_3f066cae1b5548939ab67a67431751f8" contextRef="c20260122to20260122" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
          </td>

    <td style="width: 96%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 4%; vertical-align: top; text-align: center;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_3d2f2f4b74084ef99ba084013a18585a" contextRef="c20260122to20260122" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
          </td>

    <td style="width: 96%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 4%; vertical-align: top; text-align: center;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_3341b649c51a421cb6b0973ee3713d41" contextRef="c20260122to20260122" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
          </td>

    <td style="width: 96%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 38.18%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Title of each class</div>
          </td>

    <td style="width: 1.82%; vertical-align: top;">&#160;</td>

    <td style="width: 19.09%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Trading Symbol(s)</div>
          </td>

    <td style="width: 1.82%; vertical-align: top;">&#160;</td>

    <td style="width: 39.09%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Name of each exchange on which registered</div>
          </td>

  </tr>

  <tr>

    <td style="width: 38.18%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_6c3188cea9a24333a7b56dcd7ceeaf27" contextRef="c20260122to20260122_StatementClassOfStockAxis_ClassACommonStock0001ParValuePerShareMember">Class A Common Stock, $0.001 par value per share</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 1.82%; vertical-align: top;">&#160;</td>

    <td style="width: 19.09%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_786ffee9e8dd437aac328021fd8f578e" contextRef="c20260122to20260122_StatementClassOfStockAxis_ClassACommonStock0001ParValuePerShareMember">ASST</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 1.82%; vertical-align: top;">&#160;</td>

    <td style="width: 39.09%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_24b6ab989cd84664b903375412b82790">The Nasdaq Stock Market LLC</span><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 38.18%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_d7adc930e2bc4018ab12cff9960f7b0f" contextRef="c20260122to20260122_StatementClassOfStockAxis_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember">Variable Rate Series A Perpetual Preferred Stock, $0.001 par value per share</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 1.82%; vertical-align: top;">&#160;</td>

    <td style="width: 19.09%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_1c3e24aeea304ccea0f6cd10c1ec1cd3" contextRef="c20260122to20260122_StatementClassOfStockAxis_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember">SATA</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 1.82%; vertical-align: top;">&#160;</td>

    <td style="width: 39.09%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_14bd3851600745a9943ce5bd50bf8f37">The Nasdaq Stock Market LLC</span><br/>
            </div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Indicate by check mark whether the Company is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the
      Securities Exchange Act of 1934.</div>

    <div><br/>
    </div>

    <div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Emerging Growth Company&#160;&#160; <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_0e2a3374d6b34194b351a4cc342bcacd" contextRef="c20260122to20260122" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></div>

    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">If an emerging growth company, indicate by check mark if the Company has elected not to use the extended transition period for complying with any new or
      revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric name="dei:EntityExTransitionPeriod" id="Fact_f177263797de45debb9e82a8c02672ca" contextRef="c20260122to20260122" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

    <div>
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 7%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 1.01</div>
          </td>

    <td style="width: 93%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Entry into a Material Definitive Agreement</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">On January 22, 2026, Strive, Inc. (&#8220;Strive&#8221; or the &#8220;Company&#8221;) entered into an
        underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Barclays Capital Inc. and Cantor Fitzgerald &amp; Co., as the joint book-running managers and representatives of the several underwriters (the &#8220;Underwriters&#8221;), relating to the issuance and
        sale in an underwritten offering (the &#8220;Offering&#8221;) registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), of 1,320,000 shares (the &#8220;Shares&#8221;) of the Company&#8217;s Variable Rate Series A Perpetual Preferred Stock, $0.001 par value
        per share (the &#8220;SATA Stock&#8221;), </span>an upsize over the $150 million transaction size previously announced when taken together with the anticipated privately negotiated notes exchanges<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">, at a public offering price of $90 per share. The issuance and sale of the SATA Stock is scheduled to settle on January 27, 2026, subject to customary closing conditions.</span></div>

    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company estimates that the gross proceeds from the Offering will be approximately $118.8 million, before deducting the underwriting discounts and
      commissions and the Company&#8217;s estimated offering expenses. The Company intends to use the net proceeds of this Offering, together with cash on hand and potentially cash from terminating the existing capped call transactions relating to the
      outstanding 4.250% Convertible Senior Notes due 2030 (the &#8220;Semler Convertible Notes&#8221;) issued by Semler Scientific, Inc., a wholly-owned subsidiary of the Company (&#8220;Semler Scientific&#8221;), and guaranteed by the Company, pursuant to an indenture, dated as
      of January 28, 2025, between Semler Scientific and U.S Bank Trust Company, National Association, as trustee (the &#8220;Trustee&#8221;), as amended by a supplemental indenture, dated January 16, 2026, by and among Semler Scientific, the Company and the Trustee,
      (i) to finance the redemption, repurchase, repayment, satisfaction and discharge or other payment of all or a portion of the Semler Convertible Notes and Semler Scientific&#8217;s outstanding borrowings under its master loan agreement with Coinbase Credit
      Inc., which may include one or more repurchases pursuant to privately negotiated transactions, and the payment of accrued and unpaid interest thereon, with the purpose of returning to a perpetual-preferred only amplification model, (ii) the
      acquisition of bitcoin and bitcoin-related products and (iii) for working capital and general corporate purposes.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Underwriting Agreement contains customary representations, warranties, and agreements by the Company, customary conditions to closing, indemnification
      obligations of the Company and the Underwriters, including for liabilities under the Securities Act, other obligations of the parties, and termination provisions.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Offering is being made pursuant to an effective shelf registration statement on Form S-3ASR (Registration No. 333-290252) on file with the Securities
      and Exchange Commission (the &#8220;SEC&#8221;). The Offering will be made only by means of a prospectus supplement and an accompanying prospectus.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The foregoing description of the Underwriting Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the
      Underwriting Agreement, which is filed herewith as Exhibit 1.1 and incorporated herein by reference.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">A copy of the press release is filed hereto as Exhibit 99.1 and is incorporated herein by reference.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Neither this Current Report on Form 8-K nor the press release filed hereto constitutes an offer to sell or the solicitation of an offer to buy any
      securities or an offer to purchase, a solicitation of an offer to sell, or a notice of redemption with respect to the Semler Convertible Notes.</div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 7%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 8.01.</div>
          </td>

    <td style="width: 93%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Other Events.</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On January 22, 2026, the Company also announced that it expects to enter into privately negotiated exchange agreements with certain holders of the Semler
      Convertible Notes, representing $90 million aggregate principal amount of the Semler Convertible Notes, pursuant to which such holders would exchange their Semler Convertible Notes for approximately 930,000 newly issued shares of SATA Stock. The
      Offering is not conditioned on the consummation of all or any portion of such exchanges. Such agreements remain subject to the signing of binding agreements, and any such exchanges will be subject to customary closing conditions.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">On January 22, 2026, the Company issued a press release relating to the
        pricing of the Offering and the exchange agreements. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference.</span></div>

    <div><br/></div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Cautionary Statement Regarding Forward-Looking Statements</div>

    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Certain statements herein and the press release attached hereto may constitute &#8220;forward-looking statements&#8221; within the meaning of the Private Securities
      Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Rule 175 promulgated thereunder, and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and Rule 3b-6
      promulgated thereunder, which statements involve inherent risks and uncertainties. Examples of forward-looking statements include, but are not limited to, statements regarding the outlook and expectations of Strive and Semler Scientific,
      respectively, with respect to the merger transaction (the &#8220;merger transaction&#8221;), the strategic benefits and financial benefits of the merger transaction, including the expected impact of the merger transaction on the combined company&#8217;s future
      financial performance, the ability to successfully integrate the combined businesses, the estimated net proceeds of the Offering, the anticipated timing of settlement, the anticipated use of any proceeds from the Offering, the terms of the securities
      being offered and the Company&#8217;s intentions with respect to adjusting the SATA Stock monthly regular dividend rate per annum. Such statements are often characterized by the use of qualified words (and their derivatives) such as &#8220;may,&#8221; &#8220;will,&#8221;
      &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;assume,&#8221; &#8220;forecast,&#8221; &#8220;target,&#8221; &#8220;budget,&#8221; &#8220;outlook,&#8221; &#8220;trend,&#8221; &#8220;guidance,&#8221; &#8220;objective,&#8221; &#8220;goal,&#8221;
      &#8220;strategy,&#8221; &#8220;opportunity,&#8221; and &#8220;intend,&#8221; as well as words of similar meaning or other statements concerning opinions or judgment of Strive, Semler Scientific or their respective management about future events. Forward-looking statements are based on
      assumptions as of the time they are made and are subject to risks, uncertainties and other factors that are difficult to predict with regard to timing, extent, likelihood and degree of occurrence, which could cause actual results to differ materially
      from anticipated results expressed or implied by such forward-looking statements as a result of various important factors, including the uncertainties related to market conditions and the completion of the Offering on the anticipated terms or at all
      or the uncertainties related to the satisfaction of closing conditions for the sale of the securities being offered. Other risks, uncertainties and assumptions, including, among others, the following:</div>

    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">the outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company;</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">the possibility that the anticipated benefits of the merger transaction, including anticipated cost savings and strategic gains, are not realized when expected or at
              all, including as a result of changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets, general economic and market conditions, interest and exchange rates,
              monetary policy, and laws and regulations and their enforcement;</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">the diversion of management&#8217;s attention from ongoing business operations and opportunities;</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">dilution caused by Strive&#8217;s issuance of additional shares of its Class A common stock in connection with the merger transaction;</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">potential adverse reactions of Strive&#8217;s or Semler Scientific&#8217;s customers or changes to business or employee relationships, including those resulting from the
              announcement or completion of the merger transaction;</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br/>
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">other factors that may affect future results of Strive, Semler Scientific or the combined company.</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">These factors are not necessarily all of the factors that could cause the combined company&#8217;s actual results, performance or achievements to differ
      materially from those expressed in or implied by any of the forward-looking statements. Other factors, including unknown or unpredictable factors, also could harm the combined company&#8217;s results.</div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Although Strive believes that its expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its
      existing knowledge of its business and operations, there can be no assurance that actual results of Strive will not differ materially from any projected future results expressed or implied by such forward-looking statements. Additional factors that
      could cause results to differ materially from those described above can be found in Strive&#8217;s Annual Report on Form 10-K, Strive&#8217;s Form S-4 filed on August 6, 2025 and October 10, 2025, under the &#8220;Supplementary Risk Factors&#8221; filed as an exhibit to
      Strive&#8217;s Current Report on Form 8-K filed with the SEC on September 24, 2025, Semler Scientific&#8217;s most recent annual report on Form 10-K for the fiscal year ended December 31, 2024 and quarterly reports on Form 10-Q, and other documents subsequently
      filed by Strive and Semler Scientific with the SEC.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The actual results anticipated may not be realized or, even if substantially realized, they may not have the expected consequences to or effects on Strive
      or its businesses or operations. Investors are cautioned not to rely too heavily on any such forward-looking statements. Forward-looking statements contained herein and the press release attached hereto speak only as of the date hereof, and Strive
      and Semler Scientific undertake no obligation to update or clarify these forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable law.</div>

    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">No Offer or Solicitation</div>

    <div><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Neither this Current Report on Form 8-K nor the press release attached hereto is intended to and shall not constitute an offer to sell or the solicitation
      of an offer to sell or the solicitation of an offer to buy any securities or the solicitation of any vote of approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to
      registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or pursuant to an exemption from, or
      in a transaction not subject to, such registration requirements.</div>

    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 7%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 9.01</div>
          </td>

    <td style="width: 93%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Financial Statements and Exhibits.</div>
          </td>

  </tr>


</table>
    <div>
      <div><br/>
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d) Exhibits</div>

      <div><br/>
      </div>

    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 8%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit No.</div>
          </td>

    <td style="width: 2.17%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Description</div>
          </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; white-space: nowrap;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20063534x3_ex1-1.htm">1.1</a></div>
          </td>

    <td style="width: 2.17%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Underwriting Agreement, dated January 22, 2026, by and between the Company, Barclays Capital Inc. and Cantor Fitzgerald &amp; Co., as the
              representatives of the several underwriters with respect to the Offering.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; white-space: nowrap;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20063534x3_ex99-1.htm">99.1</a></div>
          </td>

    <td style="width: 2.17%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Press Release of Strive, Inc. dated <span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">January 22, 2026</span>.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; white-space: nowrap;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">104</div>
          </td>

    <td style="width: 2.17%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

    <div><br/>
    </div>

    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on
      its behalf by the undersigned hereunto duly authorized.</div>

    <div><br/>
    </div>

    <div><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Date: January 22, 2026</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Strive, Inc.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">/s/ Matthew Cole</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Name: Matthew Cole</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Title: Chief Executive Officer</div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

  </div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ny20063534x3_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 1.1</font><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: center;"><font style="font-weight: bold;">1,320,000 SHARES OF</font></div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">VARIABLE RATE SERIES A PERPETUAL PREFERRED STOCK</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;"><u>UNDERWRITING AGREEMENT</u></div>
      <div>&#160;</div>
      <div style="text-align: right;">January 22, 2026</div>
      <div>&#160;</div>
      <div style="font-variant: small-caps;"><a name="z_Hlk210235503"></a>Barclays Capital Inc.</div>
      <div style="font-variant: small-caps;">Cantor Fitzgerald &amp; Co.,</div>
      <div>As Representatives of the several</div>
      <div>&#160;&#160;Underwriters named in Schedule I attached hereto,</div>
      <div>c/o Barclays Capital Inc.</div>
      <div>745 Seventh Avenue</div>
      <div>New York, New York 10019</div>
      <div>&#160;</div>
      <div>Ladies and Gentlemen:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">Strive, Inc., a Nevada corporation (the &#8220;<font style="font-weight: bold; font-style: italic;">Company</font>&#8221;), proposes to sell an aggregate of 1,320,000 shares (the &#8220;<font style="font-weight: bold; font-style: italic;">Securities</font>&#8221;) of the Company&#8217;s Variable Rate Series A Perpetual Preferred Stock, par value $0.001 per share, with a stated amount of $100.00 per share (&#8220;<font style="font-weight: bold; font-style: italic;">Preferred







          Stock</font>&#8221;) in the respective amounts set forth in Schedule I attached to this agreement (this &#8220;<font style="font-weight: bold; font-style: italic;">Agreement</font>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">On January 22, 2026, the Company announced that it expects to enter into privately negotiated exchange agreements with certain holders of the 4.250% Convertible Senior Notes due 2030 (the &#8220;<font style="font-weight: bold; font-style: italic;">Semler Convertible Notes</font>&#8221;) issued by Semler Scientific, Inc., a wholly-owned subsidiary of the Company (&#8220;<font style="font-weight: bold; font-style: italic;">Semler Scientific</font>&#8221;),
        representing $90 million aggregate principal amount of the Semler Convertible Notes, pursuant to which such holders would exchange their Semler Convertible Notes for approximately 930,000 newly issued shares of Preferred Stock (the &#8220;<font style="font-weight: bold; font-style: italic;">Exchange Transactions</font>&#8221;). This offering is not conditioned on the consummation of all or any portion of such exchanges. Such agreements remain subject to the signing of binding agreements, and
        any such exchanges will be subject to customary closing conditions.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><a name="z_Ref219566337"></a>1.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-style: italic;">Representations, Warranties and Agreements of the Company</font>.&#160; The Company represents, warrants and agrees that:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; A registration statement on Form S-3 (File No. 333-290252), including a base prospectus, relating to the offer and sale of certain securities of the Company,
        including the Securities, has (i) been prepared by the Company in conformity with the requirements of the Securities Act of 1933, as amended (the &#8220;<font style="font-weight: bold; font-style: italic;">Securities Act</font>&#8221;), and the rules and
        regulations of the Securities and Exchange Commission (the &#8220;<font style="font-weight: bold; font-style: italic;">Commission</font>&#8221;) thereunder; (ii) been filed with the Commission under the Securities Act; and (iii) become effective under the
        Securities Act.&#160; Copies of such registration statement and any amendment thereto have been delivered by the Company (or made available through the Commission&#8217;s Electronic Data Gathering Analysis Retrieval System (&#8220;<font style="font-weight: bold; font-style: italic;">EDGAR</font>&#8221;)) to you upon request as the representatives (the &#8220;<font style="font-weight: bold; font-style: italic;">Representatives</font>&#8221;) of the underwriters named in Schedule I (the &#8220;<font style="font-weight: bold; font-style: italic;">Underwriters</font>&#8221;).&#160; As used in this Agreement:</div>
      <div>&#160;</div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold; font-style: italic;">Applicable Time</font>&#8221; means 7:40 AM, New York City time, on January 22, 2026;</div>
      <div>&#160; <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">(ii)&#160;&#160;&#160; &#160; &#160; &#8220;<font style="font-weight: bold; font-style: italic;">Effective Date</font>&#8221; means the date and time as of which such registration statement, or the most recent
        post-effective amendment thereto, if any, became, or is deemed to have become, effective by the Commission in accordance with the rules and regulations under the Securities Act;</div>
      <div>&#160;
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">(iii)&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold; font-style: italic;">Governmental Authority</font>&#8221; means (i) any federal, provincial, state, local, municipal, national or
        international government or governmental authority, regulatory or administrative agency, governmental commission, department, board, bureau, agency or instrumentality, court, tribunal, arbitrator or arbitral body (public or private); (ii) any
        self-regulatory organization; or (iii) any political subdivision of any of the foregoing.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<font style="font-weight: bold; font-style: italic;">Issuer Free Writing Prospectus</font>&#8221; means each &#8220;issuer free writing prospectus&#8221; (as defined in Rule 433 under
        the Securities Act) relating to the Securities;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">(v)&#160;&#160;&#160; &#160; &#160; &#8220;<font style="font-weight: bold; font-style: italic;">Preliminary Prospectus</font>&#8221; means any preliminary prospectus relating to the Securities included in such
        registration statement or filed with the Commission pursuant to Rule 424(b) under the Securities Act;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">(vi)&#160;&#160;&#160; &#160;&#160; &#8220;<font style="font-weight: bold; font-style: italic;">Pricing Disclosure Package</font>&#8221; means, as of the Applicable Time, the most recent Preliminary Prospectus,
        together with the information included in Schedule II hereto, if any, and each Issuer Free Writing Prospectus filed or used by the Company at or before the Applicable Time, other than a road show, that is an Issuer Free Writing Prospectus but is
        not required to be filed under Rule 433 under the Securities Act;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">(vii)&#160; &#160;&#160;&#160; &#8220;<font style="font-weight: bold; font-style: italic;">Prospectus</font>&#8221; means the final prospectus relating to the Securities, including any prospectus supplement
        thereto related to the Securities, as filed with the Commission pursuant to Rule 424(b) under the Securities Act; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">(viii) &#160; &#160; &#8220;<font style="font-weight: bold; font-style: italic;">Registration Statement</font>&#8221; means, collectively, the various parts of such registration statement, each as
        amended as of the Effective Date for such part, including any Preliminary Prospectus or the Prospectus, all exhibits to such registration statement and including the information deemed by virtue of Rule 430A or Rule 403B under the Securities Act to
        be part of such registration statement as of the Effective Date; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; margin-left: 72pt; text-indent: 36pt;">(ix)&#160;&#160; &#160; &#160; &#8220;<font style="font-weight: bold; font-style: italic;">Testing-the-Waters Communication</font>&#8221; means any oral or written communication with potential investors
        undertaken in reliance on Section 5(d) of the Securities Act or Rule 163B under the Securities Act; and</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">(x)&#160;&#160;&#160;&#160;&#160; &#160; &#8220;<font style="font-weight: bold; font-style: italic;">Written Testing-the-Waters Communication</font>&#8221; means any Testing-the-Waters Communication that is a written
        communication within the meaning of Rule 405 under the Securities Act.</div>
      <div>&#160;</div>
      <div style="text-align: justify; margin-left: 36pt;">Any reference to any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any documents incorporated by reference therein pursuant to Form S-3 under the Securities Act
        as of the date of such Preliminary Prospectus or the Prospectus, as the case may be.&#160; Any reference to the &#8220;most recent Preliminary Prospectus&#8221; shall be deemed to refer to the latest Preliminary Prospectus included in the Registration Statement or
        filed pursuant to Rule 424(b) under the Securities Act prior to or on the date hereof.&#160; Any reference to any amendment or supplement to any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any document filed under
        the Securities Exchange Act of 1934, as amended (the &#8220;<font style="font-weight: bold; font-style: italic;">Exchange Act</font>&#8221;), after the date of such Preliminary Prospectus or the Prospectus, as the case may be, and before the date of such
        amendment or supplement and incorporated by reference in such Preliminary Prospectus or the Prospectus, as the case may be; and any reference to any amendment to the Registration Statement shall be deemed to include any document filed with the
        Commission pursuant to Section 13(a), 14 or 15(d) of the Exchange Act after the Effective Date and before the date of such amendment that is incorporated by reference in the Registration Statement.&#160; The Commission has not issued any order
        preventing or suspending the use of any Preliminary Prospectus or the Prospectus or suspending the effectiveness of the Registration Statement, and no proceeding or examination for such purpose or pursuant to Section 8A of the Securities Act has
        been instituted or threatened by the Commission.&#160; The Commission has not notified the Company of any objection to the use of the form of the Registration Statement or any post-effective amendment thereto.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company and each of the Subsidiaries (as defined below) are duly organized, validly existing and in good standing under the laws of their respective jurisdictions of organization.&#160;
        The Company and each of the Subsidiaries (as defined below) are duly licensed or qualified as a foreign corporation for transaction of business and in good standing under the laws of each other jurisdiction in which their respective ownership or
        lease of property or the conduct of their respective businesses requires such license or qualification, and have all corporate power and authority necessary to own or hold their respective properties and to conduct their respective businesses as
        described in the Registration Statement and the Prospectus, except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect or would
        reasonably be expected to have a material adverse effect on or affecting the assets, business, operations, earnings, properties, condition (financial or otherwise), prospects, stockholders&#8217; equity or results of operations of the Company and the
        Subsidiaries (as defined below) taken as a whole, or prevent or materially interfere with consummation of the transactions contemplated hereby (a &#8220;<font style="font-weight: bold; font-style: italic;">Material Adverse Effect</font>&#8221;).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Semler Scientific, a Delaware corporation, and the subsidiaries listed in Exhibit 21.1 to Company&#8217;s S-4/A filed on December 3, 2025 and Annual Report on Form 10-K after such date, as
        applicable for the most recent fiscal year (collectively, the &#8220;<font style="font-weight: bold; font-style: italic;">Subsidiaries</font>&#8221;), are the Company&#8217;s only significant subsidiaries (as such term is defined in Rule 1&#8209;02 of Regulation S&#8209;X
        promulgated by the Commission).&#160; Except as set forth in the Registration Statement and in the Prospectus, the Company owns, directly or indirectly, all of the equity interests of the Subsidiaries free and clear of any lien, charge, security
        interest, encumbrance, right of first refusal or other restriction, and all the equity interests of the Subsidiaries are validly issued and are fully paid, nonassessable and free of preemptive and similar rights.&#160; No Subsidiary is currently
        prohibited, directly or indirectly, from paying any dividends to the Company, from making any other distribution on such Subsidiary&#8217;s capital stock, from repaying to the Company any loans or advances to such Subsidiary from the Company or from
        transferring any of such Subsidiary&#8217;s property or assets to the Company or any other Subsidiary of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160; &#160; From the time of initial filing of the Registration Statement to the Commission (or, if earlier, the first date on which the Company engaged directly or through any person authorized to
        act on its behalf in any Testing-the-Waters Communication) through the date hereof, the Company has been and will be an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act (an &#8220;<font style="font-weight: bold; font-style: italic;">Emerging Growth Company</font>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; As of the time of filing of the Registration Statement, the Company was a &#8220;smaller reporting company,&#8221; as defined in Rule 12b-2 of the Exchange Act.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160; &#160; The Company (i) has not engaged in any Testing-the-Waters Communication other than Testing-the-Waters Communications with, the consent of the Representatives, with entities that are
        reasonably believed to be qualified institutional buyers within the meaning of Rule 144A under the Securities Act, or with institutions that are accredited investors within the meaning of Rule 501 under the Securities Act and (ii) has not
        authorized anyone other than the Representatives to engage in Testing-the-Waters Communications.&#160; The Company reconfirms that the Representatives have been authorized to act on its behalf in undertaking Testing-the-Waters Communications.&#160; The
        Company has not distributed or approved for distribution any Written Testing-the-Waters Communications other than those listed on Schedule II hereto.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(g)&#160;&#160;&#160; &#160; &#160;&#160; The Company was not at the time of the initial filing of the Registration Statement and at the earliest time thereafter that the Company or another offering participant made a <font style="font-style: italic;">bona fide</font> offer (within the meaning of Rule 164(h)(2) under the Securities Act) of the Securities, is not on the date hereof and will not be on the Closing Date (as defined below), an &#8220;ineligible issuer&#8221; (as
        defined in Rule 405 under the Securities Act).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(h)&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; Since the time of initial filing of the Registration Statement, the Company has been, and continues to be, a &#8220;well-known seasoned issuer&#8221; (as defined in Rule 405) eligible to use Form
        S-3 for the offering of the Securities. The Company was not an &#8220;ineligible issuer&#8221; (as defined in Rule 405) at any such time or date.&#160; The Registration Statement is an &#8220;automatic shelf registration statement&#8221; (as defined in Rule 405)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#160;</sup>and was filed not earlier than the date that is three years prior to the Closing Date.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Registration Statement conformed and will conform in all material respects on the Effective Date and on the Closing Date, and any amendment to the Registration Statement filed
        after the date hereof will conform in all material respects when filed, to the requirements of the Securities Act and the rules and regulations thereunder.&#160; The most recent Preliminary Prospectus conformed, and the Prospectus will conform, in all
        material respects when filed with the Commission pursuant to Rule 424(b) under the Securities Act and on the Closing Date to the requirements of the Securities Act and the rules and regulations thereunder.&#160; The documents incorporated by reference
        in any Preliminary Prospectus or the Prospectus conformed, and any further documents so incorporated will conform, when filed with the Commission, in all material respects to the requirements of the Exchange Act or the Securities Act, as
        applicable, and the rules and regulations of the Commission thereunder.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(j)&#160;&#160;&#160;&#160; &#160; &#160;&#160; The Registration Statement did not, as of the Effective Date, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
        to make the statements therein not misleading; <font style="font-style: italic;">provided</font> that no representation or warranty is made as to information contained in or omitted from the Registration Statement in reliance upon and in
        conformity with written information furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information is specified in Section 8(e) hereof.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; The Prospectus will not, as of its date or as of the Closing Date, contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the
        statements therein, in the light of the circumstances under which they were made, not misleading; <font style="font-style: italic;">provided</font> that no representation or warranty is made as to information contained in or omitted from the
        Prospectus in reliance upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information is specified in Section 8(e)
        hereof.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The documents incorporated by reference in any Preliminary Prospectus or the Prospectus did not, and any further documents filed and incorporated by reference therein will not, when
        filed with the Commission, contain an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Pricing Disclosure Package did not, as of the Applicable Time, contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the
        statements therein, in the light of the circumstances under which they were made, not misleading; <font style="font-style: italic;">provided</font> that no representation or warranty is made as to information contained in or omitted from the
        Pricing Disclosure Package made in reliance upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information is specified
        in Section 8(e) hereof.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Each Issuer Free Writing Prospectus listed in Schedule II hereto, when taken together with the Pricing Disclosure Package, did not, as of the Applicable Time, contain an untrue statement
        of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <font style="font-style: italic;">provided</font> that no
        representation or warranty is made as to information contained in or omitted from such Issuer Free Writing Prospectus listed in Schedule II hereto in reliance upon and in conformity with written information furnished to the Company through the
        Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information is specified in Section 8(e) hereof.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Each Issuer Free Writing Prospectus conformed or will conform in all material respects to the requirements of the Securities Act and the rules and regulations thereunder on the date of
        first use, and the Company has complied with all prospectus delivery and any filing requirements applicable to such Issuer Free Writing Prospectus pursuant to the Securities Act and rules and regulations thereunder.&#160; The Company has not made any
        offer relating to the Securities that would constitute an Issuer Free Writing Prospectus without the prior written consent of the Representatives, except as set forth on Schedule II hereto.&#160; The Company has retained in accordance with the
        Securities Act and the rules and regulations thereunder all Issuer Free Writing Prospectuses that were not required to be filed pursuant to the Securities Act and the rules and regulations thereunder.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(p)&#160;&#160;&#160;&#160;&#160; &#160;&#160; The authorized capital stock of the Company, the Preferred Stock and the Certificate of Designation, as amended, relating to the Preferred Stock designating the &#8220;Variable Rate Series A
        Perpetual Preferred Stock&#8221; and establishing the rights, powers, preferences, limitations and entitlements thereof (the &#8220;<font style="font-weight: bold; font-style: italic;">Certificate of Designation</font>&#8221;), in each case conform as to legal
        matters to the descriptions thereof contained in the Pricing Disclosure Package and the Prospectus.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(q)&#160;&#160;&#160;&#160;&#160; &#160; &#160; The execution and filing of the Certificate of Designation has been duly authorized by the Company, and the Certificate of Designation has been duly executed and filed with the Nevada
        Secretary of State.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(r)&#160;&#160;&#160;&#160;&#160; &#160; &#160; The Securities to be issued and sold by the Company to the Underwriters hereunder have been duly authorized and, upon payment and delivery in accordance with this Agreement, will be
        validly issued, fully paid and non-assessable, will conform to the description thereof contained in the most recent Preliminary Prospectus, will be issued in compliance with federal and state securities laws and will be free of statutory and
        contractual preemptive rights, rights of first refusal and similar rights.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company has all requisite corporate power and authority to execute, deliver and perform its obligations under this Agreement.&#160; This Agreement has been duly and validly authorized,
        executed and delivered by the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(t)&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; The issuance and sale of the Securities by the Company, the execution, delivery and performance of this Agreement by the Company, the Certificate of Designation and the Securities and
        the consummation of the transactions contemplated hereby and the application of the proceeds from the sale of the Securities as described under &#8220;Use of Proceeds&#8221; in the most recent Preliminary Prospectus will not (i) conflict with or result in a
        breach or violation of any of the terms or provisions of, impose any lien, charge or encumbrance upon any property or assets of the Company and its Subsidiaries, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement,
        license, lease or other agreement or instrument to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is bound or to which any of the property or assets of the Company or any of its
        Subsidiaries is subject; (ii) result in any violation of the provisions of the articles of incorporation or bylaws (or similar organizational documents) of the Company or any of its Subsidiaries; or (iii) result in any violation of any statute or
        any judgment, order, decree, rule or regulation of any court or governmental agency or body having jurisdiction over the Company or any of its Subsidiaries or any of their properties or assets, except, with respect to clauses (i) and (iii),
        conflicts or violations that would not reasonably be expected to have a Material Adverse Effect.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(u)&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; No consent, approval, authorization or order of, or filing, registration or qualification with, any court or governmental agency or body having jurisdiction over the Company or any of
        its Subsidiaries or any of their properties or assets is required for the issue and sale of the Securities by the Company, the execution, delivery and performance by the Company of its obligations under, this Agreement, the Certificate of
        Designation and the Securities and the consummation of the transactions contemplated hereby, the application of the proceeds from the sale of the Securities as described under &#8220;Use of Proceeds&#8221; in the most recent Preliminary Prospectus, except for
        the registration of the Securities under the Securities Act and such consents, approvals, authorizations, orders, filings, registrations or qualifications as may be required under the Exchange Act, and applicable state securities laws and/or the
        bylaws and rules of the Financial Industry Regulatory Authority, Inc. (the &#8220;<font style="font-weight: bold; font-style: italic;">FINRA</font>&#8221;) in connection with the purchase and sale of the Securities by the Underwriters.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160; &#160; The consolidated financial statements of the Company included or incorporated by reference in the Registration Statement, the Prospectus and the Issuer Free Writing Prospectuses, if
        any, together with the related notes and schedules, present fairly, in all material respects, the consolidated financial position of the Company and the Subsidiaries as of the dates indicated and the consolidated results of operations, cash flows
        and changes in stockholders&#8217; equity of the Company for the periods specified and have been prepared in all material respects in compliance with the requirements of the Securities Act and Exchange Act and in conformity with U.S. Generally Accepted
        Accounting Principles (&#8220;<font style="font-weight: bold; font-style: italic;">GAAP</font>&#8221;) applied on a consistent basis during the periods involved; the other financial and statistical data with respect to the Company and the Subsidiaries
        contained or incorporated by reference in the Registration Statement, the Prospectus and the Issuer Free Writing Prospectuses, if any, are accurately and fairly presented in all material respects and prepared on a basis consistent, in all material
        respects, with the financial statements and books and records of the Company; there are no financial statements (historical or pro forma) that are required to be included or incorporated by reference in the Registration Statement, or the Prospectus
        that are not included or incorporated by reference as required; the Company and the Subsidiaries do not have any material liabilities or obligations, direct or contingent (including any off-balance sheet obligations), not described in the
        Registration Statement (excluding the exhibits thereto) and the Prospectus or in a document incorporated by reference therein; and all disclosures contained or incorporated by reference in the Registration Statement, the Prospectus and the Issuer
        Free Writing Prospectuses, if any, regarding &#8220;non-GAAP financial measures&#8221; (as such term is defined by the rules and regulations of the Commission) comply in all material respects with Regulation G of the Exchange Act and Item 10 of Regulation S-K
        under the Securities Act, to the extent applicable. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement and the Prospectus fairly presents the information called for in
        all material respects and has been prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(w)&#160;&#160;&#160; &#160; &#160; The pro forma financial statements included or incorporated by reference in the most recent Preliminary Prospectus include assumptions that provide a reasonable basis for presenting the
        significant effects directly attributable to the transactions and events described therein, the related pro forma adjustments give appropriate effect to those assumptions, and the pro forma adjustments reflect the proper application of those
        adjustments to the historical financial statement amounts in the pro forma financial statements included or incorporated by reference in the most recent Preliminary Prospectus. The pro forma financial statements included or incorporated by
        reference in the most recent Preliminary Prospectus comply as to form in all material respects with the applicable requirements of Regulation S-X under the Securities Act.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(x)&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; KPMG LLC (&#8220;<font style="font-weight: bold; font-style: italic;">KPMG</font>&#8221;), who has certified certain financial statements of the Company and its consolidated Subsidiaries, whose
        report appears in the most recent Preliminary Prospectus or is incorporated by reference therein and who have delivered the initial letter referred to in Section 7(g) hereof, are independent public accountants as required by the Securities Act and
        the rules and regulations thereunder; and BDO USA, P.C. (&#8220;<font style="font-weight: bold; font-style: italic;">BDO</font>&#8221; and, together with KPMG, the &#8220;<font style="font-weight: bold; font-style: italic;">Accountants</font>&#8221;), who has certified
        financial statements (including financial statements of acquired properties or business) that appear in the most recent Preliminary Prospectus or are incorporated by reference therein and who have delivered the initial letter referred to in Section
        7(g) hereof, were independent public accountants as required by the Securities Act and the rules and regulations thereunder during the periods covered by the financial statements on which they reported contained or incorporated by reference in the
        most recent Preliminary Prospectus.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="pickup"></a>(y)&#160;&#160;&#160;&#160;&#160;&#160; &#160; Neither the Company nor any of its Subsidiaries is (i) in violation of its articles of incorporation or bylaws or similar organizational documents; (ii) in default,
        and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan or credit
        agreement or other agreement or instrument to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is bound or to which any of the property or assets of the Company or any of its Subsidiaries
        are subject; or (iii) in violation of any law or statute or any judgment, order, rule or regulation of any Governmental Authority, except, in the case of each of clauses (ii) and (iii) above, for any such violation or default that would not,
        individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.&#160; To the Company&#8217;s knowledge, no other party under any material contract or other agreement to which it or any of its Subsidiaries is a party is in default
        in any respect thereunder where such default would have a Material Adverse Effect.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(z)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Subsequent to the respective dates as of which information is given in the Registration Statement, the Prospectus and the Issuer Free Writing Prospectuses, if any (including any document
        deemed incorporated by reference therein), there has not been (i) any Material Adverse Effect or the occurrence of any development that the Company reasonably expects will result in a Material Adverse Effect, (ii) any transaction which is material
        to the Company and the Subsidiaries taken as a whole, (iii) any obligation or liability, direct or contingent (including any off-balance sheet obligations), incurred by the Company or any Subsidiary, which is material to the Company and the
        Subsidiaries taken as a whole, (iv) any material change in the capital stock or outstanding long-term indebtedness of the Company or any of its Subsidiaries (other than (a) as a result of the sale of Securities, (b) the issuance of equity awards
        under the Company&#8217;s existing equity incentive plans or (c) changes in the number of outstanding shares of the Company&#8217;s Class A common stock, par value $0.001 per share (the &#8220;<font style="font-weight: bold; font-style: italic;">Common Stock</font>&#8221;)







        due to the issuance of shares upon the exercise or conversion of securities exercisable for, or convertible into, shares of Common Stock (including warrants) outstanding on the date hereof, or the vesting of restricted stock units outstanding on
        the date hereof) or (v) any dividend or distribution of any kind declared, paid or made on the capital stock of the Company or any Subsidiary, other than in each case above in the ordinary course of business or as otherwise disclosed in the
        Registration Statement or Prospectus (including any document deemed incorporated by reference therein).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(aa)&#160;&#160;&#160;&#160; &#160;&#160; The issued and outstanding shares of capital stock of the Company have been validly issued, are fully paid and nonassessable and, other than as disclosed in the Registration Statement
        or the Prospectus, are not subject to any preemptive rights, rights of first refusal or similar rights that have not been duly waived or satisfied.&#160; The Company has an authorized, issued and outstanding capitalization as set forth in the
        Registration Statement and the Prospectus as of the dates referred to therein (other than the grant of additional options or other equity awards under the Company&#8217;s existing stock option plans, or changes in the number of outstanding shares of
        Common Stock of the Company due to the issuance of shares upon the exercise or conversion of securities exercisable for, or convertible into, Common Stock outstanding on the date hereof, or the vesting of restricted stock units outstanding on the
        date hereof) and such authorized capital stock conforms in all material respects to the description thereof set forth in the Registration Statement and the Prospectus.&#160; The description of the securities of the Company in the Registration Statement
        and the Prospectus is complete and accurate in all material respects.&#160; Except as disclosed in or contemplated by the Registration Statement or the Prospectus, as of the date referred to therein, the Company does not have outstanding any options to
        purchase, or any rights or warrants to subscribe for, or any securities or obligations convertible into, or exchangeable for, or any contracts or commitments to issue or sell, any shares of capital stock or other securities.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(bb)&#160;&#160;&#160;&#160; &#160; The Company has full legal right, power and authority to enter into this Agreement and the Securities and to consummate the transactions contemplated by each of the Registration
        Statement and the Prospectus.&#160; This Agreement has been duly authorized, executed and delivered by the Company and is a legal, valid and binding agreement of the Company enforceable in accordance with its terms, except to the extent that
        enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#8217; rights generally and by general equitable principles.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Hlk219403952"></a>(cc)&#160;&#160;&#160; &#160;&#160; All agreements between the Company and third parties expressly referenced in the Prospectus are legal, valid and binding obligations of the Company
        enforceable in accordance with their respective terms, except to the extent that (i) enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#8217; rights generally and by general equitable
        principles and (ii) the indemnification provisions of certain agreements may be limited by federal or state securities laws or public policy considerations in respect thereof, except for any unenforceability that, individually or in the aggregate,
        would not have a Material Adverse Effect.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Hlk219403984"></a>(dd)&#160;&#160;&#160;&#160; &#160;&#160; Except as set forth in the Registration Statement or the Prospectus, there are no actions, suits or proceedings by or before any Governmental Authority
        pending, nor, to the Company&#8217;s knowledge, any audits or investigations by or before any Governmental Authority to which the Company or a Subsidiary is a party or to which any property of the Company or any of its Subsidiaries is the subject that,
        individually or in the aggregate, if determined adversely to the Company or such Subsidiary, would reasonably be expected to have a Material Adverse Effect and, to the Company&#8217;s knowledge, no such actions, suits, proceedings, audits or
        investigations&#160; are threatened or contemplated by any Governmental Authority or threatened by others that, individually or in the aggregate, if determined adversely to the Company or any of the Subsidiaries, would have a Material Adverse Effect;
        and (i) there are no current or pending audits, actions, suits or proceedings, or to the Company&#8217;s knowledge, investigations by or before any Governmental Authority that are required under the Securities Act to be described in the Prospectus that
        are not so described; and (ii) there are no contracts or other documents that are required under the Securities Act to be filed as exhibits to the Registration Statement that are not so filed.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(ee)&#160;&#160;&#160; &#160; &#160; The Company and each Subsidiary possess such valid and current certificates, authorizations or permits issued by the appropriate state, federal or foreign regulatory agencies or bodies
        necessary to conduct their respective businesses, and neither the Company nor any Subsidiary has received, or has any reason to believe that it will receive, any notice of proceedings relating to the revocation or modification of, or non-compliance
        with, any such certificate, authorization or permit which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, could reasonably be expected to result in a Material Adverse Effect.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Hlk219404045"></a>(ff)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Except as disclosed in the Registration Statement and the Prospectus, the Company and its Subsidiaries own, possess, license or have other rights to use
        all foreign and domestic patents, patent applications, trade and service marks, trade and service mark registrations, trade names, copyrights, licenses, inventions, trade secrets, technology, Internet domain names, know-how and other intellectual
        property (collectively, the &#8220;<font style="font-weight: bold; font-style: italic;">Intellectual Property</font>&#8221;), necessary for the conduct of their respective businesses as now conducted, except to the extent that the failure to own, possess,
        license or otherwise hold rights to use such Intellectual Property would not, individually or in the aggregate, have a Material Adverse Effect.&#160; Except as disclosed in the Registration Statement and the Prospectus (i) to the Company&#8217;s knowledge,
        there is no infringement by third parties of any such Intellectual Property that is owned by the Company or any of its Subsidiaries; (ii) there is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by others
        challenging the Company&#8217;s and its Subsidiaries&#8217; rights in or to any such Intellectual Property that is owned by the Company or any of its Subsidiaries; (iii) there is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or
        claim by others challenging the validity or scope of any such Intellectual Property that is owned by the Company or any of its Subsidiaries; (iv) there is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by
        others that the Company and its Subsidiaries infringe or otherwise violate any patent, trademark, copyright, trade secret or other proprietary rights of others; (v) to the Company&#8217;s knowledge, there is no third-party U.S. patent or published U.S.
        patent application which contains claims for which an Interference Proceeding (as defined in 35 U.S.C. &#167; 135) has been commenced against any patent or patent application described in the Prospectus as being owned by the Company; and (vi) the
        Company and its Subsidiaries have complied with the terms of each agreement pursuant to which Intellectual Property has been licensed to the Company or such Subsidiary, and all such agreements are in full force and effect, except, in the case of
        each of clauses (i)-(vi) above, as would not, individually or in the aggregate, result in a Material Adverse Effect.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Hlk219404069"></a>(gg)&#160;&#160;&#160;&#160; &#160; At the time the Registration Statement was or will be originally declared effective, and at the time the Company&#8217;s most recent Annual Report on Form 10-K was
        filed with the Commission, the Company met or will meet the then applicable requirements for the use of Form S-3 under the Securities Act, including, but not limited to, General Instruction I.B.1 of Form S-3. The Securities have been and remain
        eligible for inclusion by the Company on such Registration Statement. The Company is not a shell company (as defined in Rule 405 under the Securities Act) and has not been a shell company for at least 12 calendar months previously and if it has
        been a shell company at any time previously, has filed current Form 10 information (as defined in Instruction I.B.6 of Form S-3) with the Commission at least 12 calendar months previously reflecting its status as an entity that is not a shell
        company.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(hh)&#160;&#160;&#160; &#160; &#160; The information provided to the Underwriters by the Company, its counsel, and its officers and directors for purposes of the Underwriters&#8217; compliance with applicable FINRA rules in
        connection with the offering of the Securities is true, complete, and correct and compliant with <font style="color: rgb(0, 0, 0);">FINRA&#8217;s rules.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Hlk219404811"></a>(ii)&#160;&#160;&#160;&#160;&#160;&#160; &#160; Neither the Company nor any of the Subsidiaries has defaulted on any installment on indebtedness for borrowed money or on any rental on one or more
        long-term leases, which defaults, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect.&#160; The Company has not filed a report pursuant to Section 13(a) or 15(d) of the Exchange Act since the filing of its
        last Annual Report on Form 10&#8209;K, indicating that it (i) has failed to pay any dividend or sinking fund installment on preferred stock or (ii) has defaulted on any installment on indebtedness for borrowed money or on any rental on one or more
        long-term leases, which defaults, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Hlk219404969"></a>(jj)&#160;&#160;&#160;&#160;&#160; &#160;&#160; Neither the Company, nor any of the Subsidiaries, nor, to the knowledge of the Company, any of their respective directors, officers or controlling persons
        has taken, directly or indirectly, any action designed, or that has constituted or would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the
        Company to facilitate the sale or resale of the Securities.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(kk)&#160;&#160;&#160;&#160; &#160;&#160; Neither the Company nor any of the Subsidiaries (i) is required to register as a &#8220;broker&#8221; or &#8220;dealer&#8221; in accordance with the provisions of the Exchange Act or (ii) directly or
        indirectly through one or more intermediaries, controls or is a &#8220;person associated with a member&#8221; or &#8220;associated person of a member&#8221; (within the meaning set forth in the FINRA Manual).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(ll)&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; The Company has not relied upon the Underwriters or legal counsel for the Underwriters for any legal, tax or accounting advice in connection with the offering and sale of the
        Securities.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Hlk219405027"></a>(mm)&#160;&#160;&#160; &#160; The Company and each of its Subsidiaries have filed all federal, state, local and foreign tax returns which have been required to be filed and paid all taxes
        shown thereon through the date hereof, to the extent that such taxes have become due and are not being contested in good faith, except where the failure to so file or pay would not have a Material Adverse Effect.&#160; Except as otherwise disclosed in
        or contemplated by the Registration Statement or the Prospectus, no tax deficiency has been determined adversely to the Company or any of its Subsidiaries which has had, or would reasonably be expected to have, individually or in the aggregate, a
        Material Adverse Effect.&#160; The Company has no knowledge of any federal, state or other governmental tax deficiency, penalty or assessment which has been or might be asserted or threatened against it which would have a Material Adverse Effect.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(nn)&#160;&#160;&#160;&#160;&#160;&#160; The Company has made reasonable best efforts to comply and believes that it has complied with the written guidelines agreed to by the Company and the Underwriters with respect to
        &#8220;fast-pay stock&#8221; (for the avoidance of doubt, the Company may take into account written or oral representations from the financial institutions participating in this offering in determining that it has fulfilled the written guidelines) (the &#8220;<font style="font-weight: bold; font-style: italic;">Tax Guidelines</font>&#8221;) and does not believe that the Securities being issued in this offering are structured in a manner that causes the Securities to be treated as &#8220;fast-pay stock&#8221; within the
        meaning of Section 1.7701(l)-3(b)(2) of the United States Treasury Regulations.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Hlk219405108"></a>(oo)&#160;&#160;&#160;&#160;&#160;&#160; Except as set forth in the Registration Statement or the Prospectus, the Company and its Subsidiaries have good and marketable title in fee simple or other
        comparable valid title to all items of real property owned by them, good and valid title to all personal property described in the Registration Statement or Prospectus as being owned by them that are material to the ordinary course of business of
        the Company or the Subsidiaries, in each case free and clear of all liens, encumbrances and claims, except those matters that (i) do not materially interfere with the use made and proposed to be made of such property by the Company and any of its
        Subsidiaries or (ii) would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect.&#160; Any real or personal property described in the Registration Statement or Prospectus as being leased by the Company and any
        of its Subsidiaries is held by them under valid, existing and enforceable leases, except those that (A) do not materially interfere with the use made or proposed to be made of such property by the Company or any of its Subsidiaries or (B) would not
        be reasonably expected, individually or in the aggregate, to have a Material Adverse Effect.&#160; To the best of the Company&#8217;s knowledge, each of the properties of the Company and its Subsidiaries complies with all applicable codes, laws and
        regulations (including, without limitation, building and zoning codes, laws and regulations and laws relating to access to such properties), except if and to the extent disclosed in the Registration Statement or Prospectus or except for such
        failures to comply that would not, individually or in the aggregate, reasonably be expected to interfere in any material respect with the use made and proposed to be made of such property by the Company and its Subsidiaries or otherwise have a
        Material Adverse Effect.&#160; None of the Company or its Subsidiaries has received from any Governmental Authorities any notice of any condemnation of, or zoning change affecting, the properties of the Company and its Subsidiaries, and the Company
        knows of no such condemnation or zoning change which is threatened, except for such that would not reasonably be expected to interfere in any material respect with the use made and proposed to be made of such property by the Company and its
        Subsidiaries or otherwise have a Material Adverse Effect, individually or in the aggregate.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><a name="z_Hlk219405138"></a>(pp)&#160;&#160;&#160;&#160;&#160; &#160; Except as set forth in the Registration Statement or the Prospectus, the Company and its Subsidiaries (i) are in compliance with any and all applicable
        federal, state, local and foreign laws, rules, regulations, decisions and orders relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (collectively, &#8220;<font style="font-weight: bold; font-style: italic;">Environmental Laws</font>&#8221;); (ii) have received and are in compliance with all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective
        businesses as described in the Registration Statement and the Prospectus; and (iii) have not received notice of any actual or potential liability for the investigation or remediation of any disposal or release of hazardous or toxic substances or
        wastes, pollutants or contaminants, except, in the case of any of clauses (i), (ii) or (iii) above, for any such failure to comply or failure to receive required permits, licenses, other approvals or liability as would not, individually or in the
        aggregate, reasonably be expected to have a Material Adverse Effect.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(qq)&#160;&#160;&#160; &#160; &#160; The Company and each of its Subsidiaries maintain systems of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance
        with management&#8217;s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii) access to assets is permitted only
        in accordance with management&#8217;s general or specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.&#160; As of
        the end of the Company&#8217;s most recently completed fiscal year, the Company&#8217;s internal control over financial reporting was effective and as of the end of the most recently completed fiscal year, the Company is not aware of any material weaknesses in
        its internal control over financial reporting (other than as set forth in the Prospectus).&#160; Since the date of the latest audited financial statements of the Company included in the Prospectus, there has been no change in the Company&#8217;s internal
        control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting (other than as set forth in the Prospectus).&#160; The Company has established
        disclosure controls and procedures (as defined in Exchange Act Rules 13a&#8209;15 and 15d&#8209;15) for the Company and designed such disclosure controls and procedures to ensure that material information relating to the Company and each of its Subsidiaries is
        made known to the certifying officers by others within those entities, including during the period in which the Company&#8217;s Annual Report on Form 10&#8209;K or Quarterly Report on Form 10-Q, as the case may be, is being prepared.&#160; The Company&#8217;s certifying
        officers have evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures as of a date within 90 days prior to the filing date of the Annual Report on Form 10&#8209;K for the fiscal year most recently ended (such date, the <font style="font-weight: bold;">&#8220;</font><font style="font-weight: bold; font-style: italic;">Evaluation Date</font>&#8221;).&#160; The Company presented in its Annual Report on Form 10&#8209;K for the fiscal year most recently ended the conclusions of the certifying
        officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date and the disclosure controls and procedures were effective.&#160; Since the Evaluation Date, there have been no significant
        changes in the Company&#8217;s internal controls (as such term is defined in Item 307(b) of Regulation S&#8209;K under the Securities Act) or, to the Company&#8217;s knowledge, in other factors that could significantly affect the Company&#8217;s internal controls.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(rr)&#160;&#160;&#160;&#160;&#160; &#160;&#160; [Reserved].</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(ss)&#160;&#160;&#160; &#160; &#160;&#160; Except as described in the most recent Preliminary Prospectus, since the date of the latest audited financial statements included or incorporated by reference in the most recent
        Preliminary Prospectus, neither the Company nor any of its Subsidiaries has (i) sustained any loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or
        court or governmental action, order or decree (whether domestic or foreign), (ii) issued or granted any securities, (iii) incurred any material liability or obligation, direct or contingent, other than liabilities and obligations that were incurred
        in the ordinary course of business, (iv) entered into any material transaction not in the ordinary course of business, or (v) declared or paid any dividend on its capital stock, and since such date, there has not been any change in the capital
        stock, or long-term debt of the Company or any of its Subsidiaries or any material adverse change, in or affecting the condition (financial or otherwise), results of operations, stockholders&#8217; equity, properties, management, business or prospects of
        the Company and its Subsidiaries taken as a whole, in each case except as could not, in the aggregate, reasonably be expected to have a Material Adverse Effect.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(tt)&#160;&#160;&#160;&#160;&#160; &#160;&#160; There is and has been no failure on the part of the Company or any of the Company&#8217;s directors or officers, in their capacities as such, to comply in all material respects with any
        applicable provisions of the Sarbanes-Oxley Act and the rules and regulations promulgated thereunder.&#160; Each of the principal executive officer and the principal financial officer of the Company (or each former principal executive officer of the
        Company and each former principal financial officer of the Company as applicable) has made all certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2022 (the &#8220;<font style="font-weight: bold; font-style: italic;">Sarbanes-Oxley







          Act</font>&#8221;) with respect to all reports, schedules, forms, statements and other documents required to be filed by it or furnished by it to the Commission.&#160; For purposes of the preceding sentence, &#8220;principal executive officer&#8221; and &#8220;principal
        financial officer&#8221; shall have the meanings given to such terms in the Sarbanes-Oxley Act.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(uu)&#160;&#160; &#160; &#160;&#160; Neither the Company nor any of the Subsidiaries has incurred any liability for any finder&#8217;s fees, brokerage commissions or similar payments in connection with the transactions herein
        contemplated, except as may otherwise exist with respect to the Underwriters pursuant to this Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(vv)&#160;&#160;&#160;&#160;&#160; &#160; No labor disturbance by or dispute with employees of the Company or any of its Subsidiaries exists or, to the knowledge of the Company, is threatened which would reasonably be expected
        to result in a Material Adverse Effect.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(ww)&#160;&#160; &#160; The Company is not and, after giving effect to the offering and sale of the Securities and the application of the proceeds thereof, will not be an &#8220;investment company&#8221; as such term is
        defined in the Investment Company Act of 1940, as amended (the &#8220;<font style="font-weight: bold; font-style: italic;">Investment Company Act</font>&#8221;). The Company shall conduct its business in a manner so that it will not become required to register
        as an &#8220;investment company,&#8221; as such term is defined in the Investment Company Act.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(xx)&#160;&#160;&#160; &#160;&#160; The statements set forth in each of the most recent Preliminary Prospectus and the Prospectus under the captions &#8220;Description of Perpetual Preferred Stock&#8221;, &#8220;Material U.S. Federal Income
        Tax Considerations&#8221;, and &#8220;Underwriting&#8221;, insofar as they purport to summarize the provisions of the laws, regulations or legal conclusions with respect thereto and the documents referred to therein, are accurate summaries in all material respects.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(yy)&#160; &#160;&#160; &#160;&#160; Neither the Company nor any of its Subsidiaries, any of the Company&#8217;s directors or officers, nor, to the knowledge of the Company, any of the Company&#8217;s controlled affiliates, any
        employee, agent or other person associated with or acting on behalf of the Company or any of its Subsidiaries, has, in the course of its actions for, or on behalf of, the Company or any of its Subsidiaries: (i) made any unlawful contribution, gift,
        or other unlawful expense relating to political activity; (ii) made any direct or indirect bribe, kickback, rebate, payoff, influence payment, or otherwise unlawfully provided anything of value, to any &#8220;foreign official&#8221; (as defined in the U.S.
        Foreign Corrupt Practices Act of 1977, as amended (collectively, the &#8220;<font style="font-weight: bold; font-style: italic;">FCPA</font>&#8221;)) or domestic government official; or (iii) violated or is in violation of any provision of the FCPA, the
        Bribery Act 2010 of the United Kingdom, as amended (the &#8220;<font style="font-weight: bold; font-style: italic;">Bribery Act 2010</font>&#8221;), or any other applicable anti-corruption or anti-bribery statute or regulation.&#160; The Company and its
        Subsidiaries and, to the knowledge of the Company, the Company&#8217;s affiliates, have conducted their respective businesses in compliance with the FCPA, Bribery Act 2010 and all other applicable anti-corruption and anti-bribery statutes or regulations,
        and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to ensure, continued compliance therewith and with the representations and warranties contained herein. Neither the Company nor any of
        its Subsidiaries will use, directly or indirectly, the proceeds of the offering in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any person in violation of any
        applicable anti-corruption or anti-bribery laws.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(zz)&#160;&#160;&#160; &#160; &#160; The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance in all material respects with applicable financial record keeping and reporting
        requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all applicable jurisdictions to which the Company or its Subsidiaries are subject, the applicable rules and regulations
        thereunder and any applicable related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Authority (collectively, the &#8220;<font style="font-weight: bold; font-style: italic;">Money Laundering Laws</font>&#8221;);







        and no action, suit or proceeding by or before any Governmental Authority involving the Company or any of its Subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(aaa)&#160;&#160; &#160; &#160; Neither the Company nor any of its Subsidiaries, any of the Company&#8217;s directors or officers, nor, to the knowledge of the Company, any agent, employee or controlled affiliate of the
        Company or any of its Subsidiaries is: (i) currently the subject or the target of any sanctions administered or enforced by the Office of Foreign Assets Control of the U.S. Treasury Department, the U.S. Department of State, the United Nations
        Security Council, the European Union, His Majesty&#8217;s Treasury, or other relevant sanctions authority having jurisdiction over the Company or its Subsidiaries (collectively, &#8220;<font style="font-weight: bold; font-style: italic;">Sanctions</font>&#8221;); or
        (ii) located, organized or resident in a country or territory that is the subject or target of comprehensive territorial Sanctions (including, without limitation, the so-called Donetsk People&#8217;s Republic, the so-called Luhansk People&#8217;s Republic, or
        any other Covered Region of Ukraine identified pursuant to Executive Order 14065, the Crimea Region of Ukraine, Cuba, Iran and North Korea); and the Company will not directly or to its knowledge indirectly use the proceeds of the offering, or lend,
        contribute or otherwise make available such proceeds to any Subsidiary, joint venture partner or other person or entity, for the purpose of financing or facilitating the activities or business of any person, or in any country or territory, that at
        the time of such financing or facilitation and currently is the subject or target of Sanctions or in any other manner that will result in a violation by any person (including any person participating in the transaction whether as an underwriter,
        advisor, investor or otherwise) of Sanctions.&#160; The Company and each of its Subsidiaries have not knowingly engaged in for the past five years, are not now knowingly engaged in any dealings or transactions with any individual or entity, or in any
        country or territory, that at the time of the dealing or transaction, is or was the subject or target of Sanctions.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(bbb)&#160;&#160; &#160; There are no transactions, arrangements and other relationships between and/or among the Company, and/or, to the knowledge of the Company, any of its affiliates and any unconsolidated
        entity, including, but not limited to, any structured finance, special purpose or limited purpose entity (each, an &#8220;<font style="font-weight: bold; font-style: italic;">Off-Balance Sheet Transaction</font>&#8221;) that could reasonably be expected to
        affect materially the Company&#8217;s liquidity or the availability of or requirements for its capital resources, including those Off-Balance Sheet Transactions described in the Commission&#8217;s Statement about Management&#8217;s Discussion and Analysis of
        Financial Conditions and Results of Operations (Release Nos.&#160; 33&#8209;8056; 34&#8209;45321; FR&#8209;61), required to be described in the Prospectus which have not been described as required.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(ccc)&#160;&#160;&#160; &#160; To the knowledge of the Company, each material employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#8220;<font style="font-weight: bold; font-style: italic;">ERISA</font>&#8221;), that is maintained, administered or contributed to by the Company or any of its Subsidiaries for employees or former employees of the Company and any of its Subsidiaries has been
        maintained in material compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Internal Revenue Code of 1986, as amended (the &#8220;<font style="font-weight: bold; font-style: italic;">Code</font>&#8221;); no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred which would result in a material liability to the Company with respect to any such plan
        excluding transactions effected pursuant to a statutory or administrative exemption; and for each such plan that is subject to the funding rules of Section 412 of the Code or Section 302 of ERISA, no &#8220;accumulated funding deficiency&#8221; as defined in
        Section 412 of the Code has been incurred, whether or not waived, and the fair market value of the assets of each such plan (excluding for these purposes accrued but unpaid contributions) exceeds the present value of all benefits accrued under such
        plan determined using reasonable actuarial assumptions.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(ddd) &#160; &#160;&#160; No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) (a &#8220;<font style="font-weight: bold; font-style: italic;">Forward-Looking







          Statement</font>&#8221;) contained in the Registration Statement and the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(eee)&#160;&#160;&#160; &#160; Except as would not reasonably be expected to have a Material Adverse Effect, the Company and each of its Subsidiaries carry, or are covered by, insurance in such amounts and covering
        such risks as the Company and each of its Subsidiaries reasonably believe are adequate for the conduct of their properties and as is customary for companies engaged in similar businesses in similar industries.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(fff)&#160;&#160;&#160; &#160;&#160; No stamp or other issuance or transfer taxes or duties are payable by the Underwriters in the United States or any political subdivision or taxing authority thereof or therein in
        connection with the execution, delivery or performance of this Agreement by the Company or the sale and delivery by the Company of the Securities.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(ggg)&#160;&#160; &#160; The Company and each of its Subsidiaries are in material compliance with all applicable laws, regulations and statutes (including all Environmental Laws and regulations) in the
        jurisdictions in which it carries on business; the Company has not, to the Company&#8217;s knowledge, received a notice of non-compliance, nor knows of, nor has reasonable grounds to know of, any facts that could give rise to a notice of non-compliance
        with any such laws, regulations and statutes, and is not aware of any pending change or contemplated change to any such applicable law or regulation or statutes; in each case that would reasonably be expected to have a Material Adverse Effect on
        the business of the Company or the business or legal environment under which the Company operates.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(hhh)&#160; &#160;&#160; The statistical, demographic and market-related data included in the Registration Statement and Prospectus are based on or derived from sources that the Company believes to be reliable
        and accurate or represent the Company&#8217;s good faith estimates that are made on the basis of data derived from such sources.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(iii)&#160;&#160;&#160;&#160; &#160;&#160; There are no securities or preferred stock of or guaranteed by the Company or any of its Subsidiaries that are rated by a &#8220;nationally recognized statistical rating organization,&#8221; as
        such term is defined in Section 3(a)(62) of the Exchange Act.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(jjj)&#160;&#160;&#160;&#160;&#160;&#160;&#160; There are (and prior to the Closing Date, will be) no debt securities or convertible securities issued or guaranteed by the Company or any of its Subsidiaries that are rated by a
        &#8220;nationally recognized statistical rating organization,&#8221; as such term is defined in Section 3(a)(62) under the Exchange Act.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(kkk)&#160;&#160;&#160;&#160; Except as disclosed in the Registration Statement or Prospectus, and except as would not, individually or in the aggregate, have a Material Adverse Effect, (i) the Company and its
        Subsidiaries&#8217; information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively, &#8220;<font style="font-weight: bold; font-style: italic;">IT Systems</font>&#8221;) are adequate
        for, and operate and perform in all material respects as required in connection with the operation of the business of the Company as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and
        other corruptants; (ii) the Company and its Subsidiaries have implemented and maintained commercially reasonable physical, technical and administrative controls, policies, procedures, and safeguards to maintain and protect their material
        confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data, including all &#8220;Personal Data&#8221; (as defined below) and all sensitive, confidential or regulated data (&#8220;<font style="font-weight: bold; font-style: italic;">Confidential Data</font>&#8221;) used in connection with their businesses; and (iii) there have been no breaches, violations, outages or unauthorized uses of or accesses to the same, except for those that have been remedied
        without material cost or liability or the duty to notify any other person, nor are any incidents under internal review or investigation by the Company or any of its Subsidiaries relating to the same. &#8220;<font style="font-weight: bold; font-style: italic;">Personal Data</font>&#8221; means (A) a natural person&#8217;s name, street address, telephone number, e-mail address, photograph, social security number or tax identification number, driver&#8217;s license number, passport number, credit card number,
        bank information, or customer or account number; (B) any information which qualifies as &#8220;personally identifying information&#8221; under the Federal Trade Commission Act, as amended; (iii) &#8220;personal data&#8221; as defined by the European Union General Data
        Protection Regulation (&#8220;<font style="font-weight: bold; font-style: italic;">GDPR</font>&#8221;) (EU 2016/679); (iv) any information which qualifies as &#8220;protected health information&#8221; under the Health Insurance Portability and Accountability Act of 1996,
        as amended by the Health Information Technology for Economic and Clinical Health Act (collectively, &#8220;<font style="font-weight: bold; font-style: italic;">HIPAA</font>&#8221;); (v) any &#8220;personal information&#8221; as defined by the California Consumer Privacy
        Act (&#8220;<font style="font-weight: bold; font-style: italic;">CCPA</font>&#8221;); and (vi) any other piece of information that allows the identification of such natural person.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">(lll)&#160;&#160;&#160; &#160; &#160; Except as disclosed in the Registration Statement or Prospectus, and except as would not, individually or in the aggregate, have a Material Adverse Effect, (i) the Company and its
        Subsidiaries are in material compliance with all applicable state and federal data privacy and security laws and regulations, including, without limitation, to the extent applicable, HIPAA, CCPA, and the GDPR (collectively, the &#8220;<font style="font-weight: bold; font-style: italic;">Privacy Laws</font>&#8221;); (ii) the Company has in place, complies with, and takes appropriate steps to ensure compliance in all material respects with, its policies and procedures relating to data
        privacy and security and the collection, storage, use, processing, disclosure, handling, and analysis of Personal Data and Confidential Data (the &#8220;<font style="font-weight: bold; font-style: italic;">Policies</font>&#8221;); (iii) the Company has made
        all disclosures to users or customers required by Privacy Laws, and none of such disclosures made or contained in any Policy have been inaccurate or in violation of any Privacy Laws in any material respect; and (iv) neither the Company nor any
        Subsidiary of the Company has received written notice of any actual or potential liability under or relating to, or actual or potential violation of, any of the Privacy Laws.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">(mmm)&#160; Neither the Company nor any Subsidiary is in violation of or has received notice of any violation with respect to any federal or state law relating to discrimination in the hiring, promotion
        or pay of employees, nor any applicable federal or state wage and hour laws, the violation of any of which could reasonably be expected to have a Material Adverse Effect.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><a name="z_cp_change_67"></a><a name="z_cp_change_65"></a>Any certificate signed by an officer of the Company and delivered to the Representatives or counsel for the Underwriters in connection with
        the offering of the Securities shall be deemed to be a representation and warranty by the Company, as applicable, as to matters covered thereby, to each Underwriter.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><a name="z_Ref219563407"></a>2.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-style: italic;">Purchase of the Securities by the Underwriters.</font>&#160; On the basis of the representations, warranties and covenants
        contained in, and subject to the terms and conditions of, this Agreement, the Company agrees to sell 1,320,000 shares of Preferred Stock to the several Underwriters, and each of the Underwriters, severally and not jointly, agrees to purchase the
        number of shares of the Preferred Stock set forth opposite that Underwriter&#8217;s name in Schedule I hereto at the purchase price of $83.466 per share of Preferred Stock (the &#8220;<font style="font-weight: bold; font-style: italic;">Purchase Price</font>&#8221;).&#160;



        The respective purchase obligations of the Underwriters with respect to the Preferred Stock shall be rounded among the Underwriters to avoid fractional shares, as the Representatives may determine.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">The Company is not obligated to deliver any of the Securities to be delivered on the Closing Date, except upon payment for all such Securities to be purchased on such Closing Date as provided
        herein.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">3.&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-style: italic;">Offering of Securities by the Underwriters</font>.&#160; The Company is advised by the Representatives that the Underwriters propose to make a public
        offering of their respective portions of the Securities as soon after the Registration Statement and this Agreement have become effective as in the Representatives&#8217; judgment is advisable. The Company is further advised by the Representatives that
        the Securities are to be offered to the public upon the terms set forth in the Prospectus.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Delivery of and Payment for the Securities.</font>&#160; Delivery of and payment for the Securities shall be made at 10:00 A.M., New York City time, on
        January 27, 2026 or at such other date or place as shall be determined by agreement between the Representatives and the Company.&#160; This date and time are sometimes referred to as the &#8220;<font style="font-weight: bold; font-style: italic;">Closing Date</font>&#8221;.&#160;


        Time shall be of the essence, and delivery at the time and place specified pursuant to this Agreement is a further condition of the obligation of each Underwriter hereunder.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">The Preferred Stock shall be in global form and registered in such names and in such denominations as the Representatives shall request in writing not later than one full business day prior to the
        Closing Date, for the respective accounts of the several Underwriters, with any transfer taxes payable in connection with the transfer of the Securities to the Underwriters duly paid, against payment of the Purchase Price therefor.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">19</font></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Further Agreements of the Company and the Underwriters</font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company agrees:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><a name="z_Ref219566322"></a>(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; To prepare the Prospectus in a form approved by the Representatives and to file such Prospectus pursuant to Rule 424(b) under the
        Securities Act not later than the Commission&#8217;s close of business on the second business day following the execution and delivery of this Agreement; to make no further amendment or any supplement to the Registration Statement or the Prospectus prior
        to the Closing Date except as provided herein; to advise the Representatives, promptly after it receives notice thereof, of the time when any amendment or supplement to the Registration Statement or the Prospectus has been filed and to furnish the
        Representatives with copies thereof upon reasonable written request; to advise the Representatives, promptly after it receives notice thereof, of the issuance by the Commission of any stop order or of any order preventing or suspending the use of
        the Prospectus or any Issuer Free Writing Prospectus, of the suspension of the qualification of the Securities for offering or sale in any jurisdiction, of the initiation or threatening of any proceeding or examination for any such purpose or
        pursuant to Section 8A of the Securities Act, or any notice from the Commission objecting to the use of the form of the Registration Statement or any post-effective amendment thereto or of any request by the Commission for the amending or
        supplementing of the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus or for additional information; and, in the event of the issuance of any stop order or of any order preventing or suspending the use of the Prospectus
        or any Issuer Free Writing Prospectus or suspending any such qualification, to use promptly its reasonable best efforts to obtain its withdrawal of such order.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(ii)&#160;&#160;&#160; &#160; &#160;&#160; Upon written request, to furnish promptly to each of the Representatives and to counsel for the Underwriters a signed copy of the Registration Statement as
        originally filed with the Commission, and each amendment thereto filed with the Commission, including conformed copies of all consents and exhibits filed therewith.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(iii)&#160;&#160;&#160; &#160;&#160; To deliver, upon written request, promptly to the Representatives such number of the following documents as the Representatives shall reasonably request:&#160; (A)
        conformed copies of the Registration Statement as originally filed with the Commission and each amendment thereto (in each case excluding exhibits other than this Agreement and the computation of per share earnings), (B) each Preliminary
        Prospectus, the Prospectus and any amended or supplemented Prospectus, and (C) each Issuer Free Writing Prospectus, and (D) any document incorporated by reference in any Preliminary Prospectus or the Prospectus; and, if the delivery of a prospectus
        is required at any time after the date hereof in connection with the offering or sale of the Securities or any other securities relating thereto and if at such time any events shall have occurred as a result of which the Prospectus as then amended
        or supplemented would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made when such Prospectus is
        delivered, not misleading, or, <a name="z_Hlk155114529"></a>if in the opinion of counsel for the Underwriters, for any other reason it shall be necessary to amend or supplement the Prospectus or to file under the Exchange Act any document
        incorporated by reference in the Prospectus in order to comply with the Securities Act, to notify the Representatives and, upon their request, to file such document and to prepare and furnish without charge to each Underwriter and to any dealer in
        securities (whose name and address the Representative shall furnish to the Company) as many copies as the Representatives may from time to time reasonably request of an amended or supplemented Prospectus that will correct such statement or omission
        or effect such compliance.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">20</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; To file as promptly as practicable with the Commission any amendment or supplement to the Registration Statement or the Prospectus that may, in the judgment of the
        Company or the Representatives, be required by the Securities Act or requested by the Commission in connection with the offering and sale of the Securities.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Prior to filing with the Commission any amendment or supplement to the Registration Statement or the Prospectus, any document incorporated by reference in the
        Prospectus or any amendment to any document incorporated by reference in the Prospectus, to furnish a copy thereof to the Representatives and counsel for the Underwriters and obtain the consent of the Representatives to the filing (such consent not
        to be unreasonably withheld, conditioned or delayed).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(vi)&#160;&#160;&#160;&#160; &#160;&#160; Not to make any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus without the prior written consent of the Representatives
        (such consent not to be unreasonably withheld, conditioned or delayed).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(vii)&#160;&#160; &#160; &#160; To comply with all applicable requirements of Rule 433 under the Securities Act with respect to any Issuer Free Writing Prospectus.&#160; If at any time after the date
        hereof any events shall have occurred as a result of which any Issuer Free Writing Prospectus, as then amended or supplemented, would conflict with the information in the Registration Statement, the most recent Preliminary Prospectus or the
        Prospectus or would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, or, if for any
        other reason it shall be necessary to amend or supplement any Issuer Free Writing Prospectus, to notify the Representatives and, upon their request, to file such document and to prepare and furnish without charge to each Underwriter (whose name and
        address the Representative shall furnish to the Company) as many copies as the Representatives may from time to time reasonably request of an amended or supplemented Issuer Free Writing Prospectus that will correct such conflict, statement or
        omission or effect such compliance.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(viii)&#160; &#160; &#160; If requested by the Representatives, to prepare a final term sheet relating to the offering of the Securities, containing only information that describes the final
        terms of the offering in a form consented to by the Representatives, and to file such final term sheet within the period required by Rule 433(d)(5)(ii) under the Securities Act following the date the final terms have been established for the
        offering of the Securities.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">21</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(ix)&#160;&#160;&#160;&#160;&#160; &#160; As soon as practicable after the Effective Date (it being understood that the Company shall have until at least 410 days or, if the fourth quarter following the
        fiscal quarter that includes the Effective Date is the last fiscal quarter of the Company&#8217;s fiscal year, 455 days after the end of the Company&#8217;s current fiscal quarter), to make generally available to the Company&#8217;s security holders and to deliver
        to the Representatives an earnings statement of the Company and its Subsidiaries (which need not be audited) complying with Section 11(a) of the Securities Act and the rules and regulations thereunder (including, at the option of the Company, Rule
        158), which may be satisfied by filing on EDGAR.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><a name="z_Ref219565709"></a>(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Promptly from time to time to take such action as the Representatives may reasonably request to qualify the Securities for offering and
        sale in such jurisdictions as the Representatives may reasonably request and to comply with such laws so as to permit the continuance of sales and dealings therein in such jurisdictions for as long as may be necessary to complete the distribution
        of the Securities; <font style="font-style: italic;">provided</font>, that in connection therewith the Company shall not be required to (A) qualify as a foreign corporation in any jurisdiction in which it would not otherwise be required to so
        qualify, (B) file a general consent to service of process in any such jurisdiction, or (C) subject itself to taxation in any jurisdiction in which it would not otherwise be subject.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xi)&#160;&#160;&#160;&#160; &#160;&#160; In connection with any future offerings of Preferred Stock (for this purpose, including (i) each sale of the Preferred Stock pursuant to any at-the-market sales
        program and (ii) any Preferred Stock acquired and then resold by the Company or any of its Subsidiaries) (each, a &#8220;<font style="font-weight: bold; font-style: italic;">Future Offering</font>&#8221;), the Company will use its reasonable best efforts
        (which shall include obtaining advice from a qualified external tax advisor) to cause the Preferred Stock to be structured in a manner that is intended to cause the Preferred Stock not to be treated as &#8220;fast-pay stock&#8221; within the meaning of Section
        1.7701(l)-3(b)(2) of the United States Treasury Regulations. For the avoidance of doubt, fulfilling the Tax Guidelines with respect to such Future Offerings (as such Tax Guidelines may be updated by the Company and the Underwriters (and any other
        financial institutions that are parties to any Future Offering) from time to time) will be deemed sufficient to meet the Company&#8217;s obligations under this provision. The Company and the Underwriters further agree and acknowledge that the Company may
        take into account written or oral representations from one or more nationally recognized financial institutions participating in such offering in determining that it has fulfilled the Tax Guidelines.</div>
      <div>&#160;</div>
      <div style="text-align: justify; margin-left: 36pt;">If the Company makes any filing (including a protective filing) (the &#8220;<font style="font-weight: bold; font-style: italic;">Filing</font>&#8221;) pursuant to Section 1.6011-4 of the United States Treasury
        Regulations (or any successor or similar or related regulation, including similar state or local tax regulations) to the effect that it has (or may have, in the case of a protective Filing) issued &#8220;fast-pay stock&#8221; with respect to the Securities or
        any Preferred Stock sold by the Company in Future Offerings, the Company shall (A) announce such Filing by, at the Company&#8217;s option, (i) a press release through a major news service, (ii) publication on the Company&#8217;s investor relations website, or
        (iii) filing a Current Report on Form 8-K with the Securities and Exchange Commission (or provide similar notice to holders of the Securities), in each case, within four business days of the Filing and (B) use reasonable best efforts to promptly
        provide written advance notice (and in any event no later than 10 business days in advance of the Filing) to any potential &#8220;material advisors&#8221; (within the meaning of Section 6111 of the Code) in connection with the Filing. The Company further
        agrees and covenants that if the Company receives any notice of any governmental audit, assessment, claim, examination or other governmental inquiry relating to the tax treatment of the Securities or any Preferred Stock sold by the Company in
        Future Offerings being &#8220;fast-pay stock&#8221; (a &#8220;<font style="font-weight: bold; font-style: italic;">Tax Claim</font>&#8221;) it shall use reasonable best efforts to promptly provide written notice to the Underwriters and any potential &#8220;material advisors&#8221;
        (within the meaning of Section 6111 of the Code) in connection with such Tax Claim.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">22</font></div>
      </div>
      <div style="text-align: justify; margin-left: 36pt;">The foregoing obligations shall survive the sale and delivery of the Securities by the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xii)&#160;&#160;&#160; &#160;&#160; The Company will not take any action prohibited by Regulation M under the Exchange Act in connection with the distribution of the Securities contemplated hereby.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><a name="z_Hlk210298911"></a>(xiii)&#160;&#160;&#160; &#160; Except as contemplated by the Exchange Transactions and for a period commencing on the date hereof and ending on the earlier of (i) the
        first date on which the Preferred Stock is listed for trading on the Nasdaq Global Market and (ii) 15 days from the date of the Prospectus (the &#8220;<font style="font-weight: bold; font-style: italic;">Lock-Up Period</font>&#8221;), not to, and not to
        publicly disclose an intention to, directly or indirectly, (A) offer for sale, sell, pledge, or otherwise dispose of (or enter into any transaction or device that is designed to, or could reasonably be expected to, result in the disposition by any
        person at any time in the future of) any additional shares of Preferred Stock, (B) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of such
        shares of Preferred Stock, whether any such transaction described in clause (A) or (B) above is to be settled by delivery of Preferred Stock or other securities, in cash or otherwise, (C) file, confidentially submit or cause to be confidentially
        submitted or filed a registration statement, including any amendments thereto, with respect to the registration of any shares of the Preferred Stock, or (D) publicly disclose the intention to do any of the foregoing, in each case without the prior
        written consent of Barclays Capital Inc., on behalf of the Underwriters.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xiv)&#160;&#160; &#160;&#160; To apply the net proceeds from the sale of the Securities being sold by the Company substantially in accordance with the description as set forth in the Prospectus
        under the caption &#8220;Use of Proceeds.&#8221;</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xv)&#160;&#160;&#160;&#160;&#160;&#160; To file with the Commission such information on Form 10-Q or Form 10-K as may be required by Rule 463 under the Securities Act.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xvi)&#160;&#160; &#160;&#160; If the Company elects to rely upon Rule 462(b) under the Securities Act, the Company shall file a Rule 462(b) Registration Statement with the Commission in compliance
        with Rule 462(b) under the Securities Act by 10:00 P.M., New York City time, on the date of this Agreement, and the Company shall at the time of filing pay the Commission the filing fee for the Rule 462(b) Registration Statement.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">23</font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xvii)&#160; &#160;&#160; If at any time following the distribution of any Written Testing-the-Waters Communication there occurred or occurs an event or development as a result of which such
        Written Testing-the-Waters Communication included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
        existing at that subsequent time, not misleading, the Company will promptly notify the Representatives and will promptly amend or supplement, at its own expense, such Written Testing-the-Waters Communication to eliminate or correct such&#160; untrue
        statement or omission. The Company will promptly notify the Representatives of (A) any distribution by the Company of Written Testing-the-Waters Communications and (B) any request by the Commission for information concerning the Written
        Testing-the-Waters Communications.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xviii)&#160;&#160;&#160; The Company and its controlled affiliates will not take, directly or indirectly, any action designed to or that has constituted or that reasonably would be expected to
        cause or result in the stabilization or manipulation of the price of any security of the Company in connection with the offering of the Securities.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xix)&#160;&#160;&#160;&#160;&#160; The Company will do and perform all things required or necessary to be done and performed under this Agreement by it prior to the Closing Date, and to satisfy all
        conditions precedent to the Underwriters&#8217; obligations hereunder to purchase the Securities.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(xx)&#160;&#160;&#160; &#160;&#160; The Company will deliver to each Underwriter (or its agent), on or prior to the date of execution of this Agreement, a properly completed and executed Certification
        Regarding Beneficial Owners of Legal Entity Customers or applicable exemption certificate (the &#8220;<font style="font-weight: bold; font-style: italic;">FinCEN Certification</font>&#8221;), together with copies of identifying documentation, of the Company
        and the Company undertakes to provide such additional supporting documentation as each Underwriter may reasonably request in connection with the verification of the FinCEN Certification.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><a name="z_Ref219566275"></a>(b)&#160;&#160;&#160;&#160;&#160; &#160;&#160; Each Underwriter severally agrees that such Underwriter shall not include any &#8220;issuer information&#8221; (as defined in Rule 433 under the Securities Act) in any
        &#8220;free writing prospectus&#8221; (as defined in Rule 405 under the Securities Act) used or referred to by such Underwriter without the prior consent of the Company (any such issuer information with respect to whose use the Company has given its consent, &#8220;<font style="font-weight: bold; font-style: italic;">Permitted Issuer Information</font>&#8221;); <font style="font-style: italic;">provided</font> that (i) no such consent shall be required with respect to any such issuer information contained in any
        document filed by the Company with the Commission prior to the use of such free writing prospectus, and (ii) &#8220;issuer information&#8221;, as used in this Section 5(b), shall not be deemed to include information prepared by or on behalf of such Underwriter
        on the basis of or derived from issuer information.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">24</font></div>
      </div>
      <div>
        <div>
          <div style="text-align: justify; text-indent: 72pt;">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-style: italic;">Expenses.</font>&#160; The Company agrees, whether or not the transactions contemplated by this Agreement are consummated or this Agreement is
            terminated, to pay all expenses, costs, fees and taxes incident to and in connection with (a) the authorization, issuance, sale and delivery of the Securities and any stamp duties or other taxes payable in that connection, and the preparation
            and printing of certificates for the Securities; (b) the preparation, printing and filing under the Securities Act of the Registration Statement (including any exhibits thereto), any Preliminary Prospectus, the Prospectus, any Issuer Free
            Writing Prospectus, any Written Testing-the-Waters Communication and any amendment or supplement thereto; (c) the distribution of the Registration Statement (including any exhibits thereto), any Preliminary Prospectus, the Prospectus, any
            Issuer Free Writing Prospectus, any Written Testing-the-Waters Communication, and any amendment or supplement thereto, or any document incorporated by reference therein, all as provided in this Agreement; (d) the production and distribution of
            this Agreement, any supplemental agreement among Underwriters, and any other related documents in connection with the offering, purchase, sale and delivery of the Securities; (e) any required review by FINRA of the terms of sale of the
            Securities and the qualification of the Securities under the securities laws of the several jurisdictions as provided in Section 5(a)(x) and the preparation, printing and distribution of a Blue Sky Memorandum (including related reasonable and
            documented fees and expenses of counsel to the Underwriters in an amount that is not greater than $35,000); (f) the listing of the Securities on The Nasdaq Global Market and/or any other exchange; (g) the preparation, printing and distribution
            of one or more versions of the Preliminary Prospectus and the Prospectus for distribution in Canada; (h) the investor presentations on any &#8220;road show&#8221; or any Testing-the-Waters Communication, undertaken in connection with the marketing of the
            Securities, including, without limitation, expenses associated with any electronic road show, travel and lodging expenses of the representatives and officers of the Company and 50% of the cost of any aircraft chartered in connection with the
            road show (the remaining half of the cost to be borne by the Underwriters); and (i) all other costs and expenses incident to the performance of the obligations of the Company under this Agreement; <font style="font-style: italic;">provided,
              however</font>, that, except as provided in this Section 6 and in Section 11, the Underwriters shall pay their own costs and expenses, including the costs and expenses of their counsel, any transfer taxes on the Securities which they may sell
            and the expenses of advertising any offering of the Securities made by the Underwriters and travel (provided that the Underwriters are responsible for 50% of the cost of any aircraft chartered in connection with the road show), lodging and
            other expenses of the Underwriters or any of their employees or representatives incurred by them in connection with any &#8220;road show.&#8221;</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 72pt;">7.&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-style: italic;">Conditions of Underwriters&#8217; Obligations</font>.&#160; The respective obligations of the Underwriters hereunder are subject to the accuracy, when made
            and on the Closing Date, of the representations and warranties of the Company contained herein, to the performance by the Company of its obligations hereunder in all material respects, and to each of the following additional terms and
            conditions:</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160; &#160; The Prospectus shall have been timely filed with the Commission in accordance with Section 5(a)(i).&#160; The Company shall have complied with all filing requirements
            applicable to any Issuer Free Writing Prospectus used or referred to after the date hereof; no stop order suspending the effectiveness of the Registration Statement or preventing or suspending the use of the Prospectus or any Issuer Free
            Writing Prospectus shall have been issued and no proceeding or examination for such purpose or pursuant to Section 8A of the Securities Act shall have been initiated or, to the knowledge of the Company, threatened by the Commission; and any
            request of the Commission for inclusion of additional information in the Registration Statement or the Prospectus or otherwise shall have been complied with to the Representatives&#8217; reasonable satisfaction.&#160; If the Company has elected to rely
            upon Rule 462(b) under the Securities Act, the Rule 462(b) Registration Statement shall have become effective by 10:00 P.M., New York City time, on the date of this Agreement.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;[Reserved].</div>
          <div>&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">25</font></div>
          </div>
          <!--PROfilePageNumberReset%Num%25%%%-->
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(c)&#160;&#160;&#160;&#160; &#160; &#160; All corporate proceedings and other legal matters incident to the authorization, form and validity of this Agreement, the Securities, the Registration Statement,
            the Prospectus and any Issuer Free Writing Prospectus, and all other legal matters relating to this Agreement and the transactions contemplated hereby shall be reasonably satisfactory in all material respects to counsel for the Underwriters,
            and the Company shall have furnished to such counsel all documents and information that they may reasonably request to enable them to pass upon such matters.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160; Davis Polk &amp; Wardwell LLP, as counsel to the Company shall have furnished to the Representatives its written opinion and negative assurance letter, as counsel
            to the Company, addressed to the Underwriters and dated as of the Closing Date, in form and substance reasonably satisfactory to the Representatives.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(e)&#160;&#160;&#160;&#160;&#160; &#160;&#160; Brownstein Hyatt Farber Schreck, LLP, as Nevada counsel to the Company, shall have furnished to the Representatives its written opinion, as counsel to the
            Company, addressed to the Underwriters and dated the Closing Date, in form and substance reasonably satisfactory to the Representatives.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Representatives shall have received from DLA Piper LLP (US), counsel for the Underwriters, such opinion and negative assurance letter, dated the Closing Date,
            with respect to the issuance and sale of the Securities, the Registration Statement, the Prospectus and the Pricing Disclosure Package and other related matters as the Representatives may reasonably require, and the Company shall have furnished
            to such counsel such documents as they reasonably request for the purpose of enabling them to pass upon such matters.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; At the time of execution of this Agreement, the Representatives shall have received from the Accountants letters, in form and substance reasonably satisfactory to
            the Representatives, addressed to the Underwriters and dated the date hereof (i) confirming that they are independent public accountants within the meaning of the Securities Act and are in compliance with the applicable requirements relating to
            the qualification of accountants under Rule 2-01 of Regulation S&#8209;X of the Commission, and (ii) stating, as of the date hereof (or, with respect to matters involving changes or developments since the respective dates as of which specified
            financial information is given in the most recent Preliminary Prospectus, as of a date not more than three business days prior to the date hereof), the conclusions and findings of such firm with respect to the financial information and other
            matters ordinarily covered by accountants&#8217; &#8220;comfort letters&#8221; to underwriters in connection with registered public offerings.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(h)&#160;&#160;&#160;&#160;&#160; &#160;&#160; With respect to the letters of the Accountants referred to in the preceding paragraph and delivered to the Representatives concurrently with the execution of this
            Agreement (the &#8220;<font style="font-weight: bold; font-style: italic;">initial letter</font>&#8221;), the Company shall have furnished to the Representatives a letter (the &#8220;<font style="font-weight: bold; font-style: italic;">bring-down letter</font>&#8221;)
            of such accountants, addressed to the Underwriters and dated the Closing Date (i) confirming that they are independent public accountants within the meaning of the Securities Act and are in compliance with the applicable requirements relating
            to the qualification of accountants under Rule 2-01 of Regulation S-X of the Commission, (ii) stating, as of the date of the bring-down letter (or, with respect to matters involving changes or developments since the respective dates as of which
            specified financial information is given in the Prospectus, as of a date not more than three business days prior to the date of the bring-down letter), the conclusions and findings of such firm with respect to the financial information and
            other matters covered by the initial letter, and (iii) confirming in all material respects the conclusions and findings set forth in the initial letter.</div>
          <div>&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">26</font></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; The Company shall have furnished to the Representatives a certificate, dated the Closing Date, of its Chief Executive Officer and its Chief Financial Officer as
            to such matters as the Representatives may reasonably request, including, without limitation, a statement:</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">(i)&#160;&#160;&#160;&#160;&#160; &#160;&#160; That the representations, warranties and agreements of the Company in Section 1 (A) to the extent such representations and warranties are subject to
            qualifications and exceptions contained therein relating to materiality or Material Adverse Effect, are true and correct on and as of the Closing Date with the same force and effect as if expressly made on and as of the date hereof, except for
            those representations and warranties that speak solely as of a specific date and which were true and correct as of such date, and (B) to the extent such representations and warranties are not subject to any qualifications or exceptions, are
            true and correct in all material respects on and as of the Closing Date as if made on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof, except for those representations and warranties
            that speak solely as of a specific date and which were true and correct as of such date; <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>, that in the case of clauses (A) and (B) such
            representations and warranties also shall be qualified by the disclosure included or incorporated by reference in the Registration Statement and Prospectus, and the Company has complied with all its agreements contained herein and satisfied all
            the conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date;</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">(ii)&#160;&#160; &#160; &#160;&#160; That no stop order suspending the effectiveness of the Registration Statement has been issued; and no proceedings or examination for that purpose or pursuant to
            Section 8A of the Securities Act have been instituted or, to the knowledge of such officers, threatened; and the Commission shall not have notified the Company of any objection to the use of the form of the Registration Statement or any
            post-effective amendment thereto;</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">(iii)&#160;&#160;&#160;&#160;&#160; That they have examined the Registration Statement, the Prospectus and the Pricing Disclosure Package, and, in their opinion, (A) (1) the Registration Statement,
            as of the Effective Date, (2) the Prospectus, as of its date and on the Closing Date, and (3) the Pricing Disclosure Package, as of the Applicable Time, did not and do not contain any untrue statement of a material fact and did not and do not
            omit to state a material fact required to be stated therein or necessary to make the statements therein (except in the case of the Registration Statement, in the light of the circumstances under which they were made) not misleading, and (B)
            since the Effective Date, no event has occurred that should have been set forth in a supplement or amendment to the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus that has not been so set forth; and</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160; To the effect of Section 7(j).</div>
          <div>&#160;
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">27</font></div>
            </div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except as described in the most recent Preliminary Prospectus, (i) neither the Company nor any of its Subsidiaries shall have sustained, since the date of the
            latest audited financial statements included or incorporated by reference in the most recent Preliminary Prospectus, any loss or interference with its business, taken as a whole, from fire, explosion, flood or other calamity, whether or not
            covered by insurance, or from any labor dispute or court or governmental action, order or decree, or (ii) since such date there shall not have been any change in the capital stock (other than as a result of the exercise or settlement (including
            any &#8220;net&#8221; or &#8220;cashless&#8221; exercises or settlements), if any, of share options or restricted share units or the award, if any, of share options, restricted share units or restricted shares, pursuant to the Company&#8217;s equity plans described in the
            Registration Statement, the Pricing Disclosure Package and the Prospectus) or long-term debt of the Company or any of its Subsidiaries or any material adverse change, in or affecting the condition (financial or otherwise), results of
            operations, stockholders&#8217; equity, properties, management, business or prospects of the Company and its Subsidiaries taken as a whole, the effect of which, in any such case described in clause (i) or (ii), is, individually or in the aggregate,
            in the judgment of the Representatives, so material and adverse as to make it impracticable or inadvisable to proceed with the public offering or the delivery of the Securities being delivered on the Closing Date on the terms and in the manner
            contemplated in the Prospectus.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsequent to the execution and delivery of this Agreement there shall not have occurred any of the following:&#160; (i) (A) trading in securities generally on any
            securities exchange that has registered with the Commission under Section 6 of the Exchange Act (including the New York Stock Exchange, The Nasdaq Global Select Market, The Nasdaq Global Market or The Nasdaq Capital Market), or (B) trading in
            any securities of the Company on any exchange or in the over-the-counter market, shall have been suspended or materially limited or the settlement of such trading generally shall have been materially disrupted or minimum prices shall have been
            established on any such exchange or such market by the Commission, by such exchange or by any other regulatory body or governmental authority having jurisdiction, (ii) a general moratorium on commercial banking activities shall have been
            declared by federal or state authorities, (iii) the United States shall have become engaged in hostilities, there shall have been an escalation in hostilities involving the United States or there shall have been a declaration of a national
            emergency or war by the United States, or (iv) there shall have occurred such a material adverse change in general economic, political or financial conditions, including, without limitation, as a result of terrorist activities after the date
            hereof (or the effect of international conditions on the financial markets in the United States shall be such) or any other calamity or crisis, either within or outside the United States, in each case as to make it, in the reasonable judgment
            of the Representatives, impracticable or inadvisable to proceed with the public offering or delivery of the Securities being delivered on the Closing Date on the terms and in the manner contemplated in the Prospectus.</div>
          <div>&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">28</font></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(l)&#160;&#160;&#160;&#160;&#160; &#160; &#160; On or prior to the Closing Date, the Company shall have furnished to the Underwriters such further certificates and documents as the Representatives may
            reasonably request.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(m)&#160;&#160;&#160;&#160; &#160;&#160; FINRA shall not have raised any objection with respect to the fairness or reasonableness of the underwriting, or other arrangements of the transactions,
            contemplated hereby.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(n)&#160;&#160;&#160;&#160;&#160; &#160;&#160; The Company shall have filed a Notification: Listing of Additional Shares with Nasdaq to satisfy the Company&#8217;s notification obligation under Nasdaq Listing Rule
            5250(e)(2).</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 72pt;">All opinions, letters, evidence and certificates mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and
            substance reasonably satisfactory to counsel for the Underwriters.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 72pt;">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Indemnification and Contribution.</font></div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(a)&#160;&#160;&#160;&#160; &#160; &#160; The Company hereby agrees to indemnify and hold harmless each Underwriter, its affiliates, directors, officers and employees and each person, if any, who controls
            any Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any loss, claim, damage or liability, joint or several, or any action in respect thereof (including, but not limited to,
            any loss, claim, damage, liability or action relating to purchases and sales of the Securities), to which that Underwriter, affiliate, director, officer, employee or controlling person may become subject, under the Securities Act or otherwise,
            insofar as such loss, claim, damage, liability or action arises out of, or is based upon, (i) any untrue statement or alleged untrue statement of a material fact contained in (A) any Preliminary Prospectus, the Registration Statement, the
            Prospectus or in any amendment or supplement thereto, (B) any Issuer Free Writing Prospectus or in any amendment or supplement thereto, (C) any Permitted Issuer Information used or referred to in any &#8220;free writing prospectus&#8221; (as defined in
            Rule 405 under the Securities Act) used or referred to by any Underwriter, (D) any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the offering of the Securities,
            including any &#8220;road show&#8221; (as defined in Rule 433 under the Securities Act) not constituting an Issuer Free Writing Prospectus and any Written Testing-the-Waters Communication (&#8220;<font style="font-weight: bold; font-style: italic;">Marketing
              Materials</font>&#8221;), or (E) any Blue Sky application or other document prepared or executed by the Company (or based upon any written information furnished by the Company for use therein) specifically for the purpose of qualifying any or all
            of the Securities under the securities laws of any state or other jurisdiction (any such application, document or information being hereinafter called a &#8220;<font style="font-weight: bold; font-style: italic;">Blue Sky Application</font>&#8221;) or (ii)
            the omission or alleged omission to state in any Preliminary Prospectus, the Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any Permitted Issuer Information, any
            Marketing Materials or any Blue Sky Application, any material fact required to be stated therein or necessary to make the statements therein not misleading, and shall reimburse each Underwriter and each such affiliate, director, officer,
            employee or controlling person promptly upon demand for any legal or other documented out-of-pocket expenses reasonably incurred by that Underwriter, affiliate, director, officer, employee or controlling person in connection with investigating
            or defending or preparing to defend against any such loss, claim, damage, liability or action as such expenses are incurred; <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>, that the Company
            shall not be liable in any such case to the extent that any such loss, claim, damage, liability or action arises out of, or is based upon, any untrue statement or alleged untrue statement or omission or alleged omission made in any Preliminary
            Prospectus, the Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or in any such amendment or supplement thereto or in any Permitted Issuer Information, any Marketing Materials or any Blue Sky Application, in reliance
            upon and in conformity with written information concerning such Underwriter furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein, which information consists solely of the
            information specified in Section 8(e) hereof.&#160; The foregoing indemnity agreement is in addition to any liability which the Company may otherwise have to any Underwriter or to any affiliate, director, officer, employee or controlling person of
            that Underwriter.</div>
          <div>&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">29</font></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160; &#160; Each Underwriter, severally and not jointly, shall indemnify and hold harmless the Company, its respective directors, officers and employees, and each person, if
            any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any loss, claim, damage or liability, joint or several, or any action in respect thereof, to which the
            Company or any such affiliate,&#160; director, officer, employee or controlling person may become subject, under the Securities Act or otherwise, insofar as such loss, claim, damage, liability or action arises out of, or is based upon, (i) any
            untrue statement or alleged untrue statement of a material fact contained in any Preliminary Prospectus, the Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any
            Marketing Materials or Blue Sky Application, or (ii) the omission or alleged omission to state in any Preliminary Prospectus, the Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement
            thereto or in any Marketing Materials or Blue Sky Application, any material fact required to be stated therein or necessary to make the statements therein not misleading, but in each case only to the extent that the untrue statement or alleged
            untrue statement or omission or alleged omission was made in reliance upon and in conformity with written information concerning such Underwriter furnished to the Company through the Representatives by or on behalf of that Underwriter
            specifically for inclusion therein, which information is limited to the information set forth in Section 8(e) hereof.&#160; The foregoing indemnity agreement is in addition to any liability that any Underwriter may otherwise have to the Company or
            any such affiliate, director, officer, employee or controlling person.</div>
          <div>&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">30</font></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promptly after receipt by an indemnified party under this Section 8 of notice of any claim or the commencement of any action, the indemnified party shall, if a
            claim in respect thereof is to be made against the indemnifying party under this Section 8, notify the indemnifying party in writing of the claim or the commencement of that action; <font style="font-style: italic;">provided</font>,<font style="font-style: italic;"> however</font>, that the failure to notify the indemnifying party shall not relieve it from any liability which it may have under this Section 8 except to the extent it has been materially prejudiced (through the
            forfeiture of substantive rights and defenses) by such failure and, <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">further</font>, that the failure to notify the indemnifying party shall not relieve it
            from any liability which it may have to an indemnified party otherwise than under this Section 8.&#160; If any such claim or action shall be brought against an indemnified party, and it shall notify the indemnifying party thereof, the indemnifying
            party shall be entitled to participate therein and, to the extent that it wishes, jointly with any other similarly notified indemnifying party, to assume the defense thereof with counsel reasonably satisfactory to the indemnified party.&#160; After
            notice from the indemnifying party to the indemnified party of its election to assume the defense of such claim or action, the indemnifying party shall not be liable to the indemnified party under this Section 8 for any legal or other expenses
            subsequently incurred by the indemnified party in connection with the defense thereof other than reasonable and documented out-of-pocket costs of investigation; <font style="font-style: italic;">provided, however</font>, that the indemnified
            party shall have the right to employ counsel to represent jointly the indemnified party and those other indemnified parties and their respective directors, officers, employees and controlling persons who may be subject to liability arising out
            of any claim in respect of which indemnity may be sought under this Section 8 if (i) the indemnified party and the indemnifying party shall have so mutually agreed; (ii) the indemnifying party has failed within a reasonable time to retain
            counsel reasonably satisfactory to the indemnified party; (iii) the indemnified party and its directors, officers, employees and controlling persons shall have reasonably concluded based on the advice of counsel that there may be legal defenses
            available to them that are different from or in addition to those available to the indemnifying party; or (iv) the named parties in any such proceeding (including any impleaded parties) include both the indemnified parties or their respective
            directors, officers, employees or controlling persons, on the one hand, and the indemnifying party, on the other hand, and, based on the advice of counsel, representation of both sets of parties by the same counsel would be inappropriate due to
            actual or potential differing interests between them, and in any such event the reasonable and documented fees and expenses of such separate counsel shall be paid by the indemnifying party.&#160; No indemnifying party shall (x) without the prior
            written consent of the indemnified parties (which consent shall not be unreasonably withheld), settle or compromise or consent to the entry of any judgment with respect to any pending or threatened claim, action, suit or proceeding in respect
            of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such claim or action) unless such settlement, compromise or consent includes an unconditional release of
            each indemnified party from all liability arising out of such claim, action, suit or proceeding and does not include a statement as to, or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party, or (y)
            be liable for any settlement of any such action effected without its written consent (which consent shall not be unreasonably withheld), but if settled with the consent of the indemnifying party or if there be a final judgment for the plaintiff
            in any such action, the indemnifying party agrees to indemnify and hold harmless any indemnified party from and against any loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an
            indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel as contemplated by Section 8(a) or (b) hereof, the indemnifying party agrees that it shall be liable for any
            settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 30 days after receipt by such indemnifying party of the aforesaid request and (ii) such indemnifying party shall not have
            reimbursed the indemnified party in accordance with such request or disputed in good faith the indemnified party&#8217;s entitlement to such reimbursement prior to the date of such settlement.</div>
          <div>&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">31</font></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(d)&#160;&#160;&#160;&#160;&#160; &#160;&#160; If the indemnification provided for in this Section 8 shall for any reason be unavailable to or insufficient to hold harmless an indemnified party under Section
            8(a) or 8(b) in respect of any loss, claim, damage or liability, or any action in respect thereof, referred to therein, then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the amount paid or payable
            by such indemnified party as a result of such loss, claim, damage or liability, or action in respect thereof, (i) in such proportion as shall be appropriate to reflect the relative benefits received by the Company, on the one hand, and the
            Underwriters, on the other hand, from the offering of the Securities, or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits
            referred to in clause (i) above but also the relative fault of the Company, on the one hand, and the Underwriters, on the other hand, with respect to the statements or omissions that resulted in such loss, claim, damage or liability, or action
            in respect thereof, as well as any other relevant equitable considerations. The relative benefits received by the Company, on the one hand, and the Underwriters, on the other hand, with respect to such offering shall be deemed to be in the same
            proportion as the total net proceeds from the offering of the Securities purchased under this Agreement (before deducting expenses) received by the Company, as set forth in the table on the cover page of the Prospectus, on the one hand, and the
            total underwriting discounts and commissions received by the Underwriters with respect to the Securities purchased under this Agreement, as set forth in the table on the cover page of the Prospectus, on the other hand.&#160; The relative fault shall
            be determined by reference to whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or the Underwriters, the intent of the
            parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission.&#160; The Company and the Underwriters agree that it would not be just and equitable if contributions pursuant to this
            Section 8(d) were to be determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take into account the equitable considerations referred to
            herein.&#160; The amount paid or payable by an indemnified party as a result of the loss, claim, damage or liability, or action in respect thereof, referred to above in this Section 8(d) shall be deemed to include, for purposes of this Section 8(d),
            any documented out-of-pocket legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim.&#160; Notwithstanding the provisions of this Section 8(d), in no event shall
            an Underwriter be required to contribute any amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the offering of the Securities exceeds the amount of any damages
            that such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.&#160; No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
            Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.&#160; The Underwriters&#8217; obligations to contribute as provided in this Section 8(d) are several in proportion to their
            respective underwriting obligations and not joint.</div>
          <div>&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">32</font></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(e)&#160;&#160;&#160;&#160; &#160; &#160; The Underwriters severally confirm and the Company acknowledges and agrees that the statements regarding delivery of the Securities by the Underwriters set forth
            on the cover page of, and the concession and reallowance figures and the paragraph relating to stabilization by the Underwriters appearing under the caption &#8220;Underwriting&#8221; in, the most recent Preliminary Prospectus and the Prospectus are
            correct and constitute the only information concerning such Underwriters furnished in writing to the Company by or on behalf of the Underwriters specifically for inclusion in any Preliminary Prospectus, the Registration Statement, the
            Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any Marketing Materials.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 72pt;">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Defaulting Underwriters</font>.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(a)&#160;&#160;&#160; &#160;&#160; &#160; If, on the Closing Date, any Underwriter defaults in its obligations to purchase the Securities that it has agreed to purchase under this Agreement, the remaining
            non-defaulting Underwriters may in their discretion arrange for the purchase of such Securities by the non-defaulting Underwriters or other persons satisfactory to the Company on the terms contained in this Agreement.&#160; If, within 36 hours after
            any such default by any Underwriter, the non-defaulting Underwriters do not arrange for the purchase of such Securities, then the Company shall be entitled to a further period of 36 hours within which to procure other persons satisfactory to
            the non-defaulting Underwriters to purchase such Securities on such terms.&#160; In the event that within the respective prescribed periods, the non-defaulting Underwriters notify the Company that they have so arranged for the purchase of such
            Securities, or the Company notifies the non-defaulting Underwriters that it has so arranged for the purchase of such Securities, either the non-defaulting Underwriters or the Company may postpone such Closing Date for up to seven full business
            days in order to effect any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement, the Prospectus or in any other document or arrangement, and the Company agrees to
            promptly prepare any amendment or supplement to the Registration Statement, the Prospectus or in any such other document or arrangement that effects any such changes.&#160; As used in this Agreement, the term &#8220;Underwriter,&#8221; unless the context
            requires otherwise, includes any party not listed in Schedule I hereto that, pursuant to this Section 9, purchases Securities that a defaulting Underwriter agreed but failed to purchase.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(b)&#160;&#160;&#160;&#160;&#160; &#160;&#160; If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the non-defaulting Underwriters and
            the Company as provided in paragraph (a) above, the total number of Securities that remain unpurchased does not exceed one-eleventh of the total number of Securities, then the Company shall have the right to require each non-defaulting
            Underwriter to purchase the total number of Securities that such Underwriter agreed to purchase hereunder plus such Underwriter's <u>pro</u>&#160;<u>rata</u> share (based on the total number of Securities that such Underwriter agreed to purchase
            hereunder) of the Securities of such defaulting Underwriter or Underwriters for which such arrangements have not been made; <font style="font-style: italic;">provided</font> that the non-defaulting Underwriters shall not be obligated to
            purchase more than 110% of the total Securities that it agreed to purchase on the Closing Date pursuant to the terms of Section 2.</div>
          <div>&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">33</font></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160; &#160; If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the non-defaulting Underwriters and
            the Company as provided in paragraph (a) above, the total number of Securities that remain unpurchased exceeds one-eleventh of the total number of all the Securities, or if the Company shall not exercise the right described in paragraph (b)
            above, then this Agreement shall terminate without liability on the part of the non-defaulting Underwriters.&#160; Any termination of this Agreement pursuant to this Section 9 shall be without liability on the part of the Company, except that the
            Company will continue to be liable for the payment of expenses as set forth in Sections 6 and 11 and except that the provisions of Section 8 shall not terminate and shall remain in effect.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(d)&#160;&#160;&#160;&#160; &#160; &#160; Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company or any non-defaulting Underwriter for damages caused
            by its default.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 72pt;">10.&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Termination.</font>&#160; The obligations of the Underwriters hereunder may be terminated by the Representatives by notice given to and received by the
            Company prior to delivery of and payment for the Securities if, prior to that time, any of the events described in Sections 7(j) shall have occurred or if the Underwriters shall decline to purchase the Securities for any reason permitted under
            this Agreement.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 72pt;">11.&#160;&#160;&#160; &#160;&#160;&#160;&#160; <font style="font-style: italic;">Reimbursement of Underwriters&#8217; Expenses.</font>&#160; If (a) the Company shall fail to tender the Securities for delivery to the Underwriters for any
            reason, or (b) the Underwriters shall decline to purchase the Securities for any reason permitted under this Agreement, the Company will reimburse the Underwriters for all reasonable and documented out-of-pocket expenses (including the
            reasonable and documented fees and disbursements of counsel for the Underwriters) incurred by the Underwriters in connection with this Agreement and the proposed purchase of the Securities, and upon demand the Company shall pay the full amount
            thereof to the Representatives.&#160; If this Agreement is terminated pursuant to Section 9 by reason of the default of one or more Underwriters, the Company shall not be obligated to reimburse any defaulting Underwriter on account of those
            expenses.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 72pt;">12.&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-style: italic;">Research Analyst Independence. </font> The Company acknowledges that the Underwriters&#8217; research analysts and research departments are required to
            be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriters&#8217; research analysts may hold views and make statements or investment recommendations
            and/or publish research reports with respect to the Company and/or the offering that differ from the views of their respective investment banking divisions.&#160; The Company hereby waives and releases, to the fullest extent permitted by law, any
            claims that the Company may have against the Underwriters with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or
            inconsistent with the views or advice communicated to the Company by such Underwriters&#8217; investment banking divisions.&#160; The Company acknowledges that each of the Underwriters is a full service securities firm and as such from time to time,
            subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short positions in debt or equity securities of the companies that may be the subject of the transactions
            contemplated by this Agreement.</div>
          <div>&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">34</font></div>
          </div>
          <div style="text-align: justify; text-indent: 72pt;">13.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">No Fiduciary Duty</font>.&#160; The Company acknowledges and agrees that in connection with this offering, sale of the Securities or any other services
            the Underwriters may be deemed to be providing hereunder, notwithstanding any preexisting relationship, advisory or otherwise, between the parties or any oral representations or assurances previously or subsequently made by the Underwriters:
            (a) no fiduciary or agency relationship between the Company and any other person, on the one hand, and the Underwriters, on the other hand, exists; (b) the Underwriters are not acting as advisors, expert or otherwise and are not providing a
            recommendation or investment advice, to the Company, including, without limitation, with respect to the determination of the public offering price of the Securities, and such relationship between the Company, on the one hand, and the
            Underwriters, on the other hand, is entirely and solely commercial, based on arms-length negotiations and, as such, not intended for use by any individual for personal, family or household purposes; (c) any duties and obligations that the
            Underwriters may have to the Company shall be limited to those duties and obligations specifically stated herein; (d) the Underwriters and their respective affiliates may have interests that differ from those of the Company; and (e) does not
            constitute a solicitation of any action by the Underwriters.&#160; The Company hereby (x) waives any claims that the Company may have against the Underwriters with respect to any breach of fiduciary duty in connection with this offering and (y)
            agree that none of the activities of the Underwriters in connection with the transactions contemplated herein constitutes a recommendation, investment advice or solicitation of any action by the Underwriters with respect to any entity or
            natural person. The Company has consulted its own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 72pt;">14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Notices, etc.</font>&#160; All statements, requests, notices and agreements hereunder shall be in writing, and:</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160; &#160; if to the Underwriters, shall be delivered or sent by mail or facsimile transmission to Barclays Capital Inc., 745 Seventh Avenue, New York, New York 10019,
            Attention: Syndicate Registration (Fax: (646) 834-8133), with a copy, in the case of any notice pursuant to Section 8(c), to the Director of Litigation, Office of the General Counsel, Barclays Capital Inc., 745 Seventh Avenue, New York, New
            York 10019; and</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">(b)&#160;&#160;&#160;&#160;&#160; &#160;&#160; if to the Company, shall be delivered or sent by mail or facsimile transmission to the address of the Company set forth in the Registration Statement, Attention:
            <font style="color: rgb(0, 0, 0);">Logan Beirne</font> (E-mail: <font style="color: rgb(0, 0, 0);">Logan.Beirne@strive.com</font>).</div>
          <div>&#160;</div>
          <div style="text-align: justify;">Any such statements, requests, notices or agreements shall take effect at the time of receipt thereof.&#160; The Company shall be entitled to act and rely upon any request, consent, notice or agreement given or made
            on behalf of the Underwriters by Barclays Capital Inc. on behalf of the Representatives.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 72pt;">15.&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-style: italic;">Persons Entitled to Benefit of Agreement</font>.&#160; This Agreement shall inure to the benefit of and be binding upon the Underwriters, the Company,
            and their respective successors.&#160; This Agreement and the terms and provisions hereof are for the sole benefit of only those persons, except that (a) the representations, warranties, indemnities and agreements of the Company contained in this
            Agreement shall also be deemed to be for the benefit of the affiliates, directors, officers and employees of the Underwriters and each person or persons, if any, who control any Underwriter within the meaning of Section 15 of the Securities Act
            or Section 20 of the Exchange Act, and (b) the indemnity agreement of the Underwriters contained in Section 8(b) of this Agreement shall be deemed to be for the benefit of the affiliates, directors of the Company, the officers of the Company
            who have signed the Registration Statement and any person controlling the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act.&#160; Nothing in this Agreement is intended or shall be construed to give any
            person, other than the persons referred to in this Section 15, any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein.</div>
          <div>&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">35</font></div>
          </div>
          <div style="text-align: justify; text-indent: 72pt;">16.&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-style: italic;">Survival.</font>&#160; The respective indemnities, rights of contributions, representations, warranties and agreements of the Company and the
            Underwriters contained in this Agreement or made by or on behalf of them, respectively, pursuant to this Agreement, shall survive the delivery of and payment for the Securities and shall remain in full force and effect, regardless of any
            investigation made by or on behalf of any of them or any person controlling any of them.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 72pt;">17.&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-style: italic;">Definition of the Terms &#8220;Business Day,&#8221; &#8220;Affiliate&#8221; and &#8220;Subsidiary&#8221;</font>.&#160; For purposes of this Agreement, (a) &#8220;<font style="font-weight: bold; font-style: italic;">business day</font>&#8221; means each Monday, Tuesday, Wednesday, Thursday or Friday that is not a day on which banking institutions in New York are generally authorized or obligated by law or executive order to close, and (b)
            &#8220;<font style="font-weight: bold; font-style: italic;">affiliate</font>&#8221; and &#8220;<font style="font-weight: bold; font-style: italic;">subsidiary</font>&#8221; have the meanings set forth in Rule 405 under the Securities Act.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 72pt;">18.&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-style: italic;">Governing Law</font>.&#160; <font style="font-weight: bold;">This Agreement and any transaction contemplated by this Agreement shall be governed by
              and construed in accordance with the laws of the State of New York without regard to conflict of laws principles that would result in the application of any other law than the laws of the State of New York (other than Section 5-1401 of the
              General Obligations Law).</font></div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 72pt;">19.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Waiver of Jury Trial</font>.&#160; The Company and the Underwriters hereby irrevocably waive, to the fullest extent permitted by applicable law, any
            and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 72pt;">20.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Counterparts.</font>&#160; This Agreement may be executed in one or more counterparts and, if executed in more than one counterpart, the executed
            counterparts shall each be deemed to be an original but all such counterparts shall together constitute one and the same instrument. Delivery of an executed Agreement by one party to any other party may be made by facsimile, electronic mail
            (including any electronic signature complying with the New York Electronic Signatures and Records Act (N.Y. State Tech. &#167;&#167; 301-309), as amended from time to time, or other applicable law) or other transmission method, and the parties hereto
            agree that any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: 72pt;">21.&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-style: italic;">Headings.</font>&#160; The headings herein are inserted for convenience of reference only and are not intended to be part of, or to affect the meaning
            or interpretation of, this Agreement.</div>
          <div>&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">36</font></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt;">If the foregoing correctly sets forth the agreement between the Company and the Underwriters, please indicate your acceptance in the space provided for that purpose below.</div>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" border="0" id="z501a5ce04ca44f1d8af3841cc40f1b32" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">&#160;</td>
                <td colspan="2" rowspan="1" style="vertical-align: top;">
                  <div>Very truly yours,</div>
                </td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top;">&#160;</td>
                <td style="width: 5%; vertical-align: top;">&#160;</td>
                <td style="vertical-align: top; width: 45%;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top;">&#160;</td>
                <td colspan="2" rowspan="1" style="vertical-align: top;">
                  <div>STRIVE, INC.</div>
                </td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top;">&#160;</td>
                <td style="width: 5%; vertical-align: top;"><br>
                </td>
                <td style="vertical-align: top; width: 45%;"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                  <div>By:</div>
                </td>
                <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1"> /s/ Matthew Cole<br>
                </td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top;">&#160;</td>
                <td style="width: 5%; vertical-align: top;"><br>
                </td>
                <td style="vertical-align: top; width: 45%;">
                  <div>Name: Matthew Cole</div>
                </td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top;">&#160;</td>
                <td style="width: 5%; vertical-align: top;"><br>
                </td>
                <td style="vertical-align: top; width: 45%;">
                  <div>Title: Chief Executive Officer</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">37</font></div>
          </div>
          <div style="text-align: justify; text-indent: -216pt; margin-left: 216pt;">Accepted:</div>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" border="0" id="zd6f2349e06a04f8cb528a5405872129f" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

              <tr>
                <td colspan="3" rowspan="1" style="vertical-align: top;">
                  <div style="font-variant: small-caps;">Barclays Capital Inc.</div>
                </td>
                <td style="width: 50%; vertical-align: top;"><br>
                </td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="vertical-align: top;">
                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-variant: small-caps;">Cantor Fitzgerald &amp; Co</font><font style="font-size: 10pt;">.</font></div>
                </td>
                <td style="width: 50%; vertical-align: top;"><br>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
                <td colspan="2" rowspan="1" style="vertical-align: top;">&#160;</td>
                <td rowspan="1" style="width: 50%; vertical-align: top;"><br>
                </td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="vertical-align: top;">
                  <div>For themselves and as Representatives</div>
                </td>
                <td style="width: 50%; vertical-align: top;"><br>
                </td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="vertical-align: top;">
                  <div>of the several Underwriters named</div>
                </td>
                <td style="width: 50%; vertical-align: top;"><br>
                </td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="vertical-align: top;">
                  <div>in Schedule I hereto</div>
                </td>
                <td style="width: 50%; vertical-align: top;"><br>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
                <td colspan="2" rowspan="1" style="vertical-align: top;">&#160;</td>
                <td rowspan="1" style="width: 50%; vertical-align: top;"><br>
                </td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="vertical-align: top;">
                  <div style="text-align: justify;">By BARCLAYS CAPITAL INC.</div>
                </td>
                <td style="width: 50%; vertical-align: top;"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top;">&#160;</td>
                <td colspan="2" style="vertical-align: top;">&#160;</td>
                <td style="width: 50%; vertical-align: top;"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                  <div style="text-align: justify;">By:</div>
                </td>
                <td rowspan="1" style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"> /s/ Matt Gannon<br>
                </td>
                <td style="width: 19%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                <td style="width: 50%; vertical-align: top; padding-bottom: 2px;"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top;">&#160;</td>
                <td colspan="2" style="vertical-align: top;">
                  <div style="text-align: justify; font-style: italic;">Name: Matt Gannon<br>
                  </div>
                </td>
                <td style="width: 50%; vertical-align: top;"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top;">&#160;</td>
                <td colspan="2" style="vertical-align: top;">
                  <div style="text-align: justify; font-style: italic;">Title: Managing Director<br>
                  </div>
                </td>
                <td style="width: 50%; vertical-align: top;"><br>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
                <td colspan="2" rowspan="1" style="vertical-align: top;">&#160;</td>
                <td rowspan="1" style="width: 50%; vertical-align: top;"><br>
                </td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="vertical-align: top;">
                  <div style="text-align: justify;">By <font style="font-variant: small-caps;">CANTOR FITZGERALD &amp; CO.</font></div>
                </td>
                <td style="width: 50%; vertical-align: top;"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top;">&#160;</td>
                <td colspan="2" style="vertical-align: top;">&#160;</td>
                <td style="width: 50%; vertical-align: top;"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                  <div>By:</div>
                </td>
                <td rowspan="1" style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"> /s/ Sage Kelly<br>
                </td>
                <td style="width: 19%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                <td style="width: 50%; vertical-align: top; padding-bottom: 2px;"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top;">&#160;</td>
                <td colspan="2" style="vertical-align: top;">
                  <div style="font-style: italic;">Authorized Representative</div>
                </td>
                <td style="width: 50%; vertical-align: top;"><br>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div style="text-align: center; font-weight: bold;">SCHEDULE I</div>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" border="0" id="zd323290da00348679311e2b1faa85ef0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 78.92%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div>Underwriters</div>
                  </div>
                </td>
                <td style="width: 0.97%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                <td style="width: 19.97%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div>Number of Securities To Be Purchased</div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 78.92%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div>Barclays Capital Inc</div>
                </td>
                <td style="width: 0.97%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
                <td style="width: 19.97%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">686,400<br>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 78.92%; vertical-align: top;">
                  <div>Cantor Fitzgerald &amp; Co</div>
                </td>
                <td style="width: 0.97%; vertical-align: top;">&#160;</td>
                <td style="width: 19.97%; vertical-align: top;">
                  <div style="text-align: right;">580,800<br>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 78.92%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div>Clear Street LLC</div>
                </td>
                <td style="width: 0.97%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
                <td style="width: 19.97%; vertical-align: top; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">52,800<br>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 78.92%; vertical-align: top; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                  <div style="text-align: justify;">Total</div>
                </td>
                <td style="width: 0.97%; vertical-align: top; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
                <td style="width: 19.97%; vertical-align: top; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>
                    <div style="text-align: right;">1,320,000<br>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div style="text-align: center; font-weight: bold;">SCHEDULE II</div>
          <div>&#160;</div>
          <div style="text-align: center; font-weight: bold;">Pricing Disclosure Package</div>
          <div>&#160;</div>
          <div>1. Prospectus dated January 22, 2026 related to the Securities.</div>
          <div>&#160;</div>
          <div>2. Preliminary prospectus supplement dated January 21, 2026 relating to the Securities.</div>
          <div>&#160;</div>
          <div>3. Pricing Term Sheet dated January 22, 2026 relating to the Securities (attached as Exhibit A hereto).</div>
          <div>&#160;</div>
          <div style="text-align: center; font-weight: bold;">Issuer Free Writing Prospectuses</div>
          <div>&#160;</div>
          <div>1. Pricing Term Sheet dated January 22, 2026 relating to the Securities, filed with the Commission pursuant to Rule 433 on January 22, 2026.</div>
          <div>&#160;</div>
          <div style="text-align: center; font-weight: bold;">Written Testing-The-Waters Communications</div>
          <div>&#160;</div>
          <div>1. None.<br>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div style="text-align: center; font-weight: bold;">Exhibit A</div>
          <div>&#160;</div>
          <div style="text-align: center; font-weight: bold;">Pricing Term Sheet</div>
          <div style="text-align: center; font-weight: bold;"> <br>
          </div>
          <div>&#160;</div>
          <div style="text-align: right; font-weight: bold;">Issuer Free Writing Prospectus</div>
          <div style="text-align: right; font-weight: bold;">Filed Pursuant to Rule 433</div>
          <div style="text-align: right; font-weight: bold;">Registration File No. 333-290252</div>
          <div style="text-align: right; font-weight: bold;">Relating to the Preliminary Prospectus Supplement</div>
          <div style="text-align: right; font-weight: bold;">Dated January 21, 2026</div>
          <div style="text-align: right; font-weight: bold;">(To Prospectus Dated September 15, 2025)</div>
          <div>&#160;</div>
          <div style="text-align: center;"><img src="ny20063534x3_ex1-1img01.jpg"></div>
          <div>&#160;</div>
          <div style="text-align: center; font-weight: bold;">PRICING TERM SHEET</div>
          <div style="text-align: center; font-weight: bold;">January 22, 2026</div>
          <div>&#160;</div>
          <div style="text-align: center; font-weight: bold;">STRIVE, INC.</div>
          <div style="text-align: center; font-weight: bold;">Offering of</div>
          <div style="text-align: center;"><font style="font-weight: bold;">1,320,000</font> <font style="font-weight: bold;">Shares of</font></div>
          <div style="text-align: center; font-weight: bold;">Variable Rate Series A Perpetual Preferred Stock</div>
          <div>&#160;</div>
          <div style="text-align: justify; font-style: italic;">The information in this pricing term sheet supplements Strive, Inc.&#8217;s preliminary prospectus supplement, dated January 21, 2026 (the &#8220;Preliminary Prospectus Supplement&#8221;), and supersedes the
            information in the Preliminary Prospectus Supplement to the extent inconsistent with the information in the Preliminary Prospectus Supplement. In all other respects, this pricing term sheet is qualified in its entirety by reference to the
            Preliminary Prospectus Supplement, including all documents incorporated by reference therein. Terms used, but not defined, in this pricing term sheet have the respective meanings set forth in the Preliminary Prospectus Supplement. The size of
            the offering was increased from the $150 million transaction size previously announced when taken together with the anticipated privately negotiated notes exchanges. The final prospectus supplement relating to the offering of the Variable Rate
            Series A Perpetual Preferred Stock will reflect conforming changes relating to such increase in the size of the offering. As used in this pricing term sheet, &#8220;we,&#8221; &#8220;our&#8221; and &#8220;us&#8221; refer to Strive, Inc. and not to its subsidiaries.</div>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" border="0" id="z4f21131f855840f194861de084b227f8" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Issuer</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify;">Strive, Inc. (the &#8220;Company&#8221;)</div>
                </td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 78%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Securities Offered</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify;">Variable Rate Series A Perpetual Preferred Stock, $0.001 par value per share, of the Issuer (&#8220;SATA Stock&#8221;).</div>
                </td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 78%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Amount Offered</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify; text-indent: -162pt; margin-left: 162pt;">1,320,000 shares of SATA Stock.</div>
                </td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 78%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Public Offering Price</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify;">$90 per share of SATA Stock.</div>
                </td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 78%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Trade Date</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify;">January 22, 2026.</div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" id="z9b1c61a9591940c08062fd572d1ce6e6" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Settlement Date</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify;">January 27, 2026, which will be the third business day after the Trade Date (this settlement cycle being referred to as &#8220;T+3&#8221;). Under Rule 15c6-1 under the Securities Exchange Act of 1934, as amended (the
                    &#8220;Exchange Act&#8221;), trades in the secondary market generally must settle in one business day, unless the parties to the trade expressly agree otherwise. Accordingly, purchasers who wish to trade SATA Stock before the business day before
                    the Settlement Date must, because SATA Stock initially will settle T+3, specify an alternate settlement cycle at the time of such trade to prevent a failed settlement. Those purchasers should consult their advisors.</div>
                </td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 78%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Stated Amount</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify;">$100 per share of SATA Stock.</div>
                </td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 78%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Ranking</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify;">SATA Stock ranks as follows:</div>
                  <div style="text-align: justify;"> <br>
                  </div>
                  <div style="text-align: justify; text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160; senior to (i) Dividend Junior Stock (as defined in the Preliminary Prospectus Supplement, and which includes the&#160; Company&#8217;s Class A common stock, par value
                    $0.001 per share (the &#8220;Class A Common Stock&#8221;) and the Company&#8217;s Class B common stock, par value $0.001 per share (the &#8220;Class B Common Stock&#8221;)) with respect to the payment of dividends; and (ii) Liquidation Junior Stock (as defined in
                    the Preliminary Prospectus Supplement, and which includes Class A Common Stock and the Class B Common Stock) with respect to the distribution of assets upon the Company&#8217;s liquidation, dissolution or winding up;</div>
                  <div style="text-align: justify; text-indent: -18pt; margin-left: 36pt;"> <br>
                  </div>
                  <div style="text-align: justify; text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160;equally with (i) Dividend Parity Stock (as defined in the Preliminary Prospectus Supplement) with respect to the payment of dividends; and (ii) Liquidation
                    Parity Stock (as defined in the Preliminary Prospectus Supplement) with respect to the distribution of assets upon the Company&#8217;s liquidation, dissolution or winding up;</div>
                  <div style="text-align: justify; text-indent: -18pt; margin-left: 36pt;"> <br>
                  </div>
                  <div style="text-align: justify; text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;junior to the Company&#8217;s existing and future indebtedness; and</div>
                  <div style="text-align: justify; text-indent: -18pt; margin-left: 36pt;"> <br>
                  </div>
                  <div style="text-align: justify; text-indent: -18pt; margin-left: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;structurally junior to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent the Company is not a holder
                    thereof) capital stock of the Company&#8217;s subsidiaries.</div>
                  <div style="text-align: justify; text-indent: -18pt; margin-left: 36pt;"> <br>
                  </div>
                  <div style="text-align: justify;">SATA Stock is the most senior preferred stock in the Company&#8217;s capital structure. The terms of SATA Stock do not restrict the Company from issuing Dividend Parity Stock or Liquidation Parity Stock.
                    However, the Company cannot issue Dividend Senior Stock (as defined in the Preliminary Prospectus Supplement) or Liquidation Senior Stock (as defined in the Preliminary Prospectus Supplement) without the consent of holders of at least a
                    majority of the combined outstanding voting power of SATA Stock and any voting parity stockholders.</div>
                </td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 78%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Liquidation Preference</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify;">Initially $100 per share of SATA Stock. The Liquidation Preference is subject to adjustment in the manner described in the Preliminary Prospectus Supplement. However, the Liquidation Preference will not
                    be adjusted to an amount that is less than $100 per share of SATA Stock or more than $110 per share of SATA Stock.</div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" id="z263ee8156a0e43c7b2bba6a756af3ad5" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Regular Dividends</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify;">SATA Stock accumulates cumulative dividends (&#8220;Regular Dividends&#8221;) at a variable rate per annum, calculated in the manner described below, on the Stated Amount thereof, regardless of whether or not
                    declared or funds are legally available for their payment. Subject to the other provisions described in the Preliminary Prospectus Supplement, Regular Dividends will be payable when, as and if declared by our board of directors or any
                    duly authorized committee thereof, out of funds legally available for their payment, monthly in arrears on each Regular Dividend Payment Date (as defined in the Preliminary Prospectus Supplement) to the preferred stockholders of record
                    as of the close of business on the Regular Record Date immediately preceding the applicable Regular Dividend Payment Date.</div>
                  <div style="text-align: justify;"> <br>
                  </div>
                  <div style="text-align: justify;">The current rate per annum (the &#8220;Monthly Regular Dividend Rate Per Annum&#8221;) at which Regular Dividends accumulate on SATA Stock for any Regular Dividend Period is 12.25%. However, as described more fully
                    below, we will have the right, in our sole and absolute discretion, to adjust the Monthly Regular Dividend Rate Per Annum that applies to each Regular Dividend Period after the first Regular Dividend Period. To make such election, we
                    must provide notice of the adjusted Monthly Regular Dividend Rate Per Annum to preferred stockholders before the first business day of the Regular Dividend Period in which such adjusted Monthly Regular Dividend Rate Per Annum applies.
                    We will be permitted to provide such notice in the manner described in the Preliminary Prospectus Supplement under the caption &#8220;Description of Perpetual Preferred Stock&#8212;Notices,&#8221; or in a press release issued through such national
                    newswire service as we then use, or by publishing the same through such other widely disseminated public medium as we then use, including our website. If we do not timely provide such notice, then the Monthly Regular Dividend Rate Per
                    Annum that applies to such Regular Dividend Period will be the Monthly Regular Dividend Rate Per Annum that applies to the immediately preceding Regular Dividend Period.</div>
                  <div style="text-align: justify;"> <br>
                  </div>
                  <div style="text-align: justify;">If we elect to adjust the Monthly Regular Dividend Rate Per Annum in the manner described above, then the adjusted Monthly Regular Dividend Rate Per Annum will be a rate that we will choose in our sole
                    and absolute discretion. However, we will not be permitted to reduce the Monthly Regular Dividend Rate Per Annum that will apply to any Regular Dividend Period (i) by more than the following amount from the Monthly Regular Dividend Rate
                    Per Annum applicable to the prior Regular Dividend Period: the sum of (1) 25 basis points; and (2) the excess, if any, of (x) the monthly SOFR per annum on the first business day of such prior Regular Dividend Period, over (y) the
                    minimum of the monthly SOFR per annum rates that occur on the business days during the period from, and including, the first business day of such prior Regular Dividend Period to, and including, the last business day of such prior
                    Regular Dividend Period; or (ii) to a rate per annum that is less than the monthly SOFR per annum in effect on the business day before we provide notice of the next Monthly Regular Dividend Rate Per Annum.</div>
                  <div style="text-align: justify;"> <br>
                  </div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" id="zf4ff1fce7fd145b884daf8fc7f152161" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 22%; vertical-align: top;">&#160;</td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify;">Notwithstanding anything to the contrary, but subject to the more detailed provisions described in the Preliminary Prospectus Supplement, we will not be entitled to elect to reduce the Monthly Regular
                    Dividend Rate Per Annum as described above unless and until (x) three (3) months following the initial issue date, or such earlier time as the arithmetic average of the last reported sale prices per share of SATA Stock for each trading
                    day of twenty (20) consecutive trading days at any time during the three (3) months following the initial issuance date exceeds $100, (y) at the time we provide the related notice referred to above, all accumulated Regular Dividends, if
                    any, on SATA Stock then outstanding for all prior completed Regular Dividend Periods, if any, have been paid in full (or have been declared in full and consideration in kind and amount that is sufficient, in accordance with the
                    certificate of designation, to pay such accumulated Regular Dividends, is set aside for the benefit of the preferred stockholders entitled thereto), and (z) the arithmetic average of the last reported sale prices per share of SATA Stock
                    for each trading day during the immediately preceding regular dividend period is not less than $99 per share.</div>
                  <div style="text-align: justify;"> <br>
                  </div>
                  <div style="text-align: justify;">Our current intention, which is subject to change in our sole and absolute discretion, is to adjust the Monthly Regular Dividend Rate Per Annum in such a manner as we believe will maintain SATA Stock&#8217;s
                    trading price within its stated long-term range of $95 and $105 per share. For example, if the trading price of SATA Stock exceeds $105, our current intention would be to reduce the Monthly Regular Dividend Rate Per Annum with the goal
                    of causing the trading price of SATA Stock to decrease. Similarly, if the trading price of SATA Stock is less than $95, our current intention would be to increase the Monthly Regular Dividend Rate Per Annum with the goal of causing the
                    trading price of SATA Stock to appreciate. We will take any such actions at our sole discretion based on our subjective assessment of market conditions and the measures we believe are necessary to achieve our intended objectives.</div>
                  <div style="text-align: justify;"> <br>
                  </div>
                  <div style="text-align: justify;">Declared Regular Dividends on SATA Stock will be payable solely in cash, in the manner, and subject to the provisions, described in the Preliminary Prospectus Supplement.</div>
                  <div style="text-align: justify;"> <br>
                  </div>
                  <div style="text-align: justify;">On January 15, 2026, we declared a scheduled Regular Dividend on SATA Stock of $1.0208 per share, payable on February 15, 2026 to holders of record on February 1, 2026.</div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" id="z2c833dbec4814dba9d25624cc0604fa3" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 22%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 78%; vertical-align: top;" rowspan="1">
                  <div style="text-align: justify;">If any accumulated Regular Dividend (or any portion thereof) on SATA Stock is not paid on the applicable Regular Dividend Payment Date (or, if such Regular Dividend Payment Date is not a business day, the
                    next business day), then additional Regular Dividends (&#8220;Compounded Dividends&#8221;) will accumulate on the amount of such unpaid Regular Dividend, compounded monthly at the monthly &#8220;Compounded Dividend Rate&#8221; per annum applicable to the
                    relevant Regular Dividend Period from, and including, the calendar day after such Regular Dividend Payment Date to, but excluding, the date the same, including all Compounded Dividends thereon, is paid in full. The Compounded Dividend
                    Rate applicable to any unpaid Regular Dividend that was due on a Regular Dividend Payment Date (or, if such Regular Dividend Payment Date is not a business day, the next business day) will initially be a rate per annum equal to the
                    Regular Dividend Rate plus 25 basis points; <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>, that until such Regular Dividend, together with Compounded Dividends thereon, is paid in
                    full, such Compounded Dividend Rate will increase by 25 basis points per month for each subsequent Regular Dividend Period, up to a maximum rate of 20% per annum.</div>
                </td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 78%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Regular Dividend Payment Dates</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify;">The 15<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> calendar day of each calendar month.</div>
                </td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 78%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Regular Record Dates</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify;">With respect to any Regular Dividend Payment Date, the 1<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> calendar day of the month in which such Regular Dividend Payment
                    Date occurs.</div>
                </td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 78%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div style="text-indent: -10.8pt; margin-left: 10.8pt;">Regular Dividend Period</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify;">Each period from, and including, the calendar day after a Regular Dividend Payment Date (or, in the case of the first Regular Dividend Period, from, and including, the calendar day after the initial issue
                    date) to, and including, the next Regular Dividend Payment Date.</div>
                </td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 78%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Dividend Payment Account</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify;">Concurrent with the closing of our initial public offering of the SATA Stock on November 10, 2025 (the &#8220;IPO Closing&#8221;), we established an initial dividend reserve in an amount equal to the first 12 months
                    of dividend payments (which assumed dividend payments&#160; at a rate of 12.00% per annum) calculated as of the date of the IPO Closing (the &#8220;Initial Dividend Reserve&#8221;) and deposited $12.00 per share of SATA Stock into a separate account
                    (the &#8220;Dividend Payment Account&#8221;) funded by us with existing cash on hand. Concurrent with the closing of this offering, we intend to increase the dividend reserve in the Dividend Payment Account in an amount equal to the first 12 months
                    of dividend payments (assuming dividend payments are made at a rate of 12.25% per annum) calculated as of the date of the closing of this offering and will deposit $12.25 per share of SATA Stock sold this offering (together with the
                    Initial Dividend Reserve, the &#8220;Dividend Reserve&#8221;). The regular dividend rate was set at 12.25% per annum with respect to the regular dividend period beginning on&#160; December 16, 2025. Subject to compliance with Nevada law and any other
                    applicable requirements, we may make dividend distributions from the Dividend Payment Account or from any other account maintained by us to the holders of the then-outstanding SATA Stock on a monthly basis following the closing of this
                    offering.</div>
                  <div style="text-align: justify;">We intend to invest the proceeds of the Dividend Payment Account in various capital preservation instruments, including short-term investment grade, interest-bearing securities, and money-market funds.
                    Any investment income earned from the Dividend Payment Account will be remitted to us to use for working capital or general corporate purposes, including the acquisition of additional bitcoin.</div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" id="zfbc89a87028142e9868bc0afa88e62d9" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Listing</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify;">SATA Stock is listed on The Nasdaq Global Market under the symbol &#8220;SATA.&#8221;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 78%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Use of Proceeds</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify;">We estimate that the gross proceeds to us from this offering will be approximately $118.8 million, before deducting the underwriting discounts and commissions and our estimated offering expenses. We
                    intend to use the net proceeds from this offering, together with cash on hand and potentially cash from terminating the Company&#8217;s existing capped call transactions relating to the outstanding Semler Convertible Notes (i) to finance the
                    redemption, repurchase, repayment, satisfaction and discharge or other payment of all or a portion of the Semler Convertible Notes&#160; and Semler Scientific&#8217;s outstanding borrowings under its master loan agreement with Coinbase Credit
                    Inc., which may include one or more repurchases pursuant to privately negotiated transactions, and the payment of accrued and unpaid interest thereon (collectively, the &#8220;Semler Debt Transactions&#8221;), with the purpose of returning to a
                    perpetual-preferred only amplification model, (ii) the acquisition of bitcoin and bitcoin-related products and (iii) for working capital and general corporate purposes.</div>
                </td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 78%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Convertible Notes Refinancing</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-align: justify;">On January 22, 2026, the Company announced that it expects to enter into privately negotiated exchange agreements with certain holders of the Semler Convertible Notes, representing $90 million aggregate
                    principal amount of the Semler Convertible Notes, pursuant to which such holders would exchange their Semler Convertible Notes for approximately<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"> </sup>930,000 newly issued shares of SATA Stock. This offering is not conditioned on
                    the consummation of all or any portion of such exchanges. Such agreements remain subject to the signing of binding agreements, and any such exchanges will be subject to customary closing conditions.</div>
                </td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 78%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Joint Book-Running Managers</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div style="text-indent: -162pt; margin-left: 162pt;">Barclays Capital Inc.</div>
                  <div>Cantor Fitzgerald &amp; Co.</div>
                </td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 78%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div>Co-Manager</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div>Clear Street LLC</div>
                </td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;" rowspan="1">&#160;</td>
                <td style="width: 78%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 22%; vertical-align: top;">
                  <div style="text-indent: -9.35pt; margin-left: 9.35pt;">CUSIP / ISIN Numbers for SATA Stock</div>
                </td>
                <td style="width: 78%; vertical-align: top;">
                  <div>862945 201 / US8629452017</div>
                </td>
              </tr>

          </table>
          <div style="text-align: center;"> <br>
          </div>
          <div style="text-align: center;">* * *</div>
          <div>&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div style="text-align: justify; font-weight: bold;">We have filed a registration statement (including a prospectus) and the Preliminary Prospectus Supplement with the SEC for the offering to which this communication relates. Before you invest,
            you should read the Preliminary Prospectus Supplement and the prospectus in that registration statement and other documents we have filed with the SEC for more complete information about us and this offering. You may get these documents free by
            visiting EDGAR on the SEC website at <font style="font-style: italic;">www.sec.gov</font>. Alternatively, we, any underwriter or any dealer participating in the offering will arrange to send you the Preliminary Prospectus Supplement (or, when
            available, the final prospectus supplement) and the accompanying prospectus upon request to: Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by email at
            barclaysprospectus@broadridge.com or telephone at 1-888-603-5847; or Cantor Fitzgerald &amp; Co., Attention: Capital Markets, 110 East 59th Street, 6th Floor, New York, NY 10022, or by email at prospectus@cantor.com.</div>
          <div>&#160;</div>
          <div style="text-align: justify; font-weight: bold;">The information in this pricing term sheet is not a complete description of SATA Stock or the offering. You should rely only on the information contained or incorporated by reference in the
            Preliminary Prospectus Supplement and the accompanying prospectus, as supplemented by this pricing term sheet, in making an investment decision with respect to SATA Stock.</div>
          <div>&#160;</div>
          <div style="text-align: justify; font-weight: bold;">ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A
            RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.</div>
          <div>
            <div><br>
            </div>
          </div>
          <div> <br>
          </div>
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ny20063534x3_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">
      <hr align="center" noshade="noshade" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">Exhibit 99.1<br>
    </div>
    <div style="text-align: right; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"> <img src="ny20063534x3_ex99-1img01.jpg">
      <div><br>
      </div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Strive Announces Pricing of Upsized Follow-On Offering of SATA Stock and Concurrent Exchange of Semler Notes</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">The transactions represent an issuance of up to 2.25 million shares of SATA in the aggregate</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">DALLAS, TX&#8212;(GLOBE NEWSIRE)&#8212;January 22, 2026&#8212;Strive, Inc. (Nasdaq: SATA) (&#8220;Strive&#8221; or the &#8220;Company&#8221;) today announced the pricing of its follow-on offering
      (the &#8220;offering&#8221;) on January 22, 2026 of 1,320,000<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> </font>shares of Strive&#8217;s Variable Rate Series A Perpetual Preferred Stock (the &#8220;SATA Stock&#8221;), an upsize over the $150
      million transaction size previously announced when taken together with the anticipated privately negotiated notes exchanges, at an offering price of $90 per share.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Strive intends to use the net proceeds of this offering, together with cash on hand and potentially cash from terminating Strive&#8217;s existing capped call
      transactions relating to the outstanding 4.25% Convertible Senior Notes due 2030 (the &#8220;Semler Convertible Notes&#8221;) issued by Semler Scientific, Inc., a wholly-owned subsidiary of Strive (&#8220;Semler Scientific&#8221;), and guaranteed by Strive, pursuant to an
      indenture, dated as of January 28, 2025, between Semler Scientific and U.S Bank Trust Company, National Association, as trustee (the &#8220;Trustee&#8221;), as amended by a supplemental indenture, dated January 16, 2026, by and among Semler Scientific, Strive
      and the Trustee, (i) to finance the redemption, repurchase, repayment, satisfaction and discharge or other payment of all or a portion of the Semler Convertible Notes and Semler Scientific&#8217;s outstanding borrowings under its master loan agreement with
      Coinbase Credit Inc., which may include one or more repurchases pursuant to privately negotiated transactions, and the payment of accrued and unpaid interest thereon, with the purpose of returning to a perpetual-preferred only amplification model,
      (ii) the acquisition of bitcoin and bitcoin-related products and (iii) for working capital and general corporate purposes.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Strive also expects to enter into privately negotiated exchange agreements
        with certain holders of the Semler Convertible Notes, representing $90</font> <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">million aggregate principal amount of the Semler Convertible Notes, pursuant to which such
        holders would exchange their Semler Convertible Notes for approximately 930,000 newly issued shares of SATA Stock. This offering is not conditioned on the consummation of all or any portion of such exchanges. Such agreements remain subject to the
        signing of binding agreements, and any such exchanges will be subject to customary closing conditions.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The SATA Stock accumulates cumulative dividends at a variable rate (as described below) per annum on the stated amount of $100 per share (the &#8220;stated
      amount&#8221;) thereof. Regular dividends on the shares of SATA Stock are payable when, as and if declared by Strive&#8217;s board of directors or any duly authorized committee thereof, out of funds legally available for their payment, monthly in arrears on the
      15<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th </sup>calendar day of each calendar month, beginning on February 15, 2026. The monthly regular dividend rate per annum is 12.25%. However, Strive has the right, in its sole and absolute discretion, to adjust the monthly regular dividend
      rate per annum applicable to subsequent regular dividend periods. Strive&#8217;s right to adjust the monthly regular dividend rate per annum is subject to certain restrictions. For example, Strive is not permitted to reduce the monthly regular dividend
      rate per annum that applies to any regular dividend period (i) by more than the following amount from the monthly regular dividend rate per annum applicable to the prior regular dividend period: the sum of (1) 25 basis points; and (2) the excess, if
      any, of (x) the one-month term SOFR rate on the first business day of such prior regular dividend period, over (y) the minimum of the one-month term SOFR rates that occur on the business days during the period from, and including, the first business
      day of such prior regular dividend period to, and including, the last business day of such prior regular dividend period; or (ii) to a rate per annum that is less than the one-month term SOFR rate in effect on the business day before Strive provides
      notice of the next monthly regular dividend rate per annum. In addition, Strive is not entitled to elect to reduce the monthly regular dividend rate per annum unless and until (x) three (3) months following November 10, 2025, or such earlier time as
      the arithmetic average of the last reported sale prices per share of SATA Stock for each trading day of twenty (20) consecutive trading days at any time during the three (3) months following the initial issuance date exceeds $100 and (y) all
      accumulated regular dividends, if any, on the SATA Stock then outstanding for all prior completed regular dividend periods, if any, have been paid in full. Strive&#8217;s current intention (which is subject to change in Strive&#8217;s sole and absolute
      discretion) is to adjust the monthly regular dividend rate per annum in such manner as Strive believes is designed to cause the SATA Stock to trade at prices within its stated long-term range of $95 and $105 per share. Declared regular dividends on
      the SATA Stock will be payable solely in cash. In the event that any accumulated regular dividend on the SATA Stock is not paid on the applicable regular dividend payment date, then additional regular dividends (&#8220;compounded dividends&#8221;) accumulate on
      the amount of such unpaid regular dividend, compounded monthly. The compounded dividend rate applicable to any unpaid regular dividend that was due on a regular dividend payment date has been set at a rate per annum equal to 12.25% plus 25 basis
      points; provided, however, that, until such regular dividend, together with compounded dividends thereon, is paid in full, such compounded dividend rate will increase by 25 basis points per month for each subsequent regular dividend period, up to a
      maximum dividend rate of 20% per annum.</div>
    <br>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Concurrent with the closing of our initial public offering of the SATA Stock on November 10, 2025 (the &#8220;IPO Closing&#8221;), we established an initial dividend
      reserve in an amount equal to the first 12 months of dividend payments (which assumed dividend payments at a rate of 12.00% per annum) calculated as of the date of the IPO Closing (the &#8220;Initial Dividend Reserve&#8221;) and deposited $12.00 per share of
      SATA Stock into a separate account (the &#8220;Dividend Payment Account&#8221;) funded by us with existing cash on hand. Concurrent with the closing of this offering, we intend to increase the dividend reserve in the Dividend Payment Account in an amount equal
      to the first 12 months of dividend payments (assuming dividend payments are made at a rate of 12.25% per annum) calculated as of the date of the closing of this offering and will deposit $12.25 per share of SATA Stock sold in this offering into the
      Dividend Payment Account (together with the Initial Dividend Reserve, the &#8220;Dividend Reserve&#8221;).</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Strive has the right, at its election, to redeem all, or any whole number of shares, of the issued and outstanding SATA Stock, at any time, and from time
      to time, on any redemption date, at a cash redemption price per share of SATA Stock to be redeemed equal to $110 (or such higher amount as may be chosen in Strive&#8217;s sole discretion, it being understood that such higher amount (or the formula to
      determine such higher amount) will be announced by prior public notice and/or set forth in the applicable relevant notice of redemption), plus accumulated and unpaid regular dividends, if any, thereon to, and including, the redemption date. However,
      Strive may not redeem less than all of the outstanding shares of SATA Stock unless at least $50.0 million aggregate stated amount of SATA Stock is outstanding and not called for redemption as of the time Strive provides the related redemption notice.
      Strive also has the right, at its election, to redeem all, but not less than all, of the SATA Stock, at any time, for cash if the total number of shares of all SATA Stock then outstanding is less than 25% of the total number of shares of SATA Stock
      issued in the initial offering of SATA Stock and in any future offering, taken together (a &#8220;clean-up redemption&#8221;). In addition, Strive has the right to redeem all, but not less than all, of the SATA Stock if certain tax events occur (a &#8220;tax
      redemption&#8221;). The redemption price for any SATA Stock to be redeemed pursuant to a clean-up redemption or a tax redemption will be a cash amount equal to the liquidation preference (as described below) of the SATA Stock to be redeemed as of the
      business day before the date on which Strive provides the related redemption notice, plus accumulated and unpaid regular dividends, if any, thereon to, and including, the redemption date.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">If an event that constitutes a &#8220;fundamental change&#8221; under the certificate of designation governing the SATA Stock occurs, then, subject to certain
      limitations, holders of the SATA Stock have the right to require Strive to repurchase some or all of their shares of SATA Stock at a cash repurchase price equal to the stated amount of the SATA Stock to be repurchased, plus accumulated and unpaid
      regular dividends, if any, to, and including, the fundamental change repurchase date.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The liquidation preference of the SATA Stock is $100 per share. Effective immediately after the close of business on each business day after November 10,
      2025 (and, if applicable, during the course of a business day on which any sale transaction to be settled by the issuance of SATA Stock is executed, from the exact time of the first such sale transaction during such business day until the close of
      business of such business day), the liquidation preference per share of SATA Stock will be adjusted to be the greatest of (i) the stated amount per share of SATA Stock; (ii) in the case of any business day with respect to which Strive has, on such
      business day, executed any sale transaction to be settled by the issuance of SATA Stock, an amount equal to the last reported sale price per share of SATA Stock on the trading day immediately before such business day; and (iii) the arithmetic average
      of the last reported sale prices per share of SATA Stock for each trading day of the ten consecutive trading days (or, if applicable, the lesser number of trading days as have elapsed during the period from, and including, the initial issue date to,
      but excluding, such business day) immediately preceding such business day.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Barclays and Cantor are acting as joint book-running managers for the offering. Clear Street is acting as co-manager for the offering.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The offering is being made pursuant to an effective shelf registration statement on file with the Securities and Exchange Commission (the &#8220;SEC&#8221;). The
      offering will be made only by means of a prospectus supplement and an accompanying prospectus. An electronic copy of the preliminary prospectus supplement (and when available, the final prospectus supplement), together with the accompanying
      prospectus, is or will be available on the SEC&#8217;s website at <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">www.sec.gov</font>. Alternatively, copies of the preliminary prospectus supplement, together
      with the accompanying prospectus, can be obtained by contacting: Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by email at barclaysprospectus@broadridge.com or telephone at 1-888-603-5847; or
      Cantor Fitzgerald &amp; Co., Attention: Capital Markets, 110 East 59th Street, 6th Floor, New York, NY 10022, or by email at prospectus@cantor.com.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">About Strive</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Strive is the first publicly traded asset management Bitcoin treasury company. Strive is focused on increasing Bitcoin per share to outperform Bitcoin over
      the long run. Strive holds approximately 12,797.6<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font> bitcoin as of January 16, 2026.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Since launched its first ETF in August 2022, Strive Asset Management, LLC, a direct, wholly owned subsidiary of Strive and an SEC-registered investment
      adviser, has grown to manage over $2.3 billion in assets.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Cautionary Statement Regarding Forward-Looking Statements</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Certain statements in this press release may constitute &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of
      1995, Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Rule 175 promulgated thereunder, and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and Rule 3b-6 promulgated thereunder,
      which statements involve inherent risks and uncertainties. Examples of forward-looking statements include, but are not limited to, statements regarding the outlook and expectations of Strive and Semler Scientific, Inc. (&#8220;Semler Scientific&#8221;),
      respectively, with respect to the merger transaction (the &#8220;merger transaction&#8221;), the strategic benefits and financial benefits of the merger transaction, including the expected impact of the merger transaction on the combined company&#8217;s future
      financial performance, the ability to successfully integrate the combined businesses, the estimated net proceeds of the offering, the anticipated timing of settlement, the anticipated use of any proceeds from the offering, the terms of the securities
      being offered and the Company&#8217;s intentions with respect to adjusting the SATA Stock monthly regular dividend rate per annum. Such statements are often characterized by the use of qualified words (and their derivatives) such as &#8220;may,&#8221; &#8220;will,&#8221;
      &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;assume,&#8221; &#8220;forecast,&#8221; &#8220;target,&#8221; &#8220;budget,&#8221; &#8220;outlook,&#8221; &#8220;trend,&#8221; &#8220;guidance,&#8221; &#8220;objective,&#8221; &#8220;goal,&#8221;
      &#8220;strategy,&#8221; &#8220;opportunity,&#8221; and &#8220;intend,&#8221; as well as words of similar meaning or other statements concerning opinions or judgment of Strive, Semler Scientific or their respective management about future events. Forward-looking statements are based on
      assumptions as of the time they are made and are subject to risks, uncertainties and other factors that are difficult to predict with regard to timing, extent, likelihood and degree of occurrence, which could cause actual results to differ materially
      from anticipated results expressed or implied by such forward-looking statements as a result of various important factors, including the uncertainties related to market conditions and the completion of the offering on the anticipated terms or at all
      or the uncertainties related to the satisfaction of closing conditions for the sale of the securities being offered. Other risks, uncertainties and assumptions, including, among others, the following:</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1cb5dee6286144ed80ec7c7b97405457">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">the outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc12306bee6e644daa480c122403a5415">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">the possibility that the anticipated benefits of the merger transaction, including anticipated cost savings and strategic gains, are not realized when expected or at
                all, including as a result of changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets, general economic and market conditions, interest and exchange
                rates, monetary policy, and laws and regulations and their enforcement;</div>
            </td>
          </tr>

      </table>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3a54bbeba26a4b34ac58e722de4266e2">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">the diversion of management's attention from ongoing business operations and opportunities;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5729ada3057c472fbe40fc0c4f3a3b32">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the merger transaction;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5fb0f3dd8a604e7681e85bbce906bbae">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the
                announcement or completion of the merger transaction;</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf8fd267f1f994518b3ab09872bb1f8bc">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">changes in Strive's or Semler Scientific's share price before closing; and</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze25d950bb1594d4586da4af1789dafff">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">other factors that may affect future results of Strive, Semler Scientific or the combined company.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">These factors are not necessarily all of the factors that could cause the combined company&#8217;s actual results, performance or achievements to differ
      materially from those expressed in or implied by any of the forward-looking statements. Other factors, including unknown or unpredictable factors, also could harm the combined company&#8217;s results.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Although Strive believes that its expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its
      existing knowledge of its business and operations, there can be no assurance that actual results of Strive will not differ materially from any projected future results expressed or implied by such forward-looking statements. Additional factors that
      could cause results to differ materially from those described above can be found in Strive&#8217;s Annual Report on Form 10-K, Strive&#8217;s Form S-4 filed on August 6, 2025 and October 10, 2025, under the &#8220;Supplementary Risk Factors&#8221; filed as an exhibit to
      Strive&#8217;s Current Report on Form 8-K filed with the SEC on September 24, 2025, Semler Scientific&#8217;s most recent annual report on Form 10-K for the fiscal year ended December 31, 2024 and quarterly reports on Form 10-Q, and other documents subsequently
      filed by Strive and Semler Scientific with the SEC.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The actual results anticipated may not be realized or, even if substantially realized, they may not have the expected consequences to or effects on Strive
      or its businesses or operations. Investors are cautioned not to rely too heavily on any such forward-looking statements. Forward-looking statements contained in this press release speak only as of the date hereof, and Strive and Semler Scientific
      undertake no obligation to update or clarify these forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable law.</div>
    <div><br>
    </div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">No Offer or Solicitation</div>
    </div>
    <div>
      <div><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">This press release is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer
        to buy any securities or the solicitation of any vote of approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities
        laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or pursuant to an exemption from, or in a transaction not subject to, such
        registration requirements. This press release also shall not constitute an offer to purchase, a solicitation of an offer to sell, or a notice of redemption with respect to the Semler Convertible Notes.</div>
      <div><br>
      </div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>Strive Media Contact</u></font>:</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">media@strive.com</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>Investor Contact</u></font>:</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">ir@strive.com</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Source: Strive, Inc.</div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br>
    </div>
  </div>
  <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">4</font>
    <hr align="center" noshade="noshade" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>asst-20260122.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.10.1.5333 Broadridge-->
<xs:schema targetNamespace="http://strive.com/20260122" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:asst="http://strive.com/20260122" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:srt-types="http://fasb.org/srt-types/2025">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="asst-20260122_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="asst-20260122_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="asst-20260122_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://strive.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2025" schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
  <xs:element name="VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember" id="asst_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ClassACommonStock0001ParValuePerShareMember" id="asst_ClassACommonStock0001ParValuePerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>asst-20260122_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.10.1.5333 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://strive.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="asst-20260122.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://strive.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="definition: EntityListingsLineItems to DocumentType" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="definition: EntityListingsLineItems to AmendmentFlag" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="definition: EntityListingsLineItems to DocumentPeriodEndDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalYearFocus" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="definition: EntityListingsLineItems to EntityFileNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="definition: EntityListingsLineItems to EntityRegistrantName" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="definition: EntityListingsLineItems to EntityCentralIndexKey" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="definition: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="definition: EntityListingsLineItems to EntityTaxIdentificationNumber" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine1" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine2" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine3" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="definition: EntityListingsLineItems to EntityAddressCityOrTown" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="definition: EntityListingsLineItems to EntityAddressStateOrProvince" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="definition: EntityListingsLineItems to EntityAddressCountry" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="definition: EntityListingsLineItems to EntityAddressPostalZipCode" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="definition: EntityListingsLineItems to CityAreaCode" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="definition: EntityListingsLineItems to LocalPhoneNumber" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="definition: EntityListingsLineItems to Security12bTitle" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="definition: EntityListingsLineItems to TradingSymbol" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="definition: EntityListingsLineItems to NoTradingSymbolFlag" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="definition: EntityListingsLineItems to SecurityExchangeName" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="definition: EntityListingsLineItems to EntityEmergingGrowthCompany" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="definition: EntityListingsLineItems to EntityExTransitionPeriod" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="definition: EntityListingsLineItems to WrittenCommunications" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="definition: EntityListingsLineItems to SolicitingMaterial" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementTenderOffer" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EntityListingsLineItems" xlink:to="EntityListingsTable" xlink:title="definition: EntityListingsLineItems to EntityListingsTable" order="30.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: EntityListingsTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="asst-20260122.xsd#asst_ClassACommonStock0001ParValuePerShareMember" xlink:label="ClassACommonStock0001ParValuePerShareMember" xlink:title="ClassACommonStock0001ParValuePerShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="ClassACommonStock0001ParValuePerShareMember" xlink:title="definition: ClassOfStockDomain to ClassACommonStock0001ParValuePerShareMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="asst-20260122.xsd#asst_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember" xlink:label="VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember" xlink:title="VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember" xlink:title="definition: ClassOfStockDomain to VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember" order="2.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>asst-20260122_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.10.1.5333 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain" xml:lang="en-US" id="us-gaap_ClassOfStockDomain">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:label xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityExTransitionPeriod" xml:lang="en-US" id="dei_EntityExTransitionPeriod">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod" xlink:title="label: EntityExTransitionPeriod to dei_EntityExTransitionPeriod" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsTable" xml:lang="en-US" id="dei_EntityListingsTable">Entity Listings [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsTable" xlink:to="dei_EntityListingsTable" xlink:title="label: EntityListingsTable to dei_EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsLineItems" xml:lang="en-US" id="dei_EntityListingsLineItems">Entity Listings [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsLineItems" xlink:to="dei_EntityListingsLineItems" xlink:title="label: EntityListingsLineItems to dei_EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
    <link:loc xlink:type="locator" xlink:href="asst-20260122.xsd#asst_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember" xlink:label="VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember" xlink:title="VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember" />
    <link:label xlink:type="resource" xlink:label="asst_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="asst_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember_lbl1" xml:lang="en-US" id="asst_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember_lbl1">Variable Rate Series A Perpetual Preferred Stock, $0.001 par value per share [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember" xlink:to="asst_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember_lbl1" xlink:title="label: VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember to asst_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="asst-20260122.xsd#asst_ClassACommonStock0001ParValuePerShareMember" xlink:label="ClassACommonStock0001ParValuePerShareMember" xlink:title="ClassACommonStock0001ParValuePerShareMember" />
    <link:label xlink:type="resource" xlink:label="asst_ClassACommonStock0001ParValuePerShareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="asst_ClassACommonStock0001ParValuePerShareMember_lbl1" xml:lang="en-US" id="asst_ClassACommonStock0001ParValuePerShareMember_lbl1">Class A Common Stock, $0.001 par value per share [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassACommonStock0001ParValuePerShareMember" xlink:to="asst_ClassACommonStock0001ParValuePerShareMember_lbl1" xlink:title="label: ClassACommonStock0001ParValuePerShareMember to asst_ClassACommonStock0001ParValuePerShareMember_lbl1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>asst-20260122_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.10.1.5333 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://strive.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="asst-20260122.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://strive.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="asst-20260122.xsd#asst_ClassACommonStock0001ParValuePerShareMember" xlink:label="ClassACommonStock0001ParValuePerShareMember" xlink:title="ClassACommonStock0001ParValuePerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="ClassACommonStock0001ParValuePerShareMember" xlink:title="presentation: ClassOfStockDomain to ClassACommonStock0001ParValuePerShareMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="asst-20260122.xsd#asst_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember" xlink:label="VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember" xlink:title="VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember" xlink:title="presentation: ClassOfStockDomain to VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: EntityListingsTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="presentation: EntityListingsLineItems to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="presentation: EntityListingsLineItems to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: EntityListingsLineItems to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="presentation: EntityListingsLineItems to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityListingsLineItems to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityListingsLineItems to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: EntityListingsLineItems to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: EntityListingsLineItems to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: EntityListingsLineItems to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="presentation: EntityListingsLineItems to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: EntityListingsLineItems to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="presentation: EntityListingsLineItems to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="presentation: EntityListingsLineItems to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="presentation: EntityListingsLineItems to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="presentation: EntityListingsLineItems to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: EntityListingsLineItems to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="presentation: EntityListingsLineItems to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: EntityListingsLineItems to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="presentation: EntityListingsLineItems to EntityExTransitionPeriod" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="presentation: EntityListingsLineItems to WrittenCommunications" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="presentation: EntityListingsLineItems to SolicitingMaterial" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="EntityListingsLineItems" xlink:title="presentation: EntityListingsTable to EntityListingsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityListingsTable" xlink:title="presentation: CoverAbstract to EntityListingsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ny20063534x3_ex1-1img01.jpg
<TEXT>
begin 644 ny20063534x3_ex1-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  < ,L# 2(  A$! Q$!_\0
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MGOXQZ-\--#U6RU?3]1NI+NY69&M0A  7&#N8<UZL_P"U=X5"G9H6N%L< B(
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MGQ-K4JMJ6CQBWO(LX::;&(R/^NG'X[O2OFGX;^&=4^,_Q6FGU1W:&:8WNIW
MX"1Y^XOH3PJCL/I0![I^R;X6UN>PD\8>)=2U*X2<&+3[>XN9&7;T:4J3@YZ#
M\3W%>H_'+2]<UGX9ZK8^%EG;5Y#$81!-Y3\2*6PV1C@'O7;V5K!8V<%I9Q)#
M;0(L<4:#"HH& ![ 50\3WTVG:+/=6VWS4VXW#(Y(%9UJL:-.566R5_N+IP=2
M:A'=Z'Q5_P *R^-?_/'7/_!H/_CE'_"LOC7_ ,\=<_\ !H/_ (Y7TU_PFVL?
M].__ '[_ /KT?\)MK'_3O_W[_P#KUX'^M."_O?=_P3U?[$Q/E]Y\[>'?A1\7
MKW7;"VU6;6K'3Y)E6XN6U/=Y4>?F. Y).,X]Z^T[*VCLK."U@W>5#&L:;F+'
M &!DGDGW-<SX-U;5=8FFDNS$+6,;?ECP68]OPKK*]K!XN&+I*M332?<\W$4)
M8>;IRW78\G\=?'7PSX(\8S^']=M=2$L4<<GGP1JZ$,N>FX']*K1_M!?#&_3_
M $G4W7_9N+&0X_\ '35WXC?!#PGXXUJXUO5SJ46H2(JN]M<!00JX'#*1T%>2
M7G[/GA2*=E2_US />>+_ .-UTF)VWB/XS_!V2RD2XM[?50RG]RFE;BWMEU '
MYU\O^!;-O$GQDTI?#%B]K#+JRW$$"L6^SPK)OY/HJCK[5[KX?_9V\(WFH)'<
M7VN,AZ@3Q#/_ )#KW7P#\.?"_@.%U\-Z8D$T@VR7,A,DSCT+GG'L,#VH Z^B
MBB@#\[OCM_R6OQ1_U_G^0K]#;;_CWB_W!_*O&/%WP!\)>)?%.H:WJ%UK"W=Y
M-YTBQ3HJ!N.@*$XX]:]IC4)&JCHH % #J^=/VVO^1"T'_L)_^TGKZ+KB?BK\
M/](^(>CV=AKLMY'!;3^>AM9%1BVTKSE3Q@F@#YE_9I^%'AGXA^']8N_$27C3
M6MTL49@G\L;2F>1CUKI/C7^SMI>B^#9M7\$)>O=6.9;BWEE\TRPX^8KQU7K[
MC/M7N?PI^'FC_#O3;ZST*6]DBNIA-(;J17((&.,*.*[D@$$$9!X(- 'Q5^R)
MXRTK0O%\VBZK:VL<VJ82UOV0>8DG_/(MV5NW^UCUK[5KPK5_V;_!-SK5S?0R
MZQ9-+,9ECM;A$2(DYPF4) !Z<\5[9ID30:=;0O-+<-'&J&68@N^!C<Q  R>_
M% 'S/^W%_P @[PE_UUN?Y1UUW[''_)(I/^PE-_Z#'7:?%CX::+\1H=-CUZ:^
MB6R9VB^RR*F=V,YRI_NBM+X8^"M,\!>&VT?19+J2U,[SDW+AVW, #R !CY1V
MH ZVL'QSX7L/&7A74-"U5,V]U'M#@9,;CE77W!P:WJ* /S-\2^&M9\->*+WP
MM=1S?;5N%A\F/.)VS^[8#OD-D?[U?=OP+^'D/P[\$064BJVK76)[^4<YD(X0
M'T4<#\3WK:U?P-H6J>.M(\4WEH'U?3XG2%^-I]"PQR5RVT]LGVQU= !6!X[\
M4Z=X,\+W>N:RDSV-L4#K"@=CN8*, D=R*WZYSXA^%['QEX3O-#U5[A+.Y*%V
MMV"N-K!A@D$=1Z4 >4_\-.?#[_GUUC_P$3_XNC_AISX??\^NL?\ @(G_ ,75
M#_AF3P1_S^:]_P"!,?\ \;H_X9D\$?\ /YKW_@3'_P#&Z7*NP[LTH_VGO 0P
ML=MK62> MHG)_P"^Z]OL;C[796]SY4L/G1K)Y4HPZ9&<,.Q'>O$?#'[.W@O2
?/$%AJ,<FK7,EI,LR17$Z-&S+R-P"#(R!QFO=:8C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ny20063534x3_ex99-1img01.jpg
<TEXT>
begin 644 ny20063534x3_ex99-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  C 0(# 2(  A$! Q$!_\0
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M*7_);-'_ .N5Q_Z*:OO:O@G]E+_DMFC_ /7*X_\ 135][4 %%%% 'YD>/?\
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MN5S7Q*UZY\+^ M<UNQCBDN;&V::-)02A(]<$&HJ052#A+9JQ4).$E);HY_\
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A7=VVC*MQ;R>;&S3RN%902#AF(.#SR*** /H>BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 22, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 22,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">STRIVE, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001920406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-1293236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">200 Crescent Ct<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dallas<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">855<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">427-7360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=asst_ClassACommonStock0001ParValuePerShareMember', window );">Class A Common Stock, $0.001 par value per share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ASST<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=asst_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember', window );">Variable Rate Series A Perpetual Preferred Stock, $0.001 par value per share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Variable Rate Series A Perpetual Preferred Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SATA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=asst_ClassACommonStock0001ParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=asst_ClassACommonStock0001ParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=asst_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=asst_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ny20063534x3_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://strive.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>asst-20260122.xsd</File>
    <File>asst-20260122_def.xml</File>
    <File>asst-20260122_lab.xml</File>
    <File>asst-20260122_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ny20063534x3_8k.htm">ny20063534x3_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ny20063534x3_8k.htm": {
   "nsprefix": "asst",
   "nsuri": "http://strive.com/20260122",
   "dts": {
    "schema": {
     "local": [
      "asst-20260122.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "asst-20260122_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "asst-20260122_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "asst-20260122_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ny20063534x3_8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 5,
    "http://xbrl.sec.gov/dei/2025": 5
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 36,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 27
   },
   "report": {
    "R1": {
     "role": "http://strive.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20260122to20260122",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20063534x3_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20260122to20260122",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20063534x3_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "asst_ClassACommonStock0001ParValuePerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://strive.com/20260122",
     "localname": "ClassACommonStock0001ParValuePerShareMember",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Common Stock, $0.001 par value per share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "asst_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://strive.com/20260122",
     "localname": "VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate Series A Perpetual Preferred Stock, $0.001 par value per share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://strive.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001140361-26-002005-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-26-002005-xbrl.zip
M4$L#!!0    ( #EK-ER =S%VZ@,  "<2   1    87-S="TR,#(V,#$R,BYX
M<V3-5]N.VS80?2_0?V#U+LFRXZ!KK#;8YH8%-LUB-PWZ%M#2V"9"D2I)[=I_
MWR$EVO*UEI6B?>/EG)G#X6@TO'ZS+#AY!J69%&F01(. @,ADSL0\#2H=4ITQ
M%KRY^?FGZU_"\",(4-1 3J8K\IN2-%<LGP-Y>/P\8QS(<!PE@RB)QJ/1J+4?
MAI:_U!.=+:"@Q% U!_,[+4"7-(,T6!A33N)8&\6>(<ID$0\'P]>#9#A$.1P*
M$.:#5,4[F-&*FS3XJZ*<S1CD 4']0D^6>FWDY>4E>AE%4LW1R"")__QT_^3<
M>BS5VIQV6>,X$]^WK"ZGBGN[H]AN3ZF&M80]?*,BN;JZBMWN&HJ&V G33&A#
M109M?+[1W :/XWK30W-@VS@-6327SS%NV!..UT"C0K,J01_6@=NQW;:<5^$@
M"4>)9V)6;!-G5$\=R>]L.=+*',.OMVH")@DA-DVH$-)0@RGIEIK%LF1B)IL5
M7+,1G?A;>(09<3&>6(-IH%E1<AM M[90,$L#>_&AO^5OI8((%7J(DAQ.7(G=
MCI&B,16=LON-8V^"JFS/REX.H!%9@C(,3[U)H?B''2N'6==C(84)]G\^%*?3
MKH=""O!_]SS6SA<\ ;&#/Q[O#A45I^6=S"I;PVY%_EX89E9WF,BJ<'D4$):G
MP4G$VJUWO+FPFP&6N,& A,1;: ^IR$EMCK3L7<>[1G;M5QKRS^+&C7=SOF$W
MD%/,C/*LXA<0M_/Q,*]9]5?@ZT2\4RCJA>UR8HL)9IQ4AHB]7U"[ELTI+9M2
M5O^X[F7FS-1H[4OL04X,W&B_8C-Y'"UU[I/HI(8C=?NDAEVX'?3PFLE*&+7J
MXKE-\9,^"BJEL!/I)J'-6<]ZB(!EMN@B8(UWHQZ.!669[N)Y0ZB'/7QKEG7Q
M[.%VT,WK;N6^JJNE@+EM,0^[WZ5QI;98H;43)L,P>=U?A^FLP5SB?SN<IE2=
MPN_Q;M3O MJ=YSD'=Q0["SW/'G]DCS]*+E;Q*E;V=WVF (>V;K%+_37$UT>G
MJ.]UT6=Z]03K^/QX'VN4>_Q=G)F^GUW3$Z&^S(2P+#D5U$BU^H#S\S^!MI7W
M&R.7?!'M%T*G&'E\'1_[ON@4FF,ODXN]][V>@\^P8V+^B>GF>E=(\[YV2M+@
M*U6,3CD\8C%] H4-\.T#J!(,OK@?\$L#_*?F3T9FWVWG^4#55\HK0,C3@BKX
M!,445-W2V@[^VX\Q5S\3UB_622X+RL2=@<+V?AB0:JJQRZUL.#XJ695IX)[8
M$X:0@ C&N161!D95"*>(5IBD?EYCL=]G,O]2NZI4TYP?B]-;CN>[?2N+0HKS
MP]&)]1^?VK7.=:K=_ U02P,$%     @ .6LV7$H:L&8Q!P  ED<  !4   !A
M<W-T+3(P,C8P,3(R7V1E9BYX;6S5G%USXC84AN\[T_] Z3483+-M,LONT&S2
M89K=,"'=?MQDA"U L[;%2"(A_[Z2D1)+EFSS$:^Y2<!Z?71>/9(MRS;O/V[B
MJ/4("44X&;;[W5Z[!9, ARA9#-MKV@$T0*C]\<.//[S_J=/Y R:0  ;#UNRY
M]3O!("0H7,#6Y.YVCB+8\L^Z_5ZWWST;# :9\DY'[!^AY-N%^#,#%+9XO0F]
MV% T;"\96UUXWM/34_=IT,5DX?F]7M_[Y_/--%C"&'100AE( MAN<?T%33?>
MX "P-.G,[IL9B52 @?=2EU,AOG64K",V=?I^9]#O;FC8EBF*X@J5*/DFIY>>
M^N?GYUY:^B+E@5!!Z(SM5,_Z+^*L\"S]%K(V;^16:]O,!$?P#LY;XO]?=^.7
M_2@CZ!%V QQ[HLC[A(-U#!,V2L*KA"'V/$[FF,1IR_)JTUCL>06';8KB5035
MMB6!\V$;4,IXJ_GO>GW?%VWV<W$\+Y,A((%*4G[,YOGB#R7,"U'L28T'HJ@\
M+T>+JH82H,_2=--H1\B*?X:)&$*=$,[!.F)'S-$2^[@9XQB@"K#W25B&/D:^
M::A.#.,9),=,5H][A$R7/"D2K&>P\](01\S7&CV;->\D*$%BO-WPKUK%<,-@
M$L)052W2W>_(D-:G:HQPH%43B2,S)GF#5#4;A4%W@1^]$"+NTC\3'\1Q1"*!
MZ&%;Y0VBC)^(*'<"QPS&5,6,P Q&PW:)BA<*@TZ5]^8V5"/>\XA&[K8BF;!>
MI&?YBG=$]'QY_U-Q9%?<<U3-"8[+VQ876GA-\Z+EB-1BN*5'P"2$1$Y"WI[-
MB%<<BLJO([ PX%C+I#6CK+EXBDQ4Y&.$D(#\>@"ISC&!!&%^$ H_\9FG8Q19
M-<9P,C3-!5?%U(X#S @E00[J!7F-: "B?R$@UWR+>3 O41DP<ZKFXRPVMB/0
M7#")])?O@73;N\JA6G16K)KN5,"ZS>V%5@LGX9[5 W>;XS6_H/^RSC:,-NO*
M%VO3K6QQ<PF66*D(+A]%\GI7)Z\[N.#)$9"P+R VSY-%$HV;*6DZNT)+._$S
M(TF&O];)\)(/?P*B,;]*V_P)GZT0'1J-8D[3=(S%IG;BF LE0?Y6)\AQ$F"R
MPB2]7)XR/NFZQ&N>U_,E#NUCL](>&N22/9J.?!?#.W6 DL"R.YS7V1WNP68<
M\GZ)YFB[:EUP8BW1:EW J6TZ_&HF=\+N#*F6%7IU$A^%(8&4RG\BW;Z5=H%.
M(VW5-9URN;F="%O#*;HUK1JY,O$KTO4KTO5/D:YI[D"Z_BO=FI:<7)D,*M(=
M5*0[.$6ZIKD#Z0Y>Z=:T#J5E<LD_WI)[_)04L<VK;&2SJA/AZC2V#]5L,,6T
MIH4H+8]TLG=+)@0_HNU]<R=8A]1&-R<]$<3%%O?AG(NH8->Z,*4ZW7927SAZ
M=8EUZ"K)B4"U6]IKT*I("F*MJU4RB0FF#$3_H97SNKA(: -J"$\$:Y&]?> :
M\13BFA:SQ/E@1""P0+4529]Z47/!%5BHB$J/H.#4M$ E'IR+)DN<V%?W7<72
M8;ZXN:!*K%2$E8^B@-6TA#2%P9KP[/K^[%YD;@!S%4N7^>+F BNQ4A%8/HIZ
M;J&F%:![ L3SL]/G>(8C@Y:U3/HSRIK+J<A$14A&"$6HIE6<+UBKW_($4(%"
M&K4JFLNLW%!%<M9 BE]-ZS1JB%]M@B5(%M!RQ[-(8AP:=4ES$5:PM.,A4H^D
M(-:Z'',50[+@"?Y!\!-;7N)X!1+[15VA4KL4<"B;2[:ZP9TN!AP!%>=:EVBN
M-ORPD= T]>VS+7;(3IE.V")K/-XR:[NQM4138&M:COF;'T(83'B_BM>)O.EF
M/@!6J)&^'9KF\JQBJB),1RA%LJ8UF2F.4(!$=I\!XYT)F--6MT"=2RV"Y@(L
MM5/U/&J)H]#5M-8R(5!T'I@$,'V27KSA06[G\]R%?;E0>B\2-A=I97L5T1;%
M4XAK6K$Q4AE3NH:D,FBGW([;(C\9Z&56]T-OB:HZ0*T/$:E<[\$LMPA4H-#F
M38;B+<EFWM3<<:)49&.G.9(12+WUD"X#L?Y%$&$*PV&;D37<;L )@QMV%:7<
MAVT*%^+#X8CG@,[21EK3S@* U98SC!A56UZ!RPT/Z<TV4?UE!"B]G4\9#KZ-
M-LB<897JU!G:K7O+;E#P.J2M6^C,<75[[HZ1ADS/UNY0QWSU;!_8V8P^:2_D
MJOLF3H&Z>V(1O.F!V_$"\19J.35<P5.6J3-B>D/%$ND$D3Z8#U!]1ZCZ>^P'
M4<W9.H#K@W_P:XCY7RT06[:\1N+$+YX:YA7V>KW^!)"O(%I#?H4]70("/T/+
M+;,]]LSRK;KG=YJ&%8Q2?(CW;"?(U_%"OVKL X>[HU-\!?RBCI\^[G@GG?(+
M/$A'O.(59&L0\6DBGPP2&.[66XX94C;E<4(VLG^]06N5=[SC5)H_3+WWC*;E
M<]9OXJ=QMMO%'_%3,A_^!U!+ P04    "  Y:S9<*LZ\T:$*  "];   %0
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MQ]B;J> !?H&O153$XN#-GOR4U_ZGVV4?(E\DN0A8D>ZS'[.4!UD43 1['R7
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MG;*;>E_:\1'>'HMY04<G,LO1,&ZV7F<IO=G.EWO*$DD[*[BJ<H5AE(.!P!;
M^$S6?KV#9VDTVZ31'+T1*X/5HQH4["UO=O>O3C,NFOJEY"C<."Y^+^%[G>FE
M&5;N[/K:JA8&GDR1,NY\6V+&9@0<C1KD1D_4(>XTZU!) ![9ALC U+.D?]VD
M(S/\^N$IO] GMZFX.%8T$@Y]Z82@[T&F$RV Q*+";9JU!(W<F51+FAX[24!0
M5G:&+PM&ZU/C,BR6+](4U >_0,N#]HEO(1.NJ790.W/K76;;U7*"O.:?U9[H
M*AN!.^JI01JJ(L?F[-=3$O$RGEV"DK7Q#D,\#F).':+/%8.E)5]WF%]GMG2J
MPR.74A%X:EZ4R /E*$G2*@>I2E(N(]P5)JY\8&B=UI<U%M#7[V64*1,*I U8
M[:AY8G[Y1.A__?'ZJ2QV('^ZL=7M:8!\U]V#RT2Y],Y,RG)-N5+"C<KC;387
M:I9=W1)XBZV(2YL0US^U8!=I(<.$N"OF@L<=FJ\$71H?>) +=J?J1AK=1E($
M_ :_<S3%L=LH:>[2(: Z2P-GLB^Y<\?#RA:@Y+#$C#R>7U*IQM9V;KBA"A'5
M 0BU(FY 1.DO-3,"H E;CP%)2C2UYR%GJS=E*Q;<N"U[)D15A:DX4XHSM+[T
MP9;&^MINF8Q<VL5^I3=URJ1D=<(FHK=5<(NDU-P#33-L8:D)S]:RX65GYI/9
MOD@[,T??XAF$[ZOZ[W'#JZ*C%,@BOJ_=F@TGNQ6G:U+\(RB7W>!5-;/5H3="
M]F?GRW4O:I#QE96S<JLW";%LXNV"?X;_O7J-VJ<0!([ 4W8O,_[UB5]OY#M-
MOWC'M=4SUPDMA9Q;'EX_6O=F]L?#\P.^T^E=?>;(@[U19..[V;XRZ>T<O.%L
MFN&9ULG",HR!W;>=*_N_XLKLFKUI,=LY,'N@6?C!TR7"1W^OXZ:S8=HGM-5[
MA=4);?IPN=;14'<Z?G4I]7>;PU;7;2S3=>:W5*O?-!N,1IH/<$?U"R,LO^ 4
MW-LSY=XV<FU$Q)(=[G4K_C)OJ<WI?T:"-0WGA1+KO=YT'C$FO8#V0,!QN:WJ
M'2\X2% PB7<Q!!T$*AJN$BXG21PE@OWZX]F'*LK\:._3?<D4/DZF\ $MQ_')
M/TX/SW\Y.Q[?5X"2+LI#7_>9/;BUB%PGI!NAHW7QIUMNY6\??8+OB@E*.KF8
MZ@HI,*K20_) /CQXIKDWD3(*8LKCL-HSC':):B8W^6.&#SOE93%-:7_Q;8+6
M+S&K2CCWGX1P!BD,/U9U]Y=IKZ<QIZ:E\V#6QS53O96.OF4_3QC@+2,-CTH*
M>_D>OB$%1-DER,58/&=R>$2TX:NT]U\0]P5U _BZUWUV-(U$".H:5#?9NA]Q
M'[[('MI\K0S-VD3\4IMOG976?M?9%[QA3']3GV_VO#18X"<X\?'!_P-02P,$
M%     @ .6LV7"#.SZ=LJ0  .YD# !8   !N>3(P,#8S-3,T>#-?97@Q+3$N
M:'1M['WY<]Q&EN;O$S'_ \;3GF5%@#(/4;(LCR-H67)KVX=6DK=G8V-C E6%
M(F&A@&H<I,I__>:[,E\F$G7PD-RVW#.V1%;AR'SYSN]][^O+;EE^\Z__DB1?
M7^;9'/]D_MP579E_\_47]%_^X;\='B8_%+.\:O-YTM5?)=\V=39OBOE%GKPH
MJJR:%5F9O*G+OBOJJJ5OX3_?U;-^F5==,FORK#/?[MNBNM#??_7ZYT51YLG)
MV8/CHP?'#\Y.3T_5!9[5JW537%QVR?&3)V?)87)R=/)(?__PD%[B"WZ+KZ?U
M?)U,+V9U63?_^=F_+_"?SY*V6Y?Y?WZVJ*ON<)$MBW+]5?(_WA;+O$U^RJ^3
MU_4RJ_['TP1_WQ:_Y5\EQT>K[FG2Y>^[PZPL+JJODC)?F)_@E;]*_OT(_WGZ
M&=U_7ES)<ETV256WE]G<W(__\%F"E_C/S\PB=GEC'^<RAW?[*GFX>C^X<#+-
M9N\NFKJOYH?AK_13T26?)LNLN2BJ0WC(KY*L[VK[HX9N0C^;ULT\-]>JZBKG
MAZ?'EV?2U\9OFD]]#>OBK>$U/_FT+N?F \_?7Q;3PNS2@^.OOX /?//UM)&+
M?Z$6!_Z8;/B=[/W8$_';[O!(Q^GIR5%JEBMY\]?SU\_?)#^_D$?[(KS3-__Q
M[\>/CIX.?['A$9+83?_W^>N7Y]_^\#QY??[V>?+F^>N7YL;GR:OGKU\]?_O+
M^0]&WI^_>/[Z]?/ODC=O?W[VM]O?42VFOYR_B\M]W7_SRT_?/7_]]]<OW[[\
MZ?OD_/O7SY__^/RGMU]_T=]V'T0X_V=6]5FS3DY.4E0/-[@L/OI5UA1999Z]
M769E>3C+5BV\0994V=)\YK?__FOY[N3XZ.3T[.SHU/SBB^R;;[-F5F;K-GF6
MK8K.*,&7U>S!C6[SS/RH;HPZ[7Z[R)NLG"?_D2U73XT"?)!&7NB\35[GJR9O
MS=IG77%EU%B]2+K+/&GS*_C^Z"+0OW^IC!*X;@JS<2V^WSPIJN3-[#*?]T8;
MOTRRKLO@;\EEWN1='7N&V1=ULN,"?//XX5GRQCQ9U5TFY^8_?1[Y$"CB_U,W
M[])$_F24\-'QDSTV])L?LGEA%B.KYLGWYFYE;LS/5[<4M%_[MBL6:U:[A5DZ
MV+[')RN0OC==8Y8_Q1=/D\P\^E4VSXPR;U9UDX%!3 Y@7_[CW[\\.3%WW*RV
MV #!K[]*8$&+&0A'O5QEU9K5%U[I^.DD359-O:I;\[I=;?:]+,UK)]G%19-?
M&&,+ N%TH#%#1EIN_RAO\EEOQ,:L<? T(G_\K/#CX\=/V^1_@[A/C4R]AF=Z
MDS>P/48CYLTJ[WHC,:^:?)$WC1&U-UT],YN_RIKD*BO[//G+T0.S_\DJ;^CY
MT^2Z, *4F8=&;R);&NO8P9W_8@3%?-9]-#FXS5O:9_K7?_'_9QT3>MAP#<P9
M@C4P*[W*9W L^1%;LSV=N55CGG[DG)DM["X+([EF^W+TF0[P[[=YC7.Y5O"<
ML1-Z9P?BYRH)-7*J)<,(:6769 ;O?)EUYFF3_#TL%XHQVA*S1N:/*W.PS#:7
MZZ3*+^JNP"W/W\\NL\HX?G:=6A**6=YTF5G;2[,<H-18'!\^.#D[^MS<NS)J
ML2M $-_D56%4[4]U9R1Q;L3LY.CTZ"Y.QK(TCZ[OA+<8R$C;]N9%INN$O_%F
M5IC7*!;%S&F1:_,:Y?JPOJ[,1]M^VA;S E;4/V2W$_+![4/]XL2]$5L#WOM?
MGAPEQH$N0;4Y;6-VR\0!*W.@W:F$1QU;%G/.^Z;MC=F#;;^^+&:7YD7-OV0#
MK^N^5/MMKE4THU>#LY5D*Z,0WQ=+$IHGIZ3YJOS:_(U7G=6@>;9 [=Q^_Y_+
MD[YMLJK-9A@+A0<O>0MGNEZ86\-2FC]7M8F.ZFI>P.?-T]2D0LR/VGZY) -B
M'M>X"@F\HMET8U?DI[A@LD3M@^0-_%V=C"9?PIDP O2K.6"D8XR+8 XQW-U<
M8&H.+_S1?2<%V^EV'F[HW\4<-_,LTUQ?=684@HF@C(#.RAI#//M*[;TJ&^6=
MO<X7)\=/SAX].CU]3-[9\0/M\FS^=^+]92@ X6YK[\N\9)K\/6O,OG?B?)R[
M3?#/+$L$/YJ1!W>:[2DSE[NFR]'%<'=:5)?WX\N</H)8UXL@\4>??7.0379?
M1'ZG<_,F%T7;L?N#QAHMFOG+B[I9)F\.3Y.#%P4>W@>)B?@/3YX<G9R=&)?&
M*)&R)Y$T 7 +>J5&8]J;16GR,D,5Q(*,YPA7J,U*='C$"K3630F67RDU=RO2
M4_*--+G,C*=43(R0YY5Y@-QX)*2QM>XU=S%";O3.LNC69(/(]O^C+QI_Z]VU
MD_,9:L;C)Z>GYJ29[34?G)N+WZ%C!O<8N(JP2/AXQNUH_2-N-JLO28PC#PQ?
MM*K-O/O2:-*[<FKY6J&%["#FZ"%">6JV0?8!TD1SM\[J4?"CD85^B@]OKH"7
MF-7+/,F-Q)!C9K_D%L+_MIS09_6*Q0CUX(AHXS$%YP;V$W_24>1DA,G<#=]@
MGI?FSA%1.C":?9G-C5-SE14E>LO=95/W%^&K6J_Z>6E>HZFK8I9\EW59\GT&
MMP-9/J^R<MT6$!^:R,0$(V7R9MV:I[R=L_#\N^_/7P<;-8%SN*[[I%^9M0#!
MS]L.A)K.@1^>WEI>@GAW)/SHMP6VMWX.'3J'YET48)OT+=T9?7AK#';6WO]V
M>,B9T5?91?Y3OYSFS6OS]MWGYL^?GWS^^>><^+P37<_&U*B\O77]K<*3U<K\
M <4=,K'^8B;+W+A1R>.O'AXEYS^JE, S4+>=^7P*]B0,-6(Y 3'J>V>V]E_
MV HFX7]N<0JM^C*G/KY@(-YS<,A1XYME@@-I#H?RL.,J+ 7_$KZ]K,TI;G)(
MZSG=N#(_/'3:<Z#FC.5>@ ),0=-FN#D-N+=S$'R,;ED/@AI.E1YVJE#4N3DU
MV6Q6-_/,!(G*L(KE\@S6J.X?E0/W3KCMLS)KV__\[-O7KU[ 4?NVR;-WY^9?
M-D<_*_.L@5WI+NVN=_5*"@3\$_-KXP'S#S_[1F<*1F]C;[$R/SF<PH\.LT4'
MV?FLO,[6;7"AL=H"7X6>!(L)R1$4%*Z+>7<)CW3TN>3]#_EG1@ZE]G"R9^U!
MK\=G00YWTV'B=&VX$J3;<,4C.7TJQ7P)"^V=D<JX75GIGQ+^V6??G$3S_(-#
M?U\J8)L6O94&^+XV'D0%)\\8]O.^NZR-S*^CF@ \6/ N%OD<,L*8+KPJL%B7
MTK%/D[*>P=^6O?$D('A/C<V$@Y5!M*E=92.5]C<7]AG@D%_H)\KDB5(YI35D
M+8R3/E\6%6L=T!\7>34S'_*^/+,Z(#5ZPSC='>FE:9TU<_.?W@A)G_)W4;]4
MYH(]?1OO.:O[QGS!.#[3OH*WR9II ?<T'X:'H+^9Z!6*A >K?FH6%7[!J:8)
M^YMFU=R[MWFY./1>YB*KBM]P,9["E\G!I,C</(:Q:"7$QD:@BE:B]\JF;DS
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M!:4BYE\O:^]2A8#(?H2],\["W:GYUUK7OA%=&]<9QI,O*>HJUZ0F (M0F^T
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MHO/'Y%"[_1R>;L;-P.6Y,,UZ^&ST0-Y9^!RK>IYC-79A_!%0(\;B[&.O &1
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M"\ZRN(L,^GMUC5$ KQY2&Z"ZQF9%[ ?<M#=D/4^FAR>Q!./]+MABKU.KLR$
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M8@[AK+E#TT.''31LN0E/ZA R&T$J) ?29>=FT'DDVVY0EWYTZ;Q:#%Z Z+\
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MITCM-X2,Z429I-D.@ID.%TW&1%9SR@[ PJPLII,^[?D6N[@4+$/4&(GN!-G
MO7P)MP2>?0PD\\/;;?]I[L<P^R+@&68+VQWMSV<L7+N5G2/6OKK/##5?_CSB
M9W5E<63=.@^@H3LI@8C$%US0S)F@7$!DHV\^G!GGZ2(.8RPLG .2<1=AH)6\
M(Q@[@?XD@GF=MPX>I64 '2,!!BC^)L$/I^(VB7JS1$X\:VQ*=7PKR)CE47O@
M(:XB8@Z->@RE\0X$-3904J6E%5LN"U=_IVX"T)5Y65(?Q*B1$07CGNN>)U2/
MCZB.#2\"A0ZVC7@4:*73T:9AP +AVB5!>^I8ET+MFA3R(28C%$0]4UH+I IU
M=SJ<FSJ2E>7:J?F8ZI80M.(*\?QM0DL6+,<N&>R?^AR4U(QD*P(I0M =]);:
MQ@<?B@6V6K5*R\4P+2&-!TC500\]S:IW3;_J9@C>;@%B6\T0XZ83_IC_AB:!
MHE]J_X"Z#.RT8LJ!UPXOS6?PPN*-<076\@,RH/BF*XLU_C UF-_^^Z_ENY/C
M)P^/3I^<G7 M9A:;M1J,.RM+MW4@(]TUB,DPU5(T<YJ]@_83X$EMJ0*@R*!-
M=-U&Y44K)5]B(KL=%YTNG-N]38XPP_?/(D+*%#C<>B93O:A>.L^7E6M(\]MQ
M!9:@=G?XKL(VP06+83<.0-&HDKJJS;_7!+>>VZG9R.FGLN'@"[D&)K0*?14L
M.17+MI85W *X;M2/F$V/'K4O'_)1FX\/O/0/W/Y3;"/N1Z<!Z&Q(4N,+%)VT
MZ$/S&?1O,?7A-#=WRC>4EY2TY7A H>;2I$':-5::0171S_G6-+C.GNP=[SY>
M,@S&QZHZH5?K<T6^G7.R!8%F;5P)0KE/T:M8&',)&@<KK#SWOER'B>JZ"2>Y
M2@7XIE4S@:+L4#.C^,&3CU1+1^IV3K^ZWD(66YH2;1[9*%,*D4._9</NH@3;
M[TYY-&V[JR+88ZE5W3= 5>U0C'OJQR 'I&;=0>/9Q7C"<O9Z</G2S6<P97'=
MLE\W/3J#AI+13E#J- E[);3)]KTMFWNIW9>>>C9(+8X.%7CHLN53W_L9F8"]
M58T9&X=->=TM;4W?_Y2+_;/F8H^/[BT9F\>&"D?Z#+3WC"&=,F2K&M.F#,:P
MKK'HEYGKB!\T:)/R@0;(5I*.'*II6#[Z<JGV[D"+F+<3N DRA0$_@<#_ZKD'
M=_$F"@"BJ"<'S_>WI0J3,]B_VH#F4J]/I)^S')*MJ!LIH2JE<E(!.)"7SG71
M2<4<OT,NA\"L%IZW$])+-OE5/;/U[*5YRX5K,,![0Z^3ZU%5/J=E=Z#>>;<G
M$?8(VA'R1XP-, ^PP91IKP,K:T89+K(K$TU G#//9P5-B6AZ(C'$OE!RR69;
M'(<=, 4?VD<V_SMC'WFQVWCI$7=YQV)")"?BI^)B]%))?5VE<BQ3X8(BT;R2
M[EPI'N"@3[^E2DX7YE#J)9AQ$S"!OX,.5Z:;RMA1, \^9W* O+D"43:Z^]WH
M+WP:!OD4+#9T?]>KM51!^-E;\B<J[^,M\DS"7_/9965T^@52(Q@YJ4PL8AX<
MXD6^)C@FAY?U-=4T< &@"ZZ$GIU>0TZLZWU@K$1)FJ%<WQX7_5+=#383;S)
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MOG-!CJ@5@AH<8WPH7;O>'2$ZJ(K%6T>]EK3;M8I ?MSL"B0X9@5.A'!@_+U
M;0/ID V&128SNXNWM(O7I29#[>U?^\X()IT\L75E"&]:AK]&*51CLM*QMK0M
MY3_M*^,"@K;'B>M3I)[,&W8K='&&4_P"S[A[6HY/&9X_4H;GY-XR/%6UFQ$.
MCQ3VUVN26*,L(<MO?(F6X%E$]0E]! 2;:FTD.1R,#2==1CMKMEZH[)!I&';^
M#&QXP$3O-I"=I(4)?0]!+[=Z!N^!^ /955W,I8-S7O?3+B@<F&]"H$%=5NP:
MV*<&_=%@KY^;1 TNI)W9XJC7"@XV\/>(.9@5*XJU4>D5K?,G"J>/=2S.O6'&
MV)1,4S=<O<GMF2S>&O7WO;W@8+H XHIR2>PK;%R0+B.+ZJ:+^J^()%:86^^%
MX!EBHBKG &V6\2CLR+S7#C4J8G(W;K+S?!51';O 1&]""98'CQ\?'1^4D\/3
M@^GDX&3BTHQ8O$&3VB9O&^0=MV-=8",_N%=W?/0E>W5UO=L1OJLFCQW*Q.@P
MP:^A]I\S]3,,JL;J;)Y#8]*J=%8WJ&80Z) PJ/0U.''&%S2[0,5FLP.EZJ]0
M->YEZNX>N0*%1_K+@RKZ3IP<T?KZ,K&0[Y B:"-=B*I!!U[6,,/B,9+@I%U,
M-X,%0]<&&D:-MP(=9V[29<L? O""PY0A.;8=RRVM:#PR05X :? 9X."4=8_?
M9$@@+&7=6A^>J%<6Y&_;98YH<.="CC F2:R];?#?+M[CSLG9<\+\E@RAO5MI
MP9QCM)'5ZS$<:0VZS$LG:I1Q0A%/'?D!1FZJ0U&2G-Z>TUZ?[[O7U$"R]U9O
M"!9@@[]5^ZLKND..LCO>:";X0\]EA#Q*08MT![1FJ=T^)E9\'?90X(2JDM2L
MGL/^R"@QS;'L2%X/%*( +E+WC"C@KL]I7Y1SV?[?ZHHB6._"WO7@[_@+#4TW
M+@UHHZ[VMM,\]\2*#U+>S8/@>E<(IW\DJ,-?6C+AC@K*02&U=B0#(LA;\3\Z
M&6?JQ)"IX8[U7$SL%1@7A77GV/8G3"@.&@HC=MCU,Y 7.MJN19P NGN!:1:@
MD]?K2Q#1HG2H;2A.;W JW"2&08<UG#J\AC0+^H\2/H:EY7,!=AK*5B _OR_A
M&+=^H92,<S)N.P\?WC\]%?]TM=JMZ/2!'%0DU&PXE1L@!<06>RI:Z:6MJ4Y0
MJD2C2T,J1>.FMH6&E"\-M!QT!AE!Z3@6,;)SV9LXR!C]K,1G@\SR(N]D!&IU
M531U)<MPF?V6-29J;0F=_;Z8(0M+1]X?9.%,8(3#!.NR[(EZG+.(&3!T(U&[
MWRMQF\CQN7LZLT(_F%4)HL>G4OH%KBQ14Y*&C6T-^>[+0K>3N*R=G1WJ$LJD
M@\1/4A9W^&R;^LF42^+U:>SJ" X;%VRSJKP_*21> U\)9X26!<^K!F.K1Y>Y
M[A*O29?J?EAETCR)QDH;_437,F*7,U'S-KE1O6=;!6B4#9K=/X6K91+9NME
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M^\5]-LU>(/3_^SH'SI%\_O_N][':=FL<-62O")- VZ??I:I'8U]GZJ;#@)V
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M1U^L"%T%GE_?8;*7F7N!TZF[KIMWV)70S,&;,[^L%QW]Z3HWMR2?S[6H\C*
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M#J)A&;V@#]%RD5Q)TK\W 6YIT3XA8"5(QO@5:LL=,L3&$4D>=BA @H3KJ5E
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MAF**%Q.N&.T/YB*3];R?.1)\?[6#@S^HHVC6>P 8.JV" ^&&LP U=R-I),=
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M2.X)\"_;B$R_?V$U@/U]"&6OO3!SO^D96^%OF>MB_^ 0 @:O;-W#</<8;Q2
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M =ALE^J*%=]B@#.+.AIWX4+<J_MP'Q[#)Z3.'Q6I\^7'0.J4NZ$\Y#\_#WG
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M).3$%R6:2Q'L4E<B%UB,+K )TH4Q;7T);]J7*UV)T.$0Y(5'RNF12 )T\3I
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M1/9J7"G>:P&W)HHG*=8E8V(-7UU;N !N%GI*>3P):*T!\YV;'/8RZCA6+V/
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M" DP.^:%2"#*>ITH!-XP8F?F=L[C0]96 3V$S+3*D%FZE&?26%+@K3@;,XU
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MYI=[D[.OZN$U@>\ 6T#31ES-, #V5,]A]A$,Y.,:9_C"3.8Q#A7K'+8W0XW
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M+Z,.>)<4Q8M M L )3#,3WNC/?I[C:4XYN^O<RY?(]#]Z4/Z;)C]Y\OWK]^
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M=')XJ";?#=Y#,W@P''@[1NG7[O^/V%UB3R<@)Q9<HXQ."G15E6N5>TJUCGB
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M<W0M,C R-C Q,C(N>'-D4$L! A0#%     @ .6LV7$H:L&8Q!P  ED<  !4
M             ( !&00  &%S<W0M,C R-C Q,C)?9&5F+GAM;%!+ 0(4 Q0
M   ( #EK-EPJSKS1H0H  +UL   5              "  7T+  !A<W-T+3(P
M,C8P,3(R7VQA8BYX;6Q02P$"% ,4    "  Y:S9<F,R& #0'  !:4   %0
M            @ %1%@  87-S="TR,#(V,#$R,E]P<F4N>&UL4$L! A0#%
M  @ .6LV7)(,F:X\(@  ML8  !,              ( !N!T  &YY,C P-C,U
M,S1X,U\X:RYH=&U02P$"% ,4    "  Y:S9<(,[/IVRI   [F0, %@
M        @ $E0   ;GDR,# V,S4S-'@S7V5X,2TQ+FAT;5!+ 0(4 Q0    (
M #EK-ESY!6AYD!X  /)^   7              "  <7I  !N>3(P,#8S-3,T
C>#-?97@Y.2TQ+FAT;5!+!08     !P ' -(!  "*" $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>ny20063534x3_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:asst="http://strive.com/20260122"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="asst-20260122.xsd" xlink:type="simple"/>
    <context id="c20260122to20260122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001920406</identifier>
        </entity>
        <period>
            <startDate>2026-01-22</startDate>
            <endDate>2026-01-22</endDate>
        </period>
    </context>
    <context id="c20260122to20260122_StatementClassOfStockAxis_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001920406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">asst:VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-22</startDate>
            <endDate>2026-01-22</endDate>
        </period>
    </context>
    <context id="c20260122to20260122_StatementClassOfStockAxis_ClassACommonStock0001ParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001920406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">asst:ClassACommonStock0001ParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-22</startDate>
            <endDate>2026-01-22</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20260122to20260122"
      id="Fact_22c7004511a34a66ab3d6b9048af361a">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20260122to20260122"
      id="Fact_358e7cdac84e415d86e5d5d4b7934f1a">0001920406</dei:EntityCentralIndexKey>
    <dei:EntityAddressStateOrProvince
      contextRef="c20260122to20260122"
      id="Fact_80deb7176f0f47178894d59ecea12264">TX</dei:EntityAddressStateOrProvince>
    <dei:SecurityExchangeName
      contextRef="c20260122to20260122_StatementClassOfStockAxis_ClassACommonStock0001ParValuePerShareMember"
      id="Fact_24b6ab989cd84664b903375412b82790">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="c20260122to20260122_StatementClassOfStockAxis_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember"
      id="Fact_14bd3851600745a9943ce5bd50bf8f37">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20260122to20260122"
      id="Fact_c315a1d0e4bc41b0b926f684ab6026c3">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20260122to20260122"
      id="Fact_df120e472c91452f9dbd4aae818a98a4">2026-01-22</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20260122to20260122"
      id="Fact_b8287a6aba0b467dbced28b6b9278476">STRIVE, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20260122to20260122"
      id="Fact_49b487f7ab844947af08c7a6a5f2579b">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20260122to20260122"
      id="Fact_ec4955b7dbc949da98deee6a74566c5c">001-41612</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20260122to20260122"
      id="Fact_85533a8a2e6f430595002a733ee65754">88-1293236</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20260122to20260122"
      id="Fact_63f10eccc74446bf8e6c17776034c873">200 Crescent Ct</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20260122to20260122"
      id="Fact_cc577476b6b24626a2043648da48ed08">Suite 1400</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20260122to20260122"
      id="Fact_6c60f85d359b44c1aea70e544af6535e">Dallas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="c20260122to20260122"
      id="Fact_ed3508ea180741b99e64425e27541513">75201</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20260122to20260122"
      id="Fact_140592797eff4b99ab312b5683ff66db">855</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20260122to20260122"
      id="Fact_d313a6e2805642a891cdf982d39e7dfd">427-7360</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20260122to20260122"
      id="Fact_c2ae78445c6148f69c8a1d237ee62956">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20260122to20260122"
      id="Fact_3f066cae1b5548939ab67a67431751f8">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20260122to20260122"
      id="Fact_3d2f2f4b74084ef99ba084013a18585a">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20260122to20260122"
      id="Fact_3341b649c51a421cb6b0973ee3713d41">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20260122to20260122_StatementClassOfStockAxis_ClassACommonStock0001ParValuePerShareMember"
      id="Fact_6c3188cea9a24333a7b56dcd7ceeaf27">Class A Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20260122to20260122_StatementClassOfStockAxis_ClassACommonStock0001ParValuePerShareMember"
      id="Fact_786ffee9e8dd437aac328021fd8f578e">ASST</dei:TradingSymbol>
    <dei:Security12bTitle
      contextRef="c20260122to20260122_StatementClassOfStockAxis_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember"
      id="Fact_d7adc930e2bc4018ab12cff9960f7b0f">Variable Rate Series A Perpetual Preferred Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20260122to20260122_StatementClassOfStockAxis_VariableRateSeriesAPerpetualPreferredStock0001ParValuePerShareMember"
      id="Fact_1c3e24aeea304ccea0f6cd10c1ec1cd3">SATA</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20260122to20260122"
      id="Fact_0e2a3374d6b34194b351a4cc342bcacd">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="c20260122to20260122"
      id="Fact_f177263797de45debb9e82a8c02672ca">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
